https://pre.almirall.com 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/companyia 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/companyia/sobre-nosaltres 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/companyia/proveidors 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/companyia/proposit 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/pacients 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/companyia/ubicacions 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/companyia/sostenibilitat/persones 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/companyia/sostenibilitat/principis 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/pacients/benestar-psicologic 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/patients/commitment/campaigns 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/companyia/sostenibilitat/planeta 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/companyia/sostenibilitat 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/companyia/sostenibilitat/pacients 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/companyia/sostenibilitat/socis 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/pacients/histories 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/patients/commitment/campaigns/sanctuary-salon 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/innovacio/assaigs-clinics 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/innovacio/colaboracio-rd 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/innovacio/collaboracions 2026-09-04T15:08:04+00:00 weekly 1 https://pre.almirall.com/dermatologia 2026-09-04T15:08:16+00:00 weekly 1 https://pre.almirall.com/innovacio 2026-09-04T15:08:16+00:00 weekly 1 https://pre.almirall.com/innovacio/pipeline 2026-09-04T15:08:16+00:00 weekly 1 https://pre.almirall.com/premsa-mitjans/sala-de-premsa 2026-09-04T15:08:16+00:00 weekly 1 https://pre.almirall.com/pacients/compromis 2026-09-07T10:41:07+00:00 weekly 1 https://pre.almirall.com/companyia/integritat 2026-09-04T15:08:16+00:00 weekly 1 https://pre.almirall.com/companyia/faq 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/companyia/faq/tractaments 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/companyia/faq/patologia 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/companyia/faq/arees-terapeutiques 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/companyia/historia 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/contacte/comunicar-efecte-advers 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/politiques-consell 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/premsa-mitjans/contacte 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/news-media/event-calendar 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/premsa-mitjans 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/contacte/mitjans 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/contacte/inversors 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/contacte/recerca-desenvolupament 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/contacte/persones-cultura 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/contacte/socis 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/contacte/informacio-medica 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/contacte/ajuda-a-millorar 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/noticies-mitjans/recursos-mitjans 2026-09-04T15:08:27+00:00 weekly 1 https://pre.almirall.com/patients/commitment/campaigns/sanctuary-salon/patients 2026-09-04T15:08:37+00:00 weekly 1 https://pre.almirall.com/termes-condicions 2026-09-04T15:08:37+00:00 weekly 1 https://pre.almirall.com/companyia/sostenibilitat/transparencia 2026-09-08T15:43:24+00:00 weekly 1 https://pre.almirall.com/politica-privacitat-global-esdeveniments 2026-09-04T15:08:37+00:00 weekly 1 https://pre.almirall.com/politica-privacitat 2026-09-04T15:08:37+00:00 weekly 1 https://pre.almirall.com/politica-privacitat-hcp 2026-09-04T15:08:37+00:00 weekly 1 https://pre.almirall.com/politica-accessibilitat 2026-09-04T15:08:37+00:00 weekly 1 https://pre.almirall.com/politica-cookies 2026-09-04T15:08:37+00:00 weekly 1 https://pre.almirall.com/termes-us 2026-09-04T15:08:37+00:00 weekly 1 https://pre.almirall.com/seguretat-medicaments 2026-09-04T15:08:37+00:00 weekly 1 https://pre.almirall.com/company/sustainability/other-relevant-documentation 2026-09-04T15:08:37+00:00 weekly 1 https://pre.almirall.com/contacte 2026-09-04T15:08:37+00:00 weekly 1 https://pre.almirall.com/avis-privacitat-professional 2026-09-04T15:08:37+00:00 weekly 1 https://pre.almirall.com/professionals-sanitaris/tractaments 2026-09-07T11:14:08+00:00 weekly 1 https://pre.almirall.com/professionals-sanitaris 2026-09-07T11:11:30+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-recognized-top-employer-spain-and-germany 2026-04-15T08:53:51+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-meets-2025-guidance-delivering-124-net-sales-growth-and-continued 2026-04-27T09:31:34+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/women-advancing-science 2026-04-09T09:46:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/impulsant-la-dermatologia-medica-innovacio-traves-de-collaboracions-la-xina 2026-06-28T07:55:05+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/uncommon-nature-thinking-pensar-de-manera-diferent-donar-forma-al-futur-de-la 2026-06-04T15:14:28+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/skin-academy-impulsant-lintercanvi-cientific-i-latencio-holistica-en 2026-06-04T15:14:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-meets-guidance-2025-delivering-124-net-sales-growth-and-further 2026-04-22T14:31:40+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-approval-seysarar-china-treatment-moderate-severe-acne 2026-04-15T08:46:10+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-lumine-phase-iii-clinical-study-assessing-efficacy 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-presents-rd-pipeline-advances-supported-sustained-growth-and 2026-04-15T08:59:33+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-immunoskin-gathers-leading-experts-advance-science-and-treatment 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-continues-its-sustained-growth-trajectory-9m-2025-delivering-128-net 2026-04-15T11:42:19+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-presents-long-term-results-first-real-world-dermatology-study-using 2026-04-15T08:46:12+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/eadv-2025-almirall-advances-skin-science-and-leads-innovation-holistic-patient 2026-04-15T08:46:12+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-absci-expand-ai-drug-creation-collaboration-adding-second 2026-04-15T08:46:13+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-h1-2025-results-almirall-continues-deliver-its-long-term-growth 2026-04-15T11:44:35+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-shows-efficacy-biologics-real-world-evidence-and-new-patient-centric 2026-04-15T08:46:13+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-leads-paradigm-shift-holistic-patient-care-dermatology-applying-who-5 2026-04-15T08:46:13+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-delivers-strong-start-2025-growing-q1-overall-sales-15-and-234-its 2026-04-15T11:44:49+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-biofrontera-launch-hats-challenge-raise-awareness-and-support 2026-04-15T08:46:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-16th-skin-academy-brings-together-leading-experts-advance-skin 2026-04-15T08:46:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-cfo-transition-plan-and-appoints-jon-u-garay-alonso-cfo 2026-04-15T08:46:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-surpassed-guidance-2024-entering-era-sustained-growth-and-further 2026-04-15T11:45:04+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-jpmorgan-conference-entering-new-era-sustained-growth 2026-04-15T08:46:16+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-almirall-innovation-hub-hive-creating-novel-collaborative 2026-04-15T08:46:16+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-nine-month-2024-results-almirall-reports-strong-performance-q3-2024 2026-04-15T11:45:23+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-campaign-me-my-inner-circle-acknowledge-vital-role-friends 2026-04-15T09:00:33+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-2024-immunoskin-conference-hosts-leading-experts-inflammatory-skin 2026-04-15T08:46:17+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-completion-decentralized-regulatory-approval-procedure 2026-04-15T08:46:19+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/new-data-show-almiralls-ebglyssr-lebrikizumab-provided-sustained-disease 2026-04-15T08:46:19+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/33rd-congress-european-academy-dermatology-and-venereology-eadv 2026-04-15T08:46:19+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/14th-september-world-atopic-eczema-day 2026-04-15T08:46:20+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-h1-2024-results 2026-04-15T08:46:20+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/nice-recommends-ebglyss-lebrikizumab-use-moderate-severe-atopic-dermatitis-nhs 2026-04-15T08:46:20+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-act4impact-its-updated-sustainability-strategy-setting 2026-04-15T08:46:21+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-ilumetrir-tildrakizumab-demonstrates-high-rates-skin-clearance-and 2026-04-15T08:46:21+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/fda-approves-almiralls-klisyrir-tirbanibulin-treatment-actinic-keratosis 2026-04-15T08:46:21+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/ebglyssr-lebrikizumab-ranked-number-one-interleukin-inhibitors-severe-atopic 2026-04-15T08:46:21+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/may-24th-actinic-keratosis-ak-global-day 2026-04-15T08:46:22+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-q1-2024-results-almirall-delivers-strong-start-2024-q1-net-sales 2026-04-15T11:45:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-eloxx-pharmaceuticals-enter-exclusive-agreement-license-zkn-013 2026-04-15T10:32:19+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-licenses-anti-il-21-monoclonal-antibody-novo-nordisk-develop-it-first 2026-04-15T08:46:24+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-receives-rating-cdp-its-contributions-fight-against-climate-change 2026-04-15T08:46:24+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-partnership-centre-genomic-regulation-crg-identify 2026-04-15T08:46:24+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-microsoft-announce-partnership-digital-transformation-enable 2026-04-15T08:46:24+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-initiates-first-phase-i-clinical-study-alm223-interleukin-2-mutant 2026-04-15T08:46:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-participate-42nd-annual-jp-morgan-healthcare-conference 2026-04-15T08:46:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-etherna-enter-multi-target-alliance-develop-mrna-based-therapies 2026-04-15T08:46:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-barcelona-supercomputing-center-bsc-and-nostrum-biodiscovery 2026-04-15T08:46:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-receives-european-commission-approval-ebglyssr-lebrikizumab-moderate 2026-04-15T08:46:28+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-absci-announce-ai-drug-discovery-partnership-rapidly-develop-novel 2026-04-15T08:46:28+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-achieves-net-sales-growth-64-driven-strong-european-dermatology 2026-04-15T11:47:05+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/psoriasis-was-found-impact-wellbeing-similar-level-breast-cancer 2026-04-15T08:46:29+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-opens-new-call-proposals-better-understand-key-pathological-mechanisms 2026-04-15T08:46:29+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-nearly-80-patients-moderate-severe-atopic-dermatitis-maintained-clear 2026-04-15T08:46:29+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-lebrikizumab-improves-signs-and-symptoms-moderate-severe-atopic 2026-04-15T08:46:30+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/epimab-biotherapeutics-and-almirall-announce-bispecific-antibody-license 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-ilumetrir-tildrakizumab-significantly-improves-wellbeing-patients-and 2026-04-15T08:46:30+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/centrient-pharmaceuticals-joins-almiralls-growing-innovation-hub-barcelona 2026-04-15T08:46:30+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/ebglyssr-lebrikizumab-receives-positive-chmp-opinion-moderate-severe-atopic 2026-04-15T08:46:32+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/moving-ahead-almirall-message-raise-awareness-about-atopic-eczema 2026-04-15T08:46:32+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-achieves-net-sales-growth-7-eu4661mm-driven-strong-growth-european 2026-04-15T11:46:45+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/science-based-targets-initiative-sbti-validates-almiralls-2030-emission 2026-04-15T08:46:33+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-ilumetrir-tildrakizumab-significantly-improved-wellbeing-patients 2026-04-15T08:46:33+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-pricing-and-closing-its-eu200mm-non-pre-emptive-share 2026-04-15T08:46:33+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-launch-eu200mm-non-pre-emptive-share-capital-increase 2026-04-15T08:46:34+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-nina-first-series-highlight-major-impact-psoriasis-patients 2026-04-15T08:46:34+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-centre-genomic-regulation-crg-collaborate-develop-and-characterize 2026-04-15T08:46:34+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/85-people-unaware-actinic-keratosis-most-common-pre-cancerous-skin-condition 2026-04-15T08:46:34+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-net-sales-reach-eu-232mm-and-increase-6-boosted-solid-european 2026-04-15T11:46:32+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-73-atopic-dermatitis-patients-taking-lebrikizumab-had-improved-or 2026-04-15T08:46:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-first-assess-wellbeing-dermatology-clinical-study 2026-04-15T08:46:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-new-england-journal-medicine-nejm-and-british-journal-dermatology-bjd 2026-04-15T08:46:37+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-opens-doors-its-rd-centre-biotech-zeclinics 2026-04-15T08:59:24+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-full-year-2022-results-almirall-closes-2022-core-net-sales-growth-66 2026-04-15T11:46:19+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-participate-41st-annual-jp-morgan-healthcare-conference 2026-04-15T08:46:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-appoints-mercedes-diz-vp-corporate-strategy 2026-04-15T08:46:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-joins-facilitate-patient-driven-innovative-medicines-initiative-imi 2026-04-15T08:46:40+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-nine-month-2022-results-almirall-achieves-core-net-sales-eu6338-mm 2026-04-15T08:46:40+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-opens-new-subsidiary-czech-republic-and-slovakia 2026-04-15T08:46:40+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-chairman-carlos-gallardo-appointed-interim-ceo 2026-04-15T08:46:40+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-shedding-light-psoriasis-campaign-exposes-impact-disease-mental 2026-04-15T08:46:41+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-ema-acceptance-filing-marketing-authorization-application 2026-04-15T08:46:41+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-partners-chemical-institute-sarria-iqs-bring-pharmacy-students 2026-04-15T08:46:41+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-simcere-enter-licensing-agreement-il-2-mu-fc 2026-04-15T08:46:41+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-initiation-phase-i-study-anti-il-1rap-first-class-monoclonal 2026-04-15T08:46:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-lebrikizumab-dosed-every-four-weeks-maintained-durable-skin-clearance 2026-04-15T08:46:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-lebrikizumabs-52-week-late-breaking-data-will-be-presented-31st 2026-04-15T08:46:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-h1-2022-results 2026-04-15T08:46:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-new-call-find-innovative-therapies-skin-diseases 2026-04-15T08:46:44+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/happify-health-and-almirall-go-live-digital-solution-support-psoriasis-patients 2026-04-15T08:46:44+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-eight-out-ten-patients-maintained-skin-clearance-one-year-lebrikizumab 2026-04-15T08:46:44+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-initiates-decentralised-procedure-europe-treatment-mild-moderate 2026-04-15T08:46:44+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-innovative-wynzorar-cream-denmark-treatment-mild-moderate 2026-04-15T08:46:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-actinic-keratosis-ak-global-day-during-skin-cancer-awareness 2026-04-15T08:46:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-happify-health-go-live-digital-therapeutics-support-psoriasis 2026-04-15T08:46:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-evotec-enter-multi-target-alliance-medical-dermatology 2026-04-15T08:46:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-inserm-transfert-enter-licensing-and-research-collaboration 2026-04-15T08:46:47+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-delivers-good-business-performance-q1-and-reiterates-full-year-2022 2026-04-15T12:14:57+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/carlos-gallardo-asume-la-presidencia-de-almirall 2026-04-15T08:46:47+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-lebrikizumab-combined-topical-corticosteroids-showed-significant 2026-04-15T08:46:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-new-research-collaboration-university-dundee-develop 2026-04-15T08:46:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-majority-patients-treated-lebrikizumab-achieved-skin-clearance-pivotal 2026-04-15T08:46:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-collaboration-university-michigan-gain-understanding-disease 2026-04-15T08:46:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/dr-jorge-gallardo-ballart-announces-his-intention-retire-his-positions 2026-04-15T08:46:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-full-year-2021-results 2026-04-15T08:46:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-multi-target-licensing-agreement-ablexis-and-collaboration 2026-04-15T08:46:52+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-irb-barcelona-announce-research-collaboration-discover-novel 2026-04-15T08:46:52+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-lebrikizumab-demonstrated-significant-skin-improvement-and-itch-relief 2026-04-15T08:46:52+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/hoy-si-me-puedo-levantar-campaign-support-people-living-multiple-sclerosis-ms 2026-04-15T08:46:52+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/ichnos-sciences-and-almirall-enter-licensing-agreement-first-class-il-1rap 2026-04-15T08:46:53+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-delivers-solid-nine-months-2021-results-and-tightens-its-upgraded 2026-04-15T08:46:53+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-shedding-light-psoriasis-campaign-raise-awareness-world 2026-04-15T08:46:53+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-roadmap-more-sustainable-future 2026-04-15T08:46:55+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/experts-highlight-need-focus-psoriasis-patients-wellbeing-clinical-practice 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-klisyrirvtirbanibulin-treatment-actinic-keratosis-europe 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-pricing-eu300-million-issuance-senior-notes-due-2026 2026-04-15T08:46:55+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/lebrikizumab-significantly-improved-skin-clearance-and-itch-people-moderate 2026-04-15T08:46:56+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-delivers-robust-h1-performance-and-increases-full-year-guidance 2026-04-15T08:46:56+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-receives-european-commission-approval-klisyrir-v-tirbanibulin 2026-04-15T10:48:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-mc2-therapeutics-announce-completion-decentralized-procedure 2026-04-15T08:46:56+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-new-call-establish-partnerships-innovative-therapies-skin 2026-04-15T08:46:58+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-kaken-pharmaceutical-enter-license-and-distribution-agreement 2026-04-15T08:46:58+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-joins-biomap-new-partner-advance-field-inflammatory-skin-conditions 2026-04-15T08:46:58+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-appoints-dr-karl-ziegelbauer-chief-scientific-officer 2026-04-15T08:46:58+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-receives-fda-approval-produce-seysara-r-sarecycline-sant-andreu-de-la 2026-04-15T08:46:59+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-receives-positive-chmp-opinion-klisyrirv-tirbanibulin-innovative 2026-04-15T08:46:59+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-solid-core-business-q1-performance-boosted-growth-drivers-momentum 2026-04-15T08:46:59+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-proposes-ruud-dobber-new-member-its-board-directors 2026-04-15T08:46:59+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-receives-qualification-excellent-profarma-2020-program 2026-04-15T08:47:01+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-2020-full-year-results 2026-04-15T08:47:01+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-mc2-therapeutics-enter-license-collaboration-and-commercialization 2026-04-15T08:47:01+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-new-england-journal-medicine-publication-phase-iii-data 2026-04-15T08:47:01+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-new-publication-british-journal-dermatology-ilumetrirv 2026-04-15T08:47:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-gianfranco-nazzi-new-ceo 2026-04-15T08:47:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-happify-health-enter-strategic-partnership-develop-evidence 2026-04-15T08:47:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/cdp-recognizes-almirall-its-commitment-fight-against-climate-change 2026-04-15T08:47:03+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-tyris-therapeutics-enter-strategic-partnership-develop-next 2026-04-15T08:47:03+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-fda-approval-klisyrir-tirbanibulin-new-innovative-topical 2026-04-15T08:47:03+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-has-selected-six-digital-health-start-ups-join-second-harvest-digital 2026-04-15T08:47:04+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-collaborations-university-south-australia-and-fundacio 2026-04-15T08:47:04+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/popit-and-almirall-start-offering-new-support-tool-help-psoriasis-patients 2026-04-15T08:47:04+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/pablo-alvarez-appointed-president-and-gm-almirall-us 2026-04-15T08:47:06+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-demonstrates-resilient-performance-year-date-despite-covid-19-impacts 2026-04-15T08:47:06+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/board-directors-nominates-carlos-gallardo-vice-president-board 2026-04-15T08:47:06+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/first-complete-dataset-il-23p19-class-demonstrates-ilumetrirv-tildrakizumab 2026-04-15T08:47:06+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-its-second-innovation-initiative-dermatology-focused-digital 2026-04-15T08:47:07+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-approval-reimbursed-price-ilumetrirtildrakizumab-france 2026-04-15T08:47:07+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-university-dundee-announce-multi-target-research-collaboration 2026-04-15T08:47:07+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/ceo-peter-guenter-leave-almirall-31122020-pursue-new-opportunities 2026-04-15T08:47:08+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sustained-performance-key-growth-drivers-and-excellent-progress-pipeline-h1 2026-04-15T08:47:08+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-calls-collaborative-innovation-advance-new-treatments-skin-diseases 2026-04-15T08:47:08+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-joins-amr-action-fund-support-fight-against-antimicrobial-resistance 2026-04-15T08:47:10+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-enters-ibex-35 2026-04-15T08:47:10+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-e-ms-experts-summit-season-2020 2026-04-15T08:47:10+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-uc3m-and-medina-foundation-research-new-treatments-rare-genetic 2026-04-15T08:47:11+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/solid-q1-2020-performance 2026-04-15T08:47:11+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-ensure-business-continuity-all-drugs-essential-patients 2026-04-15T08:47:11+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announcement 2026-04-15T08:47:12+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-fda-acceptance-filing-us-new-drug-application-nda 2026-04-15T08:47:12+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-ema-acceptance-filing-marketing-authorization-application-0 2026-04-15T08:47:12+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-full-year-2019-results-strong-operational-performance-excellent 2026-04-15T08:47:12+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-paratek-enter-license-agreement-seysarar-china 2026-04-15T08:47:14+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-partners-plug-and-play-accelerate-digital-innovation-dermatology 2026-04-15T12:17:03+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-participate-jp-morgan-healthcare-conference-san-francisco 2026-04-15T08:47:16+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-signs-strategic-agreement-23andme-license-rights-bispecific-monoclonal 2026-04-15T08:47:16+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-wuxi-biologics-sign-strategic-collaboration-agreement-multiple 2026-04-15T08:47:16+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-enters-option-agreement-acquire-bioniz-therapeutics-and-establish 2026-04-15T08:47:16+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirallshare-responsible-50-private-public-collaborations-almirall 2026-04-15T08:47:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-iktos-announce-research-collaboration-artificial-intelligence-new 2026-04-15T08:47:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/volker-koscielny-new-chief-medical-officer-and-new-member-management-board 2026-04-15T08:47:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-accelerator-digital-garden-drive-digital-innovation 2026-04-15T08:47:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/majority-shareholders-almirall-give-mandate-increase-free-float 2026-04-15T08:47:20+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-llc-announces-publication-long-term-safety-data-use-seysarar 2026-04-15T08:47:20+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-9m-2019-business-results-continued-good-business-momentum-driven 2026-04-15T08:47:20+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/duaklirr-will-be-available-united-states-21st-october 2026-04-15T08:47:20+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/tildrakizumab-confirms-its-long-term-efficacy-and-safety-longest-il23p19-data 2026-04-15T08:47:22+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-initiation-phase-3-program-evaluating-lebrikizumab-patients 2026-04-15T08:47:22+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-takes-leap-dermatology-digital-health-innovation 2026-04-15T08:47:22+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-cfo-leadership-transition-mike-mcclellan-join-almirall 2026-04-15T08:47:22+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/scottish-medicines-consortium-smc-provisionally-approves-almiralls-ilumetrirv 2026-04-15T08:47:24+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-h1-2019-continued-strong-business-momentum-while-reinforcing-pipeline 2026-04-15T08:47:24+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-calls-partners-develop-new-immune-dermatology-therapies 2026-04-15T08:47:24+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-revalidates-its-excellence-occupational-health-and-safety-environment 2026-04-15T08:47:24+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-exercises-its-option-dermira-license-rights-lebrikizumab-europe-atopic 2026-04-15T08:47:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/investment-plan-europe-eib-finances-almiralls-research-new-skin-disease 2026-04-15T08:47:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-q1-2019-strong-operating-performance 2026-04-15T08:47:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/nice-publishes-final-recommendation-almiralls-ilumetrirv-tildrakizumab-cost 2026-04-15T08:47:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-recognized-distinguished-corporate-leader-american-skin-association 2026-04-15T08:48:25+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/fda-approves-duaklirr-new-drug-application-chronic-obstructive-pulmonary 2026-04-15T08:48:25+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-hitgen-will-develop-novel-oral-compounds-atopic-dermatitis 2026-04-15T08:48:25+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/nice-provisionally-approves-almiralls-ilumetrirv-tildrakizumab-cost-effective 2026-04-15T08:48:25+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-late-breaking-oral-presentation-kx2-391-ointment-two-phase 2026-04-15T10:50:11+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-nuevolution-partnership-achieves-first-collaboration-milestone 2026-04-15T08:48:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-full-year-2018-results 2026-04-15T08:48:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-dermira-enter-option-and-license-agreement-european-rights 2026-04-15T08:48:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirallshare-successful-platform-find-innovative-solutions-medical-dermatology 2026-04-15T08:48:28+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-late-breaking-oral-presentation-kx2-391-ointment-two-phase-0 2026-04-15T08:48:28+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/novel-oral-antibiotic-treatment-seysaratm-sarecycline-now-available-us 2026-04-15T08:48:28+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/francesca-domenech-wuttke-new-chief-digital-officer-and-new-member-management 2026-04-15T08:48:29+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-sa-present-jp-morgan-healthcare-conference-san-francisco 2026-04-15T08:48:29+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-successful-pricing-eu250-mm-offering-senior-unsecured 2026-04-15T08:48:29+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-refinance-us-medical-dermatology-acquisition 2026-04-15T08:48:29+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-ilumetrir-germany-moderate-severe-chronic-plaque-psoriasis 2026-04-15T08:48:31+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-9m-2018-business-results-strong-business-momentum 2026-04-15T08:48:31+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/fda-approves-seysaratm-new-chemical-entity-moderate-severe-acne 2026-04-15T08:48:31+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-closes-agreement-allergan-and-acquires-its-us-medical-dermatology 2026-04-15T08:48:32+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/european-commission-approves-almiralls-ilumetrir-tildrakizumab-moderate-severe 2026-04-15T08:48:32+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/transformational-transaction-almirall-acquire-us-medical-dermatology-portfolio 2026-04-15T08:48:32+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/strong-h1-2018-business-results-upgrading-ebitda-guidance 2026-04-15T08:48:34+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-receives-positive-chmp-opinion-new-anti-il23-tildrakizumab-treatment 2026-04-15T08:48:34+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-both-phase-iii-trials-kx2-391-actinic-keratosis-achieved 2026-04-15T08:48:34+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-seeks-new-compounds-improve-skin-health 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/thermi-announces-settlement-patent-infringement-litigation-viveve 2026-04-15T08:48:35+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-q1-2018-encouraging-financial-results 2026-04-15T08:48:35+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-full-year-2017-results 2026-04-15T08:48:35+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/thermi-and-sinclair-terminate-their-collaboration-silhouette-instalift-tm 2026-04-15T10:50:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-athenex-announce-strategic-partnership-treatment-actinic-keratosis 2026-04-15T08:48:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/phase-iv-ascent-trial-shows-tudorza-reduces-copd-exacerbations-and-demonstrates 2026-04-15T08:48:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-q3-results-2017 2026-04-15T08:48:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/new-randomized-controlled-study-confirms-efficacy-and-tolerability-profile 2026-04-15T08:48:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-skilarencer-europe-moderate-severe-chronic-plaque-psoriasis 2026-04-15T08:48:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-renews-its-corporate-identity-aligned-its-focus-skin-health 2026-04-15T08:48:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/phase-iii-amplify-study-shows-duaklir-significantly-improves-lung-function 2026-04-15T08:48:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-appoints-peter-guenter-new-ceo 2026-04-15T08:48:40+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-h1-results-2017-reiterating-recent-guidance 2026-04-15T08:48:40+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-collaborates-icmab-csic-and-leitat-technology-center-nanomedicine 2026-04-15T08:48:40+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-guidance-update-2017 2026-04-15T08:48:40+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/international-experts-elaborate-consensus-effects-present-and-potential-medical 2026-04-15T08:48:41+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-q1-results-2017-driven-dermatology-europe 2026-04-15T08:48:41+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/data-tildrakizumab-clinical-development-program-presented-2017-american-academy 2026-04-15T08:48:41+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-full-year-2016-results-strong-dermatology-results-and-promising 2026-04-15T08:48:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-y-mercachem-anuncian-una-colaboracion-para-el-desarrollo-de 2026-04-15T08:48:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-nuevolution-enter-strategic-collaboration-develop-rorgt-inhibitors 2026-04-15T08:48:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-9m-results-2016-strong-derma-performance-eu-and-solid-progress-us 2026-04-15T08:48:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-restructuring-plan-spain 2026-04-15T08:48:44+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-h1-results-2016-growth-total-revenues-and-net-sales-driven-dermatology 2026-04-15T08:48:44+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-bicosome-enter-collaboration-and-sublicense-agreement-development 2026-04-15T08:48:44+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-q1-results-2016-track-achieve-yearly-guidance 2026-04-15T08:48:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reduces-its-accident-rate-69-spain-2015 2026-04-15T08:48:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-full-year-2015-results-normalized-net-income-growth-90 2026-04-15T08:48:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-closes-acquisition-thermigen-llc-entering-aesthetics-market 2026-04-15T08:48:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-exercises-call-option-acquire-100-thermigen-llc 2026-04-15T08:48:47+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reaches-agreement-acquire-100-poli-group 2026-04-15T08:48:47+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-has-acquired-rights-veltinr-and-altabaxr-stiefel-gsk-company-exchange 2026-04-15T08:48:47+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-september-ytd-results-2015-operational-business-outperformance-driven 2026-04-15T08:48:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-closes-15-million-strategic-investment-suneva-medical 2026-04-15T08:48:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-h1-results-2015-growth-driven-strong-sales-increase-dermatology 2026-04-15T08:48:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-q1-results-2015-growth-acceleration-driven-dermatology 2026-04-15T08:48:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-full-year-2014-results-line-guidance 2026-04-15T08:48:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-finaliza-el-acuerdo-con-astrazeneca-en-el-area-respiratoria 2026-04-15T08:48:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-aclidinium-bromideformoterol-fumarate-recommended-approval-europe 2026-04-15T08:48:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-agrees-strategic-transaction-astrazeneca-respiratory-disease 2026-04-15T08:48:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-h1-results-2014-continued-growth-acceleration 2026-04-15T08:48:51+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-q1-results-2014-growth-acceleration 2026-04-15T08:48:51+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/forest-laboratories-and-almirall-provide-update-fixed-dose-combination 2026-04-15T08:48:51+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/index-pharmaceuticals-and-almirall-enter-license-agreement-european-rights 2026-04-15T12:22:28+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-completed-senior-notes-pricing-325-million-euros-7-year-maturity-and 2026-04-15T12:23:00+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-accident-rate-spain-2013-down-20 2026-04-15T08:48:53+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-full-year-results-2013-setting-foundations-accelerating-growth 2026-04-15T08:48:53+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reaches-agreement-implement-reestructuring-plan-spain 2026-04-15T08:48:54+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reaches-agreement-acquire-aqua-pharmaceuticals-us-based-specialty 2026-04-15T12:23:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-reorganization-program-affecting-group-europe 2026-04-15T08:48:54+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/around-clock-symptom-relief-vital-many-millions-chronic-obstructive-pulmonary 2026-04-15T08:48:54+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-q3-track-deliver-year-guidance-eklirar-genuairr-s-global-rollout 2026-04-15T08:48:56+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/aclidinium-and-formoterol-fixed-dose-combination-copd-submitted-registration 2026-04-15T08:48:56+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/aclidinium-chosen-one-best-spanish-therapeutic-innovations-international-reach 2026-04-15T08:48:56+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/new-data-reinforce-efficacy-and-safety-profile-sativexr-multiple-sclerosis 2026-04-15T08:48:56+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/importance-24-hours-symptom-relief-those-suffering-copd 2026-04-15T08:48:57+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/international-pharmaceutical-company-almirall-expands-global-footprint-new 2026-04-15T08:48:57+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-h1-executing-growth-platforms-financial-delivery-track 2026-04-15T08:48:57+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-50-below-pharmaceutical-sector-accident-rate 2026-04-15T08:48:57+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-maintains-its-commitment-environment-spain-and-germany 2026-04-15T08:48:59+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-pioneer-spain-being-awarded-iso-500012011-energy-management-system 2026-04-15T08:48:59+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/constellar-linaclotide-first-approved-prescription-therapy-new-class-treatments 2026-04-15T12:24:11+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/survey-reveals-two-five-european-persons-multiple-sclerosis-ms-under-35-are 2026-04-15T12:25:04+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-begins-transformation 2026-04-15T08:49:00+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-maintains-its-shareholder-return-thanks-its-rd-and 2026-04-15T08:59:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-announce-positive-results-second-phase-iii 2026-04-15T12:26:17+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-announce-positive-results-phase-iii-study 2026-04-15T08:49:01+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-presents-latest-news-respiratory-diseases 2026-04-15T08:49:01+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/2012-results-line-guidance-positioning-almirall-transformative-growth-2013 2026-04-15T08:49:01+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/coordination-among-professionals-crucial-good-vascular-patient-care 2026-04-15T08:49:01+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-commercialises-neurofarmagen-innovative-genetic-test 2026-04-15T08:49:03+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/eklirar-genuairr-almirall-available-spain-treatment-copd 2026-04-15T08:49:03+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-celebrates-10-years-italy 2026-04-15T08:49:03+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-financial-calendar-2013 2026-04-15T08:49:03+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-announce-commercial-availability-tudorzatm 2026-04-15T12:27:34+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/constellar-linaclotide-approved-europe-treatment-irritable-bowel-syndrome 2026-04-15T12:28:32+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-appoints-karin-louise-dorrepaal-new-independent-board-member 2026-04-15T08:49:06+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/3rd-quarter-results 2026-04-15T08:49:06+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/low-awareness-chronic-obstructive-pulmonary-disease-copd-confirmed-recent 2026-04-15T12:29:08+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-invests-personalised-medicine-becoming-part-share-capital-ab-biotics 2026-04-15T11:57:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-incorporates-gerhard-mayr-board-directors 2026-04-15T08:49:08+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sativexr-confirms-clinically-relevant-benefits-multiple-sclerosis-spasticity 2026-04-15T08:49:08+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-licenses-aclidinium-invida-australia-and 2026-04-15T08:49:08+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/linaclotide-receives-positive-chmp-opinion-treatment-ibs-c 2026-04-15T08:49:10+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-eklirar-genuairr-aclidinium-europe 2026-04-15T10:58:06+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-obtains-rights-linaclotide-mexico 2026-04-15T08:49:10+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-opens-new-affiliate-canada 2026-04-15T08:49:11+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/eklirar-genuairr-provides-meaningful-and-sustained-bronchodilation-first-dose 2026-04-15T11:51:55+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-h1-strong-newsflow-and-guidance-reiterated 2026-04-15T08:49:11+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/eklirarbretarisr-genuairr-aclidinium-bromide-approved-europe-maintenance 2026-04-15T11:56:55+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-announce-fda-approval-tudorzatm-pressairtm 2026-04-15T12:30:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/que-medicamentos-tendran-nuestros-hijos-retos-para-equilibrar-investigacion-y 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/abediterol-almiralls-od-laba-shows-superiority-vs-indacaterol-phase-iia 2026-04-15T12:31:07+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-aclidinium-recommended-approval-europe-treat-copd 2026-04-15T08:49:13+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-aslan-sign-global-agreement-novel-treatment-rheumatoid-arthritis 2026-04-15T08:49:14+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sativexr-starts-third-phase-iii-clinical-trial-cancer-pain 2026-04-15T08:49:14+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/new-strategic-direction-almiralls-od-laba-following-successful-phase-iia 2026-04-15T08:49:14+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-present-aclidinium-bromide-clinical-data-american-thoracic 2026-04-15T08:49:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-grows-internationally 2026-04-15T08:49:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sativexr-mutual-recognition-procedure-closes-recommendation-approval-ten 2026-04-15T08:49:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-annual-general-meeting-approves-018-euro-pay-out-share-scrip-dividend 2026-04-15T08:49:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-announce-fda-has-extended-review-period 2026-04-15T08:49:17+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-menarini-sign-licence-agreement-and-commercial-alliance-aclidinium 2026-04-15T08:49:17+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/aclidinium-clinical-data-published-european-respiratory-journal-confirms 2026-04-15T12:31:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/el-tratamiento-personalizado-de-la-epoc-principal-reto-para-los-especialistas 2026-04-15T08:49:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-extends-sativexr-marketing-rights-mexico 2026-04-15T08:49:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-supports-european-post-graduate-clinical-research-ms-spasticity-two 2026-04-15T12:32:28+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-results-2011-line-positive-newsflow-start-2012 2026-04-15T08:49:19+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-announce-positive-fda-advisory-committees-recommendation 2026-04-15T08:49:19+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/la-vi-reunion-vam-presenta-las-nuevas-evidencias-en-el-tratamiento-de-las 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-licenses-aclidinium-daewoong-korea 2026-04-15T08:49:19+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/desciende-el-tabaquismo-pasivo-gracias-la-ley-antitabaco-y-se-mantiene-el 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/bayer-and-almirall-co-promote-anticoagulant-rivaroxaban-spain 2026-04-15T08:49:21+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sativexr-starts-new-wave-regulatory-submissions-europe 2026-04-15T12:32:58+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-celebrates-10-years-mexico 2026-04-15T08:49:22+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-galapagos-enter-research-alliance 2026-04-15T08:49:22+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-colabora-con-la-fundacion-vicente-ferrer-en-un-proyecto-de 2026-04-15T08:49:22+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-solarazer-spain-treatment-actinic-keratosis 2026-04-15T08:49:23+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-starts-phase-iii-aclidinium-and-formoterol-copd 2026-04-15T12:33:53+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-biofocus-announce-collaboration-find-new-hit-compounds-against-key 2026-04-15T08:49:23+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-colabora-con-la-sed-en-el-dia-mundial-de-la-diabetes-only-available 2026-04-15T08:49:23+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/mas-de-la-mitad-de-los-diabeticos-tipo-2-no-tiene-un-control-adecuado-de-la 2026-04-15T08:49:25+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/q3-results-almirall-prepares-future-growth 2026-04-15T08:49:25+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/8-de-cada-10-espanoles-no-sabe-que-es-la-epoc 2026-04-15T08:49:25+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/full-phase-iii-data-highlight-efficacy-and-tolerability-sativexr-therapy 2026-04-15T08:49:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/linaclotide-provides-long-term-relief-symptoms-irritable-bowel-syndrome 2026-04-15T08:49:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-lundbeck-announce-co-promotion-agreement-escitalopram-italy 2026-04-15T08:49:26+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-spanish-pharmacological-society-recognise-research-diabetes 2026-04-15T08:49:27+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-roflumilast-spain 2026-04-24T12:32:06+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-regulatory-filing-linaclotide-treatment-irritable-bowel 2026-04-15T08:49:27+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-nycomed-announce-licensing-agreement-ebastine-china-and-other-key 2026-04-15T11:40:56+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/una-nueva-guia-ayudara-los-medicos-en-el-manejo-de-la-osteoporosis 2026-04-15T11:55:17+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/copd-patients-experienced-benefits-first-dose-when-treated-aclidinium-shown 2026-04-15T08:49:29+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-enters-integrated-discovery-agreement-proteros 2026-04-15T08:49:29+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-appoints-alfredo-baron-area-director-southern-and-eastern-europe 2026-04-15T11:37:40+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-h1-financial-results 2026-04-15T08:49:30+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/aclidinium-bromide-submitted-registration-europe 2026-04-15T08:49:30+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-strengthens-its-german-business-two-new-products-sativexr-and 2026-04-15T08:49:30+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/farid-taha-new-general-manager-almirall-germany-austria-and-switzerland 2026-04-15T11:36:52+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-announce-regulatory-submission-aclidinium-bromide-treatment 2026-04-15T08:49:32+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/nuevos-datos-avalan-la-seguridad-y-la-eficacia-del-bazedoxifeno-para-prevenir 2026-04-15T11:53:42+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-empresa-comprometida-con-la-formacion-de-los-gestores-sanitarios 2026-04-15T11:54:04+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/la-sepd-en-colaboracion-con-almirall-presenta-el-libro-el-paciente-con-sintomas 2026-04-15T08:49:33+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sativexr-approved-denmark-treatment-spasticity-due-multiple-sclerosis-ms 2026-04-15T08:49:33+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/actikerallr-launched-uk-treatment-actinic-keratosis-including-grade-i-and-ii 2026-04-15T08:49:33+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/daniel-martinez-carretero-appointed-chief-financial-officer-cfo-almirall 2026-04-15T11:37:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-strengthens-their-ongoing-commitment-patients-multiple-sclerosis 2026-04-15T08:49:34+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sativexr-approved-germany-treatment-spasticity-due-multiple-sclerosis 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-q1-financial-results-line-attain-yearly-guidance 2026-04-15T08:49:34+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-annual-general-meeting-approves-dividend-029-euros-share 2026-04-15T11:34:47+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-present-data-phase-iii-studies-aclidinium-bromide-chronic 2026-04-15T08:49:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/regulators-confirm-actikerallr-treatment-actinic-keratoses-including-grade-i 2026-04-15T08:49:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-nycomed-announce-commercialization-agreement-roflumilast-spain 2026-04-15T11:35:20+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/el-tabaquismo-es-la-enfermedad-respiratoria-mas-frecuente 2026-04-15T08:49:37+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-strengthens-its-respiratory-franchise-new-generation-chronic 2026-04-15T11:36:00+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-apuesta-por-la-formacion-gestores-sanitarios-en-un-modelo-efectivo-de 2026-04-15T11:36:11+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-excellent-company-according-profarma-plan-ministry-industry-tourism 2026-04-15T11:32:51+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/ignasi-marti-rague-director-institutional-relations-almirall 2026-04-15T11:36:29+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sativexr-mutual-recognition-procedure-closes-recommendation-approval-all-six 2026-04-15T08:49:52+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/lanzamiento-balneum-intensive-espana 2026-04-15T08:49:52+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-appointment-eduardo-sanchiz-new-ceo-july-1st-2011 2026-04-15T12:35:21+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sativexr-launched-spain-treat-spasticity 2026-04-15T08:49:54+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-2010-financial-results-line-guidance 2026-04-15T08:49:54+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-kyorin-announce-licensing-agreement-japan-aclidinium-bromide 2026-04-15T11:33:09+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-appoints-eloi-crespo-new-general-director-industrial-area 2026-04-15T11:33:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/el-manejo-precoz-del-paciente-diabetico-clave-para-conseguir-una-prevencion 2026-04-15T11:34:03+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sativex-granted-reimbursement-spain-treatment-spasticity-multiple-sclerosis 2026-04-15T08:49:55+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-mexico-receives-distinction-companies-transparent-practices 2026-04-15T11:31:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/los-ultimos-avances-debate-en-el-x-symposium-de-psiquiatria-organizado-por 2026-04-15T11:30:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/bertil-lindmark-new-executive-director-rd-almirall 2026-04-21T10:00:56+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-announce-positive-results-attain-phase-iii-study-aclidinium 2026-04-15T11:29:54+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sativexr-enters-phase-iii-clinical-programme-oncological-pain 2026-04-15T08:49:58+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/q3-line-guidance-rd-momentum-continues 2026-04-15T08:59:00+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-ironwood-announce-positive-results-second-phase-iii-trial 2026-04-15T08:49:58+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-report-preliminary-topline-results-accord-copd-ii-phase-iii 2026-04-15T08:50:00+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-apoya-el-programa-de-actividades-puesto-en-marcha-por-la-sed-y-su 2026-04-15T11:32:29+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sativexr-data-presented-ectrims-congress-highlights-its-efficacy-add-therapy 2026-04-15T08:50:00+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-pioneer-obtaining-ohsas-18001-occupational-health-and-safety-renews 2026-04-15T11:12:41+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/launch-spain-urorecrsilodyxtm-new-treatment-symptoms-associated-benign 2026-04-15T11:12:13+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/conbrizar-bazedoxifene-approved-spanish-agency-medicines-and-healthcare 2026-04-15T11:17:45+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/research-chronic-pain-winning-project-pharmacology-award-presented-almirall-and 2026-04-15T11:10:40+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-receives-company-rating-excellent-ministry-industry-tourism-and-trade 2026-04-15T08:50:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-ironwood-announce-positive-results-phase-3-trial-linaclotide 2026-04-15T11:10:07+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-awarded-zero-rate-accident-frequency-2009 2026-04-15T11:28:06+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/first-half-2010-line-guidance-strong-rd-catalysts-expected-second-half 2026-04-15T08:58:52+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/sativexr-receives-regulatory-authorisation-spain 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-signs-co-promotion-agreement-pfizer-commercialise-conbrizar-spain-new 2026-04-15T11:28:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reaffirms-its-commitment-environment-renewal-its-iso-140012004 2026-04-15T11:09:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/el-tratamiento-integral-de-la-diabetes-tipo-2-y-su-cumplimiento-por-parte-del 2026-04-15T11:09:06+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/presentation-neogenius-project-brings-together-around-hundred-investigators 2026-04-15T08:50:05+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-international-agreement-basilea-commercialize-toctinor 2026-04-15T12:39:04+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-organiza-la-i-reunion-de-centros-de-excelencia-en-cardiologia-de 2026-04-15T12:39:28+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/regulators-uk-and-spain-confirm-sativexr-approvable 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-annual-general-meeting-approves-dividend-033-euros-share-figure-5 2026-04-15T08:50:08+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-first-quarter-2010-track 2026-04-15T08:50:08+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-present-data-studies-eklirar-aclidinium-bromide-chronic 2026-04-15T08:50:10+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/20-years-antihistamine-ebastelr-ebastine 2026-04-15T08:50:10+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-grants-eisai-marketing-rights-cinitapride-china 2026-04-15T08:50:10+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-thiomucase-extreme-areas-first-anti-cellulite-stick 2026-04-15T08:50:11+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-solid-performance-2009-setting-basis-sustainable-long-term-growth 2026-04-15T11:08:37+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/neogenius-alliance-between-almirall-esteve-palau-pharma-and-proteomika 2026-04-15T08:50:11+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/multidisciplinary-approach-improve-treatment-and-reduce-patient-cardiovascular 2026-04-15T08:50:12+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/silodosin-indicated-benign-prostatic-hyperplasia-bph-has-been-approved-european 2026-04-15T08:50:12+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-strengthens-its-focus-twice-daily-dosing-eklirar-chronic-obstructive 2026-04-15T08:50:12+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/9th-psychiatry-symposium-organized-almirall-presents-latest-advances-area 2026-04-15T08:50:14+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-announce-positive-results-accord-copd-i-phase-iii-study 2026-04-15T08:50:14+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-expand-respiratory-collaboration-las100977 2026-04-15T08:50:14+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-parapres-plus-32r-and-parapres-plus-forter-treat-hypertension 2026-04-15T08:50:14+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/emeachmp-adopts-positive-opinion-silodosin 2026-04-15T08:50:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reports-net-sales-7013-million-euros-increase-24 2026-04-15T08:50:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-dhodh-inhibitor-recognized-windhover-top-10-partnering-list 2026-04-15T08:50:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-us-15-m-equity-investment-ironwood-pharmaceuticals 2026-04-15T08:50:16+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/update-eklirar-aclidinium-bromide-chronic-obstructive-pulmonary-disease-copd 2026-04-15T11:24:03+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/blastoactiva-first-skin-cell-repair-cream-double-select-centella-asiatica 2026-04-15T08:50:16+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-spanish-society-pharmacology-present-8th-pharmacology-award-2009 2026-04-15T08:50:16+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-aims-file-once-daily-aclidinium-bromide-copd-europe-early-2010 2026-04-15T08:50:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reports-over-103-million-euros-net-income-first-half-year-2009 2026-04-15T08:50:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-offers-its-employees-6500-hours-training-health-and-safety 2026-04-15T08:50:18+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-appoints-new-managing-director-its-market-company-poland 2026-04-15T08:50:19+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almotriptan-axertralmogranr-approved-fda-treatment-migraine-adolescents 2026-04-15T08:50:19+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-awards-dividend-payments-52-million-euros-its-shareholders 2026-04-15T08:50:19+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-filing-sativexr-regulatory-submission 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reports-over-63-million-euros-net-income-first-quarter-2009 2026-04-15T08:50:21+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-launches-efficibr-spain-combination-product-sitagliptin-and-metformin 2026-04-15T08:50:22+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-signs-pan-european-licensing-agreement-ironwood-linaclotide-novel 2026-04-15T08:50:22+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-respiratory-pipeline-update-aclidinium-bromide-and-las100977-once 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-opens-its-doors-pharmaceutical-industry-mark-opening-new-london 2026-04-15T08:50:23+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/steve-webber-new-senior-discovery-director-almirall 2026-04-15T08:50:23+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-signs-co-marketing-agreement-recordati-marketing-silodosin-spain-new 2026-04-15T08:50:25+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-obtains-net-income-1361-million-euros-2008-38-more-previous-year 2026-04-15T08:50:25+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/encouraging-results-support-further-development-almiralls 2026-04-15T10:32:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/between-15-and-20-population-will-suffer-depression-some-time-during-their 2026-04-15T11:21:30+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/promising-results-almiralls-once-daily-long-acting-beta-agonist-laba-expected 2026-04-15T08:50:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/marc-ayas-new-director-international-human-resources-and-compensation-almirall 2026-04-15T08:50:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-ranke-quimica-reduced-its-accident-rate-57-2007 2026-04-15T08:50:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-obtains-total-revenues-around-809-million-euros-18-more-same-period 2026-04-15T08:50:36+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-signs-agreement-pfizer-commercialise-new-medicine-reduces 2026-04-15T08:50:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-signs-co-marketing-agreement-msd-commercialise-spain-new-medicine-type 2026-04-15T08:50:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/daniel-martinez-takes-new-position-deputy-cfo-almirall 2026-04-15T08:50:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-upgrades-its-company-website-wwwalmirallcom 2026-04-15T08:50:38+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-moving-forward-development-aclidinium-bromide 2026-04-15T11:20:44+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-receipt-15-million-dollars-eu105-million-forest-laboratories 2026-04-15T10:32:07+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-spanish-society-pharmacology-confer-pharmacology-award-2008 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/marketing-sales-team-almirall-germany-has-received-golden-tablet-award-best 2026-04-15T09:00:25+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/phase-iii-clinical-studies-aclidinium-bromide-show-statistical-significance-vs 2026-04-15T08:50:41+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/clarification-regarding-news-almirall-receiving-offer-acquiring-package 2026-04-15T08:50:41+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-obtains-total-revenues-around-547-million-euros-first-half-year 2026-04-15T08:50:41+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-initial-agreement-sale-its-plant-sant-just-desvern-lesvi 2026-04-15T08:50:41+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-proteros-biostructures-announce-successful-achievement-key 2026-04-15T08:50:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/laboratorios-almirall-sa-and-forest-laboratories-inc-complete-phase-iii-studies 2026-04-15T08:50:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/doctors-and-pharmacists-pool-knowledge-tackle-digestive-diseases 2026-04-15T08:50:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/philippe-bouissou-new-senior-development-director-almirall 2026-04-15T08:50:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-announce-positive-results-clinical-studies 2026-04-15T08:50:44+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-obtains-total-revenues-269-million-euros-first-quarter-year 2026-04-15T08:50:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-awards-dividend-40-its-shareholders 2026-04-15T08:50:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reinforces-its-european-expansion-opening-new-affiliates-poland-and 2026-04-15T08:50:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-promising-results-new-compound-asthma-and-copd 2026-04-15T08:50:46+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/israel-garcia-and-ma-eugenia-vellve-new-almirall-general-managers-mexico-and 2026-04-15T08:50:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reports-total-revenues-917-million-euros-2007 2026-04-15T08:50:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/carlos-gallardo-general-manager-almirall-united-kingdom-and-ireland 2026-04-15T08:50:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reinforces-its-presence-europe-opening-new-affiliate-united-kingdom 2026-04-15T08:50:49+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-closes-acquisition-portfolio-8-products-shire-plc 2026-04-15T08:50:49+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-contributes-almost-2-million-euros-renew-collaboration-agreement 2026-04-15T08:50:49+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-increases-its-net-sales-38 2026-04-15T08:50:49+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/christophe-vandeputte-and-dominique-humblet-new-almirall-general-managers 2026-04-15T08:50:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/anselm-divi-new-almirall-corporate-director-human-resources 2026-04-15T08:50:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-acquires-portfolio-eight-products-shire-plc-us213-million-eu151 2026-04-15T08:50:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/klaus-melchers-new-senior-discovery-director-almirall 2026-04-15T08:50:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-spanish-pharmacology-society-confer-pharmacology-award-2007 2026-04-15T08:50:52+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/aclidinium-bromide-demonstrates-rapid-and-long-acting-bronchodilatory-effect 2026-04-15T08:50:52+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-closes-process-acquisition-hermal-after-clearance-german-regulatory 2026-04-15T08:50:52+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-closes-its-acquisition-hermal-after-clearance-german-regulatory 2026-04-15T08:50:52+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-half-year-results-2007-almirall-reports-net-sales-4129-million-euros 2026-04-15T08:50:53+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reports-net-sales-4129-million-euros 2026-04-15T08:50:53+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/gonzalo-de-miquel-new-global-medical-director-almirall-rd-area 2026-04-15T09:13:45+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-again-receives-iso-140012004-environmental-management-certificate 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-acquires-hermal-european-prescription-dermatology-business-reckitt 2026-04-15T08:50:55+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-priced-14-euros-share-its-first-day-listed-company 2026-04-15T08:50:55+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-shares-close-first-day-trading-rising-714-over-offer-price 2026-04-15T08:50:55+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/jordi-molina-alsina-investor-relations-manager-almirall 2026-04-15T08:50:56+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/CNMV-spanish-stock-exchange-commission-registers-prospectus-public-offering 2026-04-15T08:50:56+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-will-reserve-shares-its-stock-market-listing-company-employees 2026-04-15T08:50:56+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-receives-fundamed-el-global-award-best-pharmaceutical-company-year 2026-04-15T11:03:47+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-certifies-its-occupational-risk-prevention-management-system 2026-04-15T08:50:58+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-selects-morgan-stanley-and-santander-next-phase-stock-market-listing 2026-04-15T08:50:58+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-its-intention-list-its-shares-spanish-stock-market 2026-04-15T08:50:58+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-council-catalonian-medical-associations-fundacio-galatea-sign 2026-04-15T11:04:51+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-spa-be-awarded-spanish-company-year-italy 2026-04-15T11:05:11+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/stress-and-anxiety-are-among-main-causes-acidity-spain 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-confers-2006-pharmacology-award-during-spanish-pharmacology-society 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-extends-its-collaboration-sareum 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/strategic-partnership-almirall-meda 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/his-majesty-king-spain-inaugurates-almiralls-new-research-and-development 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-new-research-and-development-centre-reference-point-biomedical 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-expands-12-international-pharmaceutical-market 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/el-dr-carsten-niederlander-nuevo-director-de-desarrollo-farmaceutico 2026-04-15T12:38:20+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-forest-announce-development-and-marketing-collaboration-agreement 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/dr-john-efthimiou-new-rd-global-medical-director-almirall 2026-04-15T09:13:07+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-publish-clinical-trials 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/dr-olof-andersson-new-executive-director-rd-area-almirall 2026-04-15T11:05:34+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-commemorates-5th-anniversary-almogran-its-own-rd-medicine-treatment 2026-04-15T09:13:40+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-gw-announce-european-development-and-marketing-agreement-sativexr 2026-04-15T09:55:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-grants-commercialisation-almogran-switzerland-pharmaceutical-company 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-italy-signs-agreement-altana-pharma-ag-commercialisation-pantopan 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-only-pharmaceutical-company-be-awarded-best-european-business-prize 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-confers-2005-pharmacology-award 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-collaboration-sareum-protein-structure-determination 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-enters-long-term-compound-library-agreement-evotec 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reveals-promising-phase-ii-data-its-once-daily-long-acting-low 2026-04-15T10:32:27+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/according-survey-el-club-de-la-farmacia-website-portal-which-over-30000 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-reaches-sales-figures-900-million-euros-2004 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-awarded-prince-felipe-prize-business-competitiveness-large-enterprises 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-announces-parkinsons-disease-research-programme-licensing-agreement 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-confers-2004-pharmacology-award 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-has-taken-strategic-decision-registering-almotriptan-japan 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-increases-sales-64-2003 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almotriptan-receives-approval-be-sold-canada 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-awarded-iso-1400196-environmental-management-certification 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-confers-2003-pharmacology-award 2026-04-15T11:06:13+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/canada-another-key-approval-almotriptan 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-presents-its-new-corporate-website 2026-04-15T11:14:53+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-has-licensed-its-triptan-ortho-mcneil-pharmaceutical-inc-us-and-canada 2026-04-15T11:15:28+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-prodesfarma-consolidates-its-international-expansion-opening 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-prodesfarma-confers-2002-pharmacology-award 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-prodesfarma-invests-30-million-euros-new-research-and-development 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/comparative-study-classifies-almogran-one-best-choices-treatment-migraines 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-prodesfarma-opens-new-laboratory-barcelona-science-park 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-prodesfarma-establishes-its-presence-france-acquisition-pharmafarm 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-prodesfarma-licenses-antipsychotic-agent-blonanserin-dainippon 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almotriptan-almogran-licensed-fda-marketing-united-states 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-prodesfarma-acquires-prasfarma 2026-04-15T10:00:02+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-inaugurates-offices-china-advance-innovation-medical-dermatology 2026-04-30T09:02:10+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/lebrikizumab-delivered-significant-skin-clearance-and-improved-disease-severity 2026-04-30T09:49:44+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almiralls-17th-skin-academy-highlights-scientific-advances-inflammatory-skin 2026-05-11T13:16:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/aad-2026-almirall-presents-new-clinical-and-real-world-evidence-across-atopic 2026-04-30T09:24:15+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-enters-collaboration-huaota-development-novel-monoclonal-antibody 2026-04-30T09:28:50+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/lebrikizumab-delivered-long-term-disease-control-four-years-patients-moderate 2026-04-30T09:37:48+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-and-barcelona-supercomputing-center-expand-their-collaboration 2026-04-30T09:47:14+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/resultats-financers-q1-2026 2026-06-04T15:14:00+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/2025-un-any-en-revisio-entrant-en-una-era-de-creixement-sostingut 2026-06-04T15:12:28+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/junta-general-anual-daccionistes 2026-06-04T15:13:43+00:00 weekly 1 https://pre.almirall.com/news-media/newsroom/almirall-continues-its-positive-trajectory-q1-2026-line-expectations-led-193 2026-05-11T15:52:07+00:00 weekly 1 https://pre.almirall.com/dermatologia/acne 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/alopecia-areata 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/cancer-de-pell-no-melanoma 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/dermatitis-atopica 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares/epidermolisi-bullosa-congenita/diagnostic 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/dermatitis-atopica/diagnostic 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/hidradenitis-supurativa/diagnostic 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/psoriasi/diagnostic 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares/pustulosi-palmoplantar/diagnostic 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/queratosi-actinica/diagnostic 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/acne/diagnostic 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/alopecia-areata/diagnostic 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/onicomicosi/diagnostic 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/cancer-de-pell-no-melanoma/diagnostic 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/vitiligen/diagnostic 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares/epidermolisi-bullosa-congenita 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares/epidermolisi-bullosa-congenita/signes-simptomes 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/dermatitis-atopica/factors-desencadenants 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/hidradenitis-supurativa/factors-desencadenants 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/psoriasi/factors-desencadenants 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares/pustulosi-palmoplantar/factors-desencadenants 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/queratosi-actinica/factors-desencadenants 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/acne/factors-desencadenants 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/alopecia-areata/factors-desencadenants 2026-09-04T15:08:49+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares/epidermolisi-bullosa-congenita/factors-desencadenants 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/onicomicosi/factors-desencadenants 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/cancer-de-pell-no-melanoma/factors-desencadenants 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/vitiligen/factors-desencadenants 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/hidradenitis-supurativa 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/onicomicosi 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/psoriasi 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares/pustulosi-palmoplantar 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/queratosi-actinica 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/dermatitis-atopica/signes-simptomes 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/hidradenitis-supurativa/signes-simptomes 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/psoriasi/signes-simptomes 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares/pustulosi-palmoplantar/signes-simptomes 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/queratosi-actinica/signes-simptomes 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/alopecia-areata/signes-simptomes 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/cancer-de-pell-no-melanoma/signes-simptomes 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/vitiligen/signes-simptomes 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/onicomicosi/signes-simptomes 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/acne/signes-simptomes 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/cancer-de-pell-no-melanoma/tipus 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/dermatitis-atopica/tipus 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/hidradenitis-supurativa/tipus 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/psoriasi/tipus 2026-09-04T15:08:57+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares/pustulosi-palmoplantar/tipus 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/queratosi-actinica/tipus 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/vitiligen/tipus 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/acne/tipus 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/alopecia-areata/tipus 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares/epidermolisi-bullosa-congenita/tipus 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/onicomicosi/tipus 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/hidradenitis-supurativa/tractaments 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/psoriasi/tractaments 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares/pustulosi-palmoplantar/tractaments 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/queratosi-actinica/tractaments 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/cancer-de-pell-no-melanoma/tractaments 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/vitiligen/tractaments 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/dermatitis-atopica/tractaments 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/acne/tractaments 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/alopecia-areata/tractaments 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/malalties-cutanies-rares/epidermolisi-bullosa-congenita/tractaments 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/onicomicosi/tractaments 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.com/dermatologia/vitiligen 2026-09-04T15:09:04+00:00 weekly 1 https://pre.almirall.fr 2026-07-20T10:00:48+00:00 weekly 1 https://pre.almirall.fr/entreprise 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/entreprise/a-propos 2026-07-22T06:34:25+00:00 weekly 1 https://pre.almirall.fr/entreprise/fournisseurs 2026-08-12T12:13:25+00:00 weekly 1 https://pre.almirall.fr/entreprise/objectif 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/patients 2026-07-21T11:57:25+00:00 weekly 1 https://pre.almirall.fr/entreprise/localisations 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/entreprise/durabilite/personnes 2026-07-20T10:35:53+00:00 weekly 1 https://pre.almirall.fr/entreprise/durabilite/principes 2026-07-23T07:51:20+00:00 weekly 1 https://pre.almirall.fr/patients/bien-etre-psychologique 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/patients/commitment/campaigns 2026-07-01T12:32:41+00:00 weekly 1 https://pre.almirall.fr/entreprise/durabilite/planete 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/entreprise/durabilite 2026-08-18T06:54:01+00:00 weekly 1 https://pre.almirall.fr/entreprise/durabilite/patients 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/entreprise/durabilite/partenaires 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/patients/histoires 2026-07-28T12:41:06+00:00 weekly 1 https://pre.almirall.fr/patients/engagement/campagnes/sanctuary-salon 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/investisseurs 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/investisseurs/communications-CNMV 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/investisseurs/gouvernance-entreprise 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/investisseurs/gouvernance-entreprise/assemblee-generale 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/innovation/essais-cliniques 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/innovation/collaboration-rd 2026-07-20T11:53:36+00:00 weekly 1 https://pre.almirall.fr/innovation/partenariats 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/investisseurs/gouvernance-entreprise/accords 2026-07-16T10:40:52+00:00 weekly 1 https://pre.almirall.fr/investisseurs/gouvernance-entreprise/conseil-administration 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/investisseurs/gouvernance-entreprise/commissions-conseil 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/dermatologie 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/investisseurs/rapports/annuel 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/investisseurs/rapports/annuel/2021 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/innovation 2026-07-20T11:49:41+00:00 weekly 1 https://pre.almirall.fr/investisseurs/informations-boursieres 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/investisseurs/informations-boursieres/performance-actions 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/investisseurs/informations-boursieres/capital-social 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/investisseurs/informations-boursieres/couverture-analystes 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/investisseurs/informations-boursieres/actions-financement 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/investisseurs/donnees-financieres/resultats-comptes 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/nvestisseurs/donnees-financieres/informations-publiques 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/investisseurs/donnees-financieres/materiels-information 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/innovation/pipeline 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/investisseurs/equipe-dirigeante 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/investisseurs/rapports 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/patients/engagement 2026-09-07T13:05:22+00:00 weekly 1 https://pre.almirall.fr/investisseurs/gouvernance-entreprise/compliance 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/entreprise/integrite 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/entreprise/faq 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/entreprise/faq/produits 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/entreprise/faq/pathologie 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/entreprise/faq/domaines-therapeutiques 2026-07-16T10:40:59+00:00 weekly 1 https://pre.almirall.fr/investisseurs/leadership/comite-direction 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/entreprise/histoire 2026-07-22T06:34:49+00:00 weekly 1 https://pre.almirall.fr/investisseurs/gouvernance-entreprise/directeur-gouvernance 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/contact/signaler-effet-indesirable 2026-07-21T08:45:42+00:00 weekly 1 https://pre.almirall.fr/actualites-medias/contact 2026-07-22T08:41:48+00:00 weekly 1 https://pre.almirall.fr/actualites-medias/calendrier-evenements 2026-07-22T08:35:42+00:00 weekly 1 https://pre.almirall.fr/contact/medias 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/contact/investisseurs 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/contact/recherche-developpement 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/contact/personnes-culture 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/contact/partenaires 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/contact/information-medicale 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/contact/aider-ameliorer 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/actualites-medias/ressources-medias 2026-07-22T09:02:01+00:00 weekly 1 https://pre.almirall.fr/patients/engagement/campagnes/sanctuary-salon/patients 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/conditions-generales 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/entreprise/durabilite/transparence 2026-09-08T15:45:09+00:00 weekly 1 https://pre.almirall.fr/global-privacy-policy 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/politique-confidentialite 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/politique-confidentialite-hcp 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/politique-accessibilite 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/politique-cookies 2026-07-16T10:41:06+00:00 weekly 1 https://pre.almirall.fr/conditions-utilisation 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/securite-medicaments 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/entreprise/durabilite/autres-documents-pertinents 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/contact 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/avis-confidentialite-carrieres 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/politique-confidentialite-globale-evenements 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/professionnels-sante/produits 2026-07-16T10:46:19+00:00 weekly 1 https://pre.almirall.fr/professionnels-sante 2026-07-16T10:45:55+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-atteint-les-objectifs-fixes-pour-2025-avec-une-croissance-de-124-de 2026-06-04T07:36:10+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/les-femmes-au-service-du-progres-scientifique 2026-06-04T07:44:24+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/les-progres-de-la-dermatologie-medicale-linnovation-grace-aux-collaborations-en 2026-06-04T07:43:01+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/une-approche-innee-penser-differemment-pour-faconner-lavenir-de-la-dermatologie 2026-06-26T08:08:03+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/skin-academy-faire-progresser-les-echanges-scientifiques-et-les-soins 2026-06-03T17:50:41+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-meets-guidance-2025-delivering-124-net-sales-growth-and-further 2026-04-22T14:31:40+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-continues-its-sustained-growth-trajectory-9m-2025-delivering-128-net 2026-04-15T11:42:19+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-presents-long-term-results-first-real-world-dermatology-study-using 2026-04-15T08:46:12+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-h1-2025-results-almirall-continues-deliver-its-long-term-growth 2026-04-15T11:44:35+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-delivers-strong-start-2025-growing-q1-overall-sales-15-and-234-its 2026-04-15T11:44:49+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-surpassed-guidance-2024-entering-era-sustained-growth-and-further 2026-04-15T11:45:04+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-nine-month-2024-results-almirall-reports-strong-performance-q3-2024 2026-04-15T11:45:23+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-q1-2024-results-almirall-delivers-strong-start-2024-q1-net-sales 2026-04-15T11:45:46+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-eloxx-pharmaceuticals-enter-exclusive-agreement-license-zkn-013 2026-04-15T10:32:19+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-achieves-net-sales-growth-64-driven-strong-european-dermatology 2026-04-15T11:47:05+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-achieves-net-sales-growth-7-eu4661mm-driven-strong-growth-european 2026-04-15T11:46:45+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-net-sales-reach-eu-232mm-and-increase-6-boosted-solid-european 2026-04-15T11:46:32+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-full-year-2022-results-almirall-closes-2022-core-net-sales-growth-66 2026-04-15T11:46:19+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-joins-facilitate-patient-driven-innovative-medicines-initiative-imi 2026-04-15T08:46:40+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-nine-month-2022-results-almirall-achieves-core-net-sales-eu6338-mm 2026-04-15T08:46:40+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-opens-new-subsidiary-czech-republic-and-slovakia 2026-04-15T08:46:40+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-chairman-carlos-gallardo-appointed-interim-ceo 2026-04-15T08:46:40+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-shedding-light-psoriasis-campaign-exposes-impact-disease-mental 2026-04-15T08:46:41+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-ema-acceptance-filing-marketing-authorization-application 2026-04-15T08:46:41+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-partners-chemical-institute-sarria-iqs-bring-pharmacy-students 2026-04-15T08:46:41+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-simcere-enter-licensing-agreement-il-2-mu-fc 2026-04-15T08:46:41+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-initiation-phase-i-study-anti-il-1rap-first-class-monoclonal 2026-04-15T08:46:43+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-lebrikizumab-dosed-every-four-weeks-maintained-durable-skin-clearance 2026-04-15T08:46:43+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-lebrikizumabs-52-week-late-breaking-data-will-be-presented-31st 2026-04-15T08:46:43+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-h1-2022-results 2026-04-15T08:46:43+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-new-call-find-innovative-therapies-skin-diseases 2026-04-15T08:46:44+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/happify-health-and-almirall-go-live-digital-solution-support-psoriasis-patients 2026-04-15T08:46:44+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-eight-out-ten-patients-maintained-skin-clearance-one-year-lebrikizumab 2026-04-15T08:46:44+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-initiates-decentralised-procedure-europe-treatment-mild-moderate 2026-04-15T08:46:44+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-innovative-wynzorar-cream-denmark-treatment-mild-moderate 2026-04-15T08:46:46+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-actinic-keratosis-ak-global-day-during-skin-cancer-awareness 2026-04-15T08:46:46+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-happify-health-go-live-digital-therapeutics-support-psoriasis 2026-04-15T08:46:46+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-evotec-enter-multi-target-alliance-medical-dermatology 2026-04-15T08:46:46+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-inserm-transfert-enter-licensing-and-research-collaboration 2026-04-15T08:46:47+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-delivers-good-business-performance-q1-and-reiterates-full-year-2022 2026-04-15T12:14:57+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/carlos-gallardo-asume-la-presidencia-de-almirall 2026-04-15T08:46:47+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-lebrikizumab-combined-topical-corticosteroids-showed-significant 2026-04-15T08:46:48+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-new-research-collaboration-university-dundee-develop 2026-04-15T08:46:48+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-majority-patients-treated-lebrikizumab-achieved-skin-clearance-pivotal 2026-04-15T08:46:48+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-collaboration-university-michigan-gain-understanding-disease 2026-04-15T08:46:48+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/dr-jorge-gallardo-ballart-announces-his-intention-retire-his-positions 2026-04-15T08:46:50+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-full-year-2021-results 2026-04-15T08:46:50+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-multi-target-licensing-agreement-ablexis-and-collaboration 2026-04-15T08:46:52+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-irb-barcelona-announce-research-collaboration-discover-novel 2026-04-15T08:46:52+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-lebrikizumab-demonstrated-significant-skin-improvement-and-itch-relief 2026-04-15T08:46:52+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/hoy-si-me-puedo-levantar-campaign-support-people-living-multiple-sclerosis-ms 2026-04-15T08:46:52+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/ichnos-sciences-and-almirall-enter-licensing-agreement-first-class-il-1rap 2026-04-15T08:46:53+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-delivers-solid-nine-months-2021-results-and-tightens-its-upgraded 2026-04-15T08:46:53+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-shedding-light-psoriasis-campaign-raise-awareness-world 2026-04-15T08:46:53+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-roadmap-more-sustainable-future 2026-04-15T08:46:55+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-pricing-eu300-million-issuance-senior-notes-due-2026 2026-04-15T08:46:55+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/lebrikizumab-significantly-improved-skin-clearance-and-itch-people-moderate 2026-04-15T08:46:56+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-delivers-robust-h1-performance-and-increases-full-year-guidance 2026-04-15T08:46:56+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-receives-european-commission-approval-klisyrir-v-tirbanibulin 2026-04-15T10:48:15+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-mc2-therapeutics-announce-completion-decentralized-procedure 2026-04-15T08:46:56+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-new-call-establish-partnerships-innovative-therapies-skin 2026-04-15T08:46:58+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-kaken-pharmaceutical-enter-license-and-distribution-agreement 2026-04-15T08:46:58+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-joins-biomap-new-partner-advance-field-inflammatory-skin-conditions 2026-04-15T08:46:58+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-appoints-dr-karl-ziegelbauer-chief-scientific-officer 2026-04-15T08:46:58+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-receives-fda-approval-produce-seysara-r-sarecycline-sant-andreu-de-la 2026-04-15T08:46:59+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-receives-positive-chmp-opinion-klisyrirv-tirbanibulin-innovative 2026-04-15T08:46:59+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-solid-core-business-q1-performance-boosted-growth-drivers-momentum 2026-04-15T08:46:59+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-proposes-ruud-dobber-new-member-its-board-directors 2026-04-15T08:46:59+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-receives-qualification-excellent-profarma-2020-program 2026-04-15T08:47:01+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-2020-full-year-results 2026-04-15T08:47:01+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-new-england-journal-medicine-publication-phase-iii-data 2026-04-15T08:47:01+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-new-publication-british-journal-dermatology-ilumetrirv 2026-04-15T08:47:02+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-gianfranco-nazzi-new-ceo 2026-04-15T08:47:02+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-happify-health-enter-strategic-partnership-develop-evidence 2026-04-15T08:47:02+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/cdp-recognizes-almirall-its-commitment-fight-against-climate-change 2026-04-15T08:47:03+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-tyris-therapeutics-enter-strategic-partnership-develop-next 2026-04-15T08:47:03+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-fda-approval-klisyrir-tirbanibulin-new-innovative-topical 2026-04-15T08:47:03+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-has-selected-six-digital-health-start-ups-join-second-harvest-digital 2026-04-15T08:47:04+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-collaborations-university-south-australia-and-fundacio 2026-04-15T08:47:04+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/popit-and-almirall-start-offering-new-support-tool-help-psoriasis-patients 2026-04-15T08:47:04+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/pablo-alvarez-appointed-president-and-gm-almirall-us 2026-04-15T08:47:06+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-demonstrates-resilient-performance-year-date-despite-covid-19-impacts 2026-04-15T08:47:06+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/board-directors-nominates-carlos-gallardo-vice-president-board 2026-04-15T08:47:06+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/first-complete-dataset-il-23p19-class-demonstrates-ilumetrirv-tildrakizumab 2026-04-15T08:47:06+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-its-second-innovation-initiative-dermatology-focused-digital 2026-04-15T08:47:07+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-approval-reimbursed-price-ilumetrirtildrakizumab-france 2026-04-15T08:47:07+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-university-dundee-announce-multi-target-research-collaboration 2026-04-15T08:47:07+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/ceo-peter-guenter-leave-almirall-31122020-pursue-new-opportunities 2026-04-15T08:47:08+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/sustained-performance-key-growth-drivers-and-excellent-progress-pipeline-h1 2026-04-15T08:47:08+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-calls-collaborative-innovation-advance-new-treatments-skin-diseases 2026-04-15T08:47:08+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-joins-amr-action-fund-support-fight-against-antimicrobial-resistance 2026-04-15T08:47:10+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-enters-ibex-35 2026-04-15T08:47:10+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-e-ms-experts-summit-season-2020 2026-04-15T08:47:10+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-uc3m-and-medina-foundation-research-new-treatments-rare-genetic 2026-04-15T08:47:11+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/solid-q1-2020-performance 2026-04-15T08:47:11+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-ensure-business-continuity-all-drugs-essential-patients 2026-04-15T08:47:11+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announcement 2026-04-15T08:47:12+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-fda-acceptance-filing-us-new-drug-application-nda 2026-04-15T08:47:12+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-ema-acceptance-filing-marketing-authorization-application-0 2026-04-15T08:47:12+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-full-year-2019-results-strong-operational-performance-excellent 2026-04-15T08:47:12+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-paratek-enter-license-agreement-seysarar-china 2026-04-15T08:47:14+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-partners-plug-and-play-accelerate-digital-innovation-dermatology 2026-04-15T12:17:03+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-participate-jp-morgan-healthcare-conference-san-francisco 2026-04-15T08:47:16+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-signs-strategic-agreement-23andme-license-rights-bispecific-monoclonal 2026-04-15T08:47:16+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-wuxi-biologics-sign-strategic-collaboration-agreement-multiple 2026-04-15T08:47:16+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-enters-option-agreement-acquire-bioniz-therapeutics-and-establish 2026-04-15T08:47:16+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirallshare-responsible-50-private-public-collaborations-almirall 2026-04-15T08:47:18+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-iktos-announce-research-collaboration-artificial-intelligence-new 2026-04-15T08:47:18+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/volker-koscielny-new-chief-medical-officer-and-new-member-management-board 2026-04-15T08:47:18+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-accelerator-digital-garden-drive-digital-innovation 2026-04-15T08:47:18+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/majority-shareholders-almirall-give-mandate-increase-free-float 2026-04-15T08:47:20+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-llc-announces-publication-long-term-safety-data-use-seysarar 2026-04-15T08:47:20+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-9m-2019-business-results-continued-good-business-momentum-driven 2026-04-15T08:47:20+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/duaklirr-will-be-available-united-states-21st-october 2026-04-15T08:47:20+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/tildrakizumab-confirms-its-long-term-efficacy-and-safety-longest-il23p19-data 2026-04-15T08:47:22+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-initiation-phase-3-program-evaluating-lebrikizumab-patients 2026-04-15T08:47:22+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-takes-leap-dermatology-digital-health-innovation 2026-04-15T08:47:22+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-cfo-leadership-transition-mike-mcclellan-join-almirall 2026-04-15T08:47:22+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/scottish-medicines-consortium-smc-provisionally-approves-almiralls-ilumetrirv 2026-04-15T08:47:24+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-h1-2019-continued-strong-business-momentum-while-reinforcing-pipeline 2026-04-15T08:47:24+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-calls-partners-develop-new-immune-dermatology-therapies 2026-04-15T08:47:24+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-revalidates-its-excellence-occupational-health-and-safety-environment 2026-04-15T08:47:24+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-exercises-its-option-dermira-license-rights-lebrikizumab-europe-atopic 2026-04-15T08:47:26+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/investment-plan-europe-eib-finances-almiralls-research-new-skin-disease 2026-04-15T08:47:26+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-q1-2019-strong-operating-performance 2026-04-15T08:47:26+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/nice-publishes-final-recommendation-almiralls-ilumetrirv-tildrakizumab-cost 2026-04-15T08:47:26+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-recognized-distinguished-corporate-leader-american-skin-association 2026-04-15T08:48:25+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/fda-approves-duaklirr-new-drug-application-chronic-obstructive-pulmonary 2026-04-15T08:48:25+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-hitgen-will-develop-novel-oral-compounds-atopic-dermatitis 2026-04-15T08:48:25+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/nice-provisionally-approves-almiralls-ilumetrirv-tildrakizumab-cost-effective 2026-04-15T08:48:25+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-late-breaking-oral-presentation-kx2-391-ointment-two-phase 2026-04-15T10:50:11+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-nuevolution-partnership-achieves-first-collaboration-milestone 2026-04-15T08:48:26+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-full-year-2018-results 2026-04-15T08:48:26+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-dermira-enter-option-and-license-agreement-european-rights 2026-04-15T08:48:26+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirallshare-successful-platform-find-innovative-solutions-medical-dermatology 2026-04-15T08:48:28+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-late-breaking-oral-presentation-kx2-391-ointment-two-phase-0 2026-04-15T08:48:28+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/novel-oral-antibiotic-treatment-seysaratm-sarecycline-now-available-us 2026-04-15T08:48:28+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/francesca-domenech-wuttke-new-chief-digital-officer-and-new-member-management 2026-04-15T08:48:29+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-sa-present-jp-morgan-healthcare-conference-san-francisco 2026-04-15T08:48:29+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-successful-pricing-eu250-mm-offering-senior-unsecured 2026-04-15T08:48:29+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-refinance-us-medical-dermatology-acquisition 2026-04-15T08:48:29+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-ilumetrir-germany-moderate-severe-chronic-plaque-psoriasis 2026-04-15T08:48:31+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-9m-2018-business-results-strong-business-momentum 2026-04-15T08:48:31+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/fda-approves-seysaratm-new-chemical-entity-moderate-severe-acne 2026-04-15T08:48:31+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-closes-agreement-allergan-and-acquires-its-us-medical-dermatology 2026-04-15T08:48:32+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/european-commission-approves-almiralls-ilumetrir-tildrakizumab-moderate-severe 2026-04-15T08:48:32+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/transformational-transaction-almirall-acquire-us-medical-dermatology-portfolio 2026-04-15T08:48:32+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/strong-h1-2018-business-results-upgrading-ebitda-guidance 2026-04-15T08:48:34+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-receives-positive-chmp-opinion-new-anti-il23-tildrakizumab-treatment 2026-04-15T08:48:34+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-both-phase-iii-trials-kx2-391-actinic-keratosis-achieved 2026-04-15T08:48:34+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/thermi-announces-settlement-patent-infringement-litigation-viveve 2026-04-15T08:48:35+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-q1-2018-encouraging-financial-results 2026-04-15T08:48:35+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-full-year-2017-results 2026-04-15T08:48:35+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/thermi-and-sinclair-terminate-their-collaboration-silhouette-instalift-tm 2026-04-15T10:50:38+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-athenex-announce-strategic-partnership-treatment-actinic-keratosis 2026-04-15T08:48:36+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/phase-iv-ascent-trial-shows-tudorza-reduces-copd-exacerbations-and-demonstrates 2026-04-15T08:48:36+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-q3-results-2017 2026-04-15T08:48:36+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/new-randomized-controlled-study-confirms-efficacy-and-tolerability-profile 2026-04-15T08:48:38+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-skilarencer-europe-moderate-severe-chronic-plaque-psoriasis 2026-04-15T08:48:38+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-renews-its-corporate-identity-aligned-its-focus-skin-health 2026-04-15T08:48:38+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/phase-iii-amplify-study-shows-duaklir-significantly-improves-lung-function 2026-04-15T08:48:38+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-appoints-peter-guenter-new-ceo 2026-04-15T08:48:40+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-h1-results-2017-reiterating-recent-guidance 2026-04-15T08:48:40+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-collaborates-icmab-csic-and-leitat-technology-center-nanomedicine 2026-04-15T08:48:40+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-guidance-update-2017 2026-04-15T08:48:40+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/international-experts-elaborate-consensus-effects-present-and-potential-medical 2026-04-15T08:48:41+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-q1-results-2017-driven-dermatology-europe 2026-04-15T08:48:41+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/data-tildrakizumab-clinical-development-program-presented-2017-american-academy 2026-04-15T08:48:41+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-full-year-2016-results-strong-dermatology-results-and-promising 2026-04-15T08:48:43+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-y-mercachem-anuncian-una-colaboracion-para-el-desarrollo-de 2026-04-15T08:48:43+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-nuevolution-enter-strategic-collaboration-develop-rorgt-inhibitors 2026-04-15T08:48:43+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-9m-results-2016-strong-derma-performance-eu-and-solid-progress-us 2026-04-15T08:48:43+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-restructuring-plan-spain 2026-04-15T08:48:44+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-h1-results-2016-growth-total-revenues-and-net-sales-driven-dermatology 2026-04-15T08:48:44+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-bicosome-enter-collaboration-and-sublicense-agreement-development 2026-04-15T08:48:44+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-q1-results-2016-track-achieve-yearly-guidance 2026-04-15T08:48:46+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-reduces-its-accident-rate-69-spain-2015 2026-04-15T08:48:46+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-full-year-2015-results-normalized-net-income-growth-90 2026-04-15T08:48:46+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-closes-acquisition-thermigen-llc-entering-aesthetics-market 2026-04-15T08:48:46+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-exercises-call-option-acquire-100-thermigen-llc 2026-04-15T08:48:47+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-reaches-agreement-acquire-100-poli-group 2026-04-15T08:48:47+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-has-acquired-rights-veltinr-and-altabaxr-stiefel-gsk-company-exchange 2026-04-15T08:48:47+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-september-ytd-results-2015-operational-business-outperformance-driven 2026-04-15T08:48:48+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-closes-15-million-strategic-investment-suneva-medical 2026-04-15T08:48:48+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-h1-results-2015-growth-driven-strong-sales-increase-dermatology 2026-04-15T08:48:48+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-q1-results-2015-growth-acceleration-driven-dermatology 2026-04-15T08:48:48+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-full-year-2014-results-line-guidance 2026-04-15T08:48:50+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-finaliza-el-acuerdo-con-astrazeneca-en-el-area-respiratoria 2026-04-15T08:48:50+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-aclidinium-bromideformoterol-fumarate-recommended-approval-europe 2026-04-15T08:48:50+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-agrees-strategic-transaction-astrazeneca-respiratory-disease 2026-04-15T08:48:50+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-h1-results-2014-continued-growth-acceleration 2026-04-15T08:48:51+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-q1-results-2014-growth-acceleration 2026-04-15T08:48:51+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/forest-laboratories-and-almirall-provide-update-fixed-dose-combination 2026-04-15T08:48:51+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/index-pharmaceuticals-and-almirall-enter-license-agreement-european-rights 2026-04-15T12:22:28+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-completed-senior-notes-pricing-325-million-euros-7-year-maturity-and 2026-04-15T12:23:00+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-accident-rate-spain-2013-down-20 2026-04-15T08:48:53+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-full-year-results-2013-setting-foundations-accelerating-growth 2026-04-15T08:48:53+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-reaches-agreement-implement-reestructuring-plan-spain 2026-04-15T08:48:54+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-reaches-agreement-acquire-aqua-pharmaceuticals-us-based-specialty 2026-04-15T12:23:38+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-reorganization-program-affecting-group-europe 2026-04-15T08:48:54+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/around-clock-symptom-relief-vital-many-millions-chronic-obstructive-pulmonary 2026-04-15T08:48:54+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-q3-track-deliver-year-guidance-eklirar-genuairr-s-global-rollout 2026-04-15T08:48:56+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/aclidinium-and-formoterol-fixed-dose-combination-copd-submitted-registration 2026-04-15T08:48:56+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/aclidinium-chosen-one-best-spanish-therapeutic-innovations-international-reach 2026-04-15T08:48:56+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/new-data-reinforce-efficacy-and-safety-profile-sativexr-multiple-sclerosis 2026-04-15T08:48:56+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/importance-24-hours-symptom-relief-those-suffering-copd 2026-04-15T08:48:57+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/international-pharmaceutical-company-almirall-expands-global-footprint-new 2026-04-15T08:48:57+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-h1-executing-growth-platforms-financial-delivery-track 2026-04-15T08:48:57+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-50-below-pharmaceutical-sector-accident-rate 2026-04-15T08:48:57+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-maintains-its-commitment-environment-spain-and-germany 2026-04-15T08:48:59+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-pioneer-spain-being-awarded-iso-500012011-energy-management-system 2026-04-15T08:48:59+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/constellar-linaclotide-first-approved-prescription-therapy-new-class-treatments 2026-04-15T12:24:11+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/survey-reveals-two-five-european-persons-multiple-sclerosis-ms-under-35-are 2026-04-15T12:25:04+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-begins-transformation 2026-04-15T08:49:00+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-forest-laboratories-announce-positive-results-second-phase-iii 2026-04-15T12:26:17+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-forest-laboratories-announce-positive-results-phase-iii-study 2026-04-15T08:49:01+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-presents-latest-news-respiratory-diseases 2026-04-15T08:49:01+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/2012-results-line-guidance-positioning-almirall-transformative-growth-2013 2026-04-15T08:49:01+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/coordination-among-professionals-crucial-good-vascular-patient-care 2026-04-15T08:49:01+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-commercialises-neurofarmagen-innovative-genetic-test 2026-04-15T08:49:03+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/eklirar-genuairr-almirall-available-spain-treatment-copd 2026-04-15T08:49:03+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-celebrates-10-years-italy 2026-04-15T08:49:03+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-financial-calendar-2013 2026-04-15T08:49:03+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-forest-laboratories-announce-commercial-availability-tudorzatm 2026-04-15T12:27:34+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/constellar-linaclotide-approved-europe-treatment-irritable-bowel-syndrome 2026-04-15T12:28:32+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-appoints-karin-louise-dorrepaal-new-independent-board-member 2026-04-15T08:49:06+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/3rd-quarter-results 2026-04-15T08:49:06+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/low-awareness-chronic-obstructive-pulmonary-disease-copd-confirmed-recent 2026-04-15T12:29:08+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-invests-personalised-medicine-becoming-part-share-capital-ab-biotics 2026-04-15T11:57:50+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-incorporates-gerhard-mayr-board-directors 2026-04-15T08:49:08+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/sativexr-confirms-clinically-relevant-benefits-multiple-sclerosis-spasticity 2026-04-15T08:49:08+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-licenses-aclidinium-invida-australia-and 2026-04-15T08:49:08+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-eklirar-genuairr-aclidinium-europe 2026-04-15T10:58:06+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-obtains-rights-linaclotide-mexico 2026-04-15T08:49:10+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/eklirar-genuairr-provides-meaningful-and-sustained-bronchodilation-first-dose 2026-04-15T11:51:55+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/eklirarbretarisr-genuairr-aclidinium-bromide-approved-europe-maintenance 2026-04-15T11:56:55+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-forest-laboratories-announce-fda-approval-tudorzatm-pressairtm 2026-04-15T12:30:18+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/abediterol-almiralls-od-laba-shows-superiority-vs-indacaterol-phase-iia 2026-04-15T12:31:07+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/aclidinium-clinical-data-published-european-respiratory-journal-confirms 2026-04-15T12:31:50+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-supports-european-post-graduate-clinical-research-ms-spasticity-two 2026-04-15T12:32:28+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/sativexr-starts-new-wave-regulatory-submissions-europe 2026-04-15T12:32:58+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-starts-phase-iii-aclidinium-and-formoterol-copd 2026-04-15T12:33:53+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-roflumilast-spain 2026-04-24T12:32:06+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-nycomed-announce-licensing-agreement-ebastine-china-and-other-key 2026-04-15T11:40:56+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/una-nueva-guia-ayudara-los-medicos-en-el-manejo-de-la-osteoporosis 2026-04-15T11:55:17+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-appoints-alfredo-baron-area-director-southern-and-eastern-europe 2026-04-15T11:37:40+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/farid-taha-new-general-manager-almirall-germany-austria-and-switzerland 2026-04-15T11:36:52+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/nuevos-datos-avalan-la-seguridad-y-la-eficacia-del-bazedoxifeno-para-prevenir 2026-04-15T11:53:42+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-empresa-comprometida-con-la-formacion-de-los-gestores-sanitarios 2026-04-15T11:54:04+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/daniel-martinez-carretero-appointed-chief-financial-officer-cfo-almirall 2026-04-15T11:37:15+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-annual-general-meeting-approves-dividend-029-euros-share 2026-04-15T11:34:47+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-nycomed-announce-commercialization-agreement-roflumilast-spain 2026-04-15T11:35:20+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-strengthens-its-respiratory-franchise-new-generation-chronic 2026-04-15T11:36:00+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-apuesta-por-la-formacion-gestores-sanitarios-en-un-modelo-efectivo-de 2026-04-15T11:36:11+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-excellent-company-according-profarma-plan-ministry-industry-tourism 2026-04-15T11:32:51+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/ignasi-marti-rague-director-institutional-relations-almirall 2026-04-15T11:36:29+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-appointment-eduardo-sanchiz-new-ceo-july-1st-2011 2026-04-15T12:35:21+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/sativexr-launched-spain-treat-spasticity 2026-04-15T08:49:54+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-kyorin-announce-licensing-agreement-japan-aclidinium-bromide 2026-04-15T11:33:09+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-appoints-eloi-crespo-new-general-director-industrial-area 2026-04-15T11:33:36+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/el-manejo-precoz-del-paciente-diabetico-clave-para-conseguir-una-prevencion 2026-04-15T11:34:03+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/sativex-granted-reimbursement-spain-treatment-spasticity-multiple-sclerosis 2026-04-15T08:49:55+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-mexico-receives-distinction-companies-transparent-practices 2026-04-15T11:31:18+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/los-ultimos-avances-debate-en-el-x-symposium-de-psiquiatria-organizado-por 2026-04-15T11:30:46+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/bertil-lindmark-new-executive-director-rd-almirall 2026-04-21T10:00:56+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-forest-announce-positive-results-attain-phase-iii-study-aclidinium 2026-04-15T11:29:54+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/sativexr-enters-phase-iii-clinical-programme-oncological-pain 2026-04-15T08:49:58+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-ironwood-announce-positive-results-second-phase-iii-trial 2026-04-15T08:49:58+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-forest-report-preliminary-topline-results-accord-copd-ii-phase-iii 2026-04-15T08:50:00+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-apoya-el-programa-de-actividades-puesto-en-marcha-por-la-sed-y-su 2026-04-15T11:32:29+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/sativexr-data-presented-ectrims-congress-highlights-its-efficacy-add-therapy 2026-04-15T08:50:00+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-pioneer-obtaining-ohsas-18001-occupational-health-and-safety-renews 2026-04-15T11:12:41+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/launch-spain-urorecrsilodyxtm-new-treatment-symptoms-associated-benign 2026-04-15T11:12:13+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/conbrizar-bazedoxifene-approved-spanish-agency-medicines-and-healthcare 2026-04-15T11:17:45+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/research-chronic-pain-winning-project-pharmacology-award-presented-almirall-and 2026-04-15T11:10:40+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-receives-company-rating-excellent-ministry-industry-tourism-and-trade 2026-04-15T08:50:02+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-ironwood-announce-positive-results-phase-3-trial-linaclotide 2026-04-15T11:10:07+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-awarded-zero-rate-accident-frequency-2009 2026-04-15T11:28:06+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-signs-co-promotion-agreement-pfizer-commercialise-conbrizar-spain-new 2026-04-15T11:28:36+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-reaffirms-its-commitment-environment-renewal-its-iso-140012004 2026-04-15T11:09:38+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/el-tratamiento-integral-de-la-diabetes-tipo-2-y-su-cumplimiento-por-parte-del 2026-04-15T11:09:06+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/presentation-neogenius-project-brings-together-around-hundred-investigators 2026-04-15T08:50:05+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-international-agreement-basilea-commercialize-toctinor 2026-04-15T12:39:04+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-organiza-la-i-reunion-de-centros-de-excelencia-en-cardiologia-de 2026-04-15T12:39:28+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-annual-general-meeting-approves-dividend-033-euros-share-figure-5 2026-04-15T08:50:08+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-first-quarter-2010-track 2026-04-15T08:50:08+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-forest-present-data-studies-eklirar-aclidinium-bromide-chronic 2026-04-15T08:50:10+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/20-years-antihistamine-ebastelr-ebastine 2026-04-15T08:50:10+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-grants-eisai-marketing-rights-cinitapride-china 2026-04-15T08:50:10+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-thiomucase-extreme-areas-first-anti-cellulite-stick 2026-04-15T08:50:11+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-solid-performance-2009-setting-basis-sustainable-long-term-growth 2026-04-15T11:08:37+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/neogenius-alliance-between-almirall-esteve-palau-pharma-and-proteomika 2026-04-15T08:50:11+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/multidisciplinary-approach-improve-treatment-and-reduce-patient-cardiovascular 2026-04-15T08:50:12+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/silodosin-indicated-benign-prostatic-hyperplasia-bph-has-been-approved-european 2026-04-15T08:50:12+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-strengthens-its-focus-twice-daily-dosing-eklirar-chronic-obstructive 2026-04-15T08:50:12+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/9th-psychiatry-symposium-organized-almirall-presents-latest-advances-area 2026-04-15T08:50:14+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-forest-announce-positive-results-accord-copd-i-phase-iii-study 2026-04-15T08:50:14+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-forest-laboratories-expand-respiratory-collaboration-las100977 2026-04-15T08:50:14+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-parapres-plus-32r-and-parapres-plus-forter-treat-hypertension 2026-04-15T08:50:14+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/emeachmp-adopts-positive-opinion-silodosin 2026-04-15T08:50:15+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-reports-net-sales-7013-million-euros-increase-24 2026-04-15T08:50:15+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-dhodh-inhibitor-recognized-windhover-top-10-partnering-list 2026-04-15T08:50:15+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-us-15-m-equity-investment-ironwood-pharmaceuticals 2026-04-15T08:50:16+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/update-eklirar-aclidinium-bromide-chronic-obstructive-pulmonary-disease-copd 2026-04-15T11:24:03+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/blastoactiva-first-skin-cell-repair-cream-double-select-centella-asiatica 2026-04-15T08:50:16+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-spanish-society-pharmacology-present-8th-pharmacology-award-2009 2026-04-15T08:50:16+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-aims-file-once-daily-aclidinium-bromide-copd-europe-early-2010 2026-04-15T08:50:18+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-reports-over-103-million-euros-net-income-first-half-year-2009 2026-04-15T08:50:18+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-offers-its-employees-6500-hours-training-health-and-safety 2026-04-15T08:50:18+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-appoints-new-managing-director-its-market-company-poland 2026-04-15T08:50:19+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almotriptan-axertralmogranr-approved-fda-treatment-migraine-adolescents 2026-04-15T08:50:19+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-awards-dividend-payments-52-million-euros-its-shareholders 2026-04-15T08:50:19+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-reports-over-63-million-euros-net-income-first-quarter-2009 2026-04-15T08:50:21+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-launches-efficibr-spain-combination-product-sitagliptin-and-metformin 2026-04-15T08:50:22+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-signs-pan-european-licensing-agreement-ironwood-linaclotide-novel 2026-04-15T08:50:22+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-opens-its-doors-pharmaceutical-industry-mark-opening-new-london 2026-04-15T08:50:23+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/steve-webber-new-senior-discovery-director-almirall 2026-04-15T08:50:23+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-signs-co-marketing-agreement-recordati-marketing-silodosin-spain-new 2026-04-15T08:50:25+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-obtains-net-income-1361-million-euros-2008-38-more-previous-year 2026-04-15T08:50:25+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/encouraging-results-support-further-development-almiralls 2026-04-15T10:32:15+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/between-15-and-20-population-will-suffer-depression-some-time-during-their 2026-04-15T11:21:30+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/promising-results-almiralls-once-daily-long-acting-beta-agonist-laba-expected 2026-04-15T08:50:36+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/marc-ayas-new-director-international-human-resources-and-compensation-almirall 2026-04-15T08:50:36+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-ranke-quimica-reduced-its-accident-rate-57-2007 2026-04-15T08:50:36+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-obtains-total-revenues-around-809-million-euros-18-more-same-period 2026-04-15T08:50:36+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-signs-agreement-pfizer-commercialise-new-medicine-reduces 2026-04-15T08:50:38+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-signs-co-marketing-agreement-msd-commercialise-spain-new-medicine-type 2026-04-15T08:50:38+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/daniel-martinez-takes-new-position-deputy-cfo-almirall 2026-04-15T08:50:38+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-upgrades-its-company-website-wwwalmirallcom 2026-04-15T08:50:38+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-moving-forward-development-aclidinium-bromide 2026-04-15T11:20:44+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-receipt-15-million-dollars-eu105-million-forest-laboratories 2026-04-15T10:32:07+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-announces-initial-agreement-sale-its-plant-sant-just-desvern-lesvi 2026-04-15T08:50:41+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-receives-fundamed-el-global-award-best-pharmaceutical-company-year 2026-04-15T11:03:47+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-council-catalonian-medical-associations-fundacio-galatea-sign 2026-04-15T11:04:51+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-spa-be-awarded-spanish-company-year-italy 2026-04-15T11:05:11+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/el-dr-carsten-niederlander-nuevo-director-de-desarrollo-farmaceutico 2026-04-15T12:38:20+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/dr-olof-andersson-new-executive-director-rd-area-almirall 2026-04-15T11:05:34+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-reveals-promising-phase-ii-data-its-once-daily-long-acting-low 2026-04-15T10:32:27+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-confers-2003-pharmacology-award 2026-04-15T11:06:13+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-presents-its-new-corporate-website 2026-04-15T11:14:53+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-has-licensed-its-triptan-ortho-mcneil-pharmaceutical-inc-us-and-canada 2026-04-15T11:15:28+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-inaugurates-offices-china-advance-innovation-medical-dermatology 2026-04-30T09:02:10+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/lebrikizumab-delivered-significant-skin-clearance-and-improved-disease-severity 2026-04-30T09:49:44+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almiralls-17th-skin-academy-highlights-scientific-advances-inflammatory-skin 2026-04-30T09:08:27+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/aad-2026-almirall-presents-new-clinical-and-real-world-evidence-across-atopic 2026-04-30T09:24:15+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-enters-collaboration-huaota-development-novel-monoclonal-antibody 2026-04-30T09:28:50+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/lebrikizumab-delivered-long-term-disease-control-four-years-patients-moderate 2026-04-30T09:37:48+00:00 weekly 1 https://pre.almirall.fr/news-media/newsroom/almirall-and-barcelona-supercomputing-center-expand-their-collaboration 2026-04-30T09:47:14+00:00 weekly 1 https://pre.almirall.fr/dermatologie/acne 2026-08-17T12:21:49+00:00 weekly 1 https://pre.almirall.fr/dermatologie/alopecie-plaques 2026-08-17T10:47:14+00:00 weekly 1 https://pre.almirall.fr/dermatologie/cancer-keratinocytaire 2026-08-17T10:55:26+00:00 weekly 1 https://pre.almirall.fr/dermatologie/dermatite-atopique 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau/epidermolyse-bulleuse-congenitale/diagnostic 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/dermatologie/cancer-keratinocytaire/diagnostic 2026-07-21T08:27:20+00:00 weekly 1 https://pre.almirall.fr/dermatologie/alopecie-plaques/diagnostic 2026-08-17T12:35:25+00:00 weekly 1 https://pre.almirall.fr/dermatologie/hidradenite-suppuree/diagnostic 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/dermatologie/onychomycose/diagnostic 2026-08-17T11:34:42+00:00 weekly 1 https://pre.almirall.fr/dermatologie/dermatite-atopique/diagnostic 2026-07-21T07:47:31+00:00 weekly 1 https://pre.almirall.fr/dermatologie/keratose-actinique/diagnostic 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau/pustulose-palmoplantaire/diagnostic 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/dermatologie/acne/diagnostic 2026-07-21T07:51:29+00:00 weekly 1 https://pre.almirall.fr/dermatologie/psoriasis/diagnostic 2026-08-17T12:04:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/vitiligo/diagnostic 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau/epidermolyse-bulleuse-congenitale 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau/epidermolyse-bulleuse-congenitale/facteurs-declenchants 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau/pustulose-palmoplantaire/facteurs-declenchants 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/dermatologie/acne/facteurs-declenchants 2026-07-16T10:41:16+00:00 weekly 1 https://pre.almirall.fr/dermatologie/hidradenite-suppuree/facteurs-declenchants 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/dermatite-atopique/facteurs-declenchants 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/keratose-actinique/facteurs-declenchants 2026-08-17T12:23:43+00:00 weekly 1 https://pre.almirall.fr/dermatologie/psoriasis/facteurs-declenchants 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/onychomycose/facteurs-declenchants 2026-08-17T11:02:42+00:00 weekly 1 https://pre.almirall.fr/dermatologie/cancer-keratinocytaire/facteurs-declenchants 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/alopecie-plaques/facteurs-declenchants 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/vitiligo/facteurs-declenchants 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/hidradenite-suppuree 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/keratose-actinique 2026-08-17T12:37:41+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/onychomycose 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/psoriasis 2026-08-17T12:52:49+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau/pustulose-palmoplantaire 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/cancer-keratinocytaire/symptomes-manifestations 2026-07-21T09:42:51+00:00 weekly 1 https://pre.almirall.fr/dermatologie/alopecie-plaques/symptomes-manifestations 2026-07-21T08:09:34+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau/epidermolyse-bulleuse-congenitale/symptomes-manifestations 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/hidradenite-suppuree/symptomes-manifestations 2026-07-21T08:35:57+00:00 weekly 1 https://pre.almirall.fr/dermatologie/dermatite-atopique/symptomes-manifestations 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/keratose-actinique/symptomes-manifestations 2026-08-17T12:26:14+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau/pustulose-palmoplantaire/symptomes-manifestations 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/acne/symptomes-manifestations 2026-08-17T11:12:56+00:00 weekly 1 https://pre.almirall.fr/dermatologie/onychomycose/symptomes-manifestations 2026-08-17T11:20:17+00:00 weekly 1 https://pre.almirall.fr/dermatologie/vitiligo/symptomes-manifestations 2026-07-16T10:41:21+00:00 weekly 1 https://pre.almirall.fr/dermatologie/psoriasis/symptomes-manifestations 2026-08-17T11:47:55+00:00 weekly 1 https://pre.almirall.fr/dermatologie/cancer-keratinocytaire/traitement 2026-07-21T09:40:17+00:00 weekly 1 https://pre.almirall.fr/dermatologie/alopecie-plaques/traitement 2026-07-16T10:41:24+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau/epidermolyse-bulleuse-congenitale/traitement 2026-07-21T08:40:03+00:00 weekly 1 https://pre.almirall.fr/dermatologie/hidradenite-suppuree/traitement 2026-07-21T08:33:34+00:00 weekly 1 https://pre.almirall.fr/dermatologie/dermatite-atopique/traitement 2026-07-16T10:41:24+00:00 weekly 1 https://pre.almirall.fr/dermatologie/keratose-actinique/traitement 2026-07-21T07:31:31+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau/pustulose-palmoplantaire/traitement 2026-07-16T10:41:24+00:00 weekly 1 https://pre.almirall.fr/dermatologie/acne/traitement 2026-08-17T11:09:53+00:00 weekly 1 https://pre.almirall.fr/dermatologie/psoriasis/traitement 2026-08-17T11:37:19+00:00 weekly 1 https://pre.almirall.fr/dermatologie/vitiligo/traitement 2026-07-21T08:31:09+00:00 weekly 1 https://pre.almirall.fr/dermatologie/onychomycose/traitement 2026-07-21T09:37:34+00:00 weekly 1 https://pre.almirall.fr/dermatologie/alopecie-plaques/types 2026-07-16T10:41:24+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau/epidermolyse-bulleuse-congenitale/types 2026-07-16T10:41:24+00:00 weekly 1 https://pre.almirall.fr/dermatologie/hidradenite-suppuree/types 2026-07-16T10:41:24+00:00 weekly 1 https://pre.almirall.fr/dermatologie/onychomycose/types 2026-07-21T08:06:19+00:00 weekly 1 https://pre.almirall.fr/dermatologie/cancer-keratinocytaire/types 2026-08-17T11:04:47+00:00 weekly 1 https://pre.almirall.fr/dermatologie/dermatite-atopique/types 2026-07-16T10:41:24+00:00 weekly 1 https://pre.almirall.fr/dermatologie/keratose-actinique/types 2026-08-17T12:32:34+00:00 weekly 1 https://pre.almirall.fr/dermatologie/psoriasis/types 2026-07-16T10:41:24+00:00 weekly 1 https://pre.almirall.fr/dermatologie/maladies-rares-peau/pustulose-palmoplantaire/types 2026-07-16T10:41:24+00:00 weekly 1 https://pre.almirall.fr/dermatologie/vitiligo/types 2026-07-16T10:41:24+00:00 weekly 1 https://pre.almirall.fr/dermatologie/acne/types 2026-07-16T10:41:24+00:00 weekly 1 https://pre.almirall.fr/dermatologie/vitiligo 2026-07-16T10:41:24+00:00 weekly 1 https://pre.almirall.de 2026-07-16T08:28:04+00:00 weekly 1 https://pre.almirall.de/menschen 2026-07-14T12:25:08+00:00 weekly 1 https://pre.almirall.de/menschen/ueber-uns 2026-06-29T09:52:20+00:00 weekly 1 https://pre.almirall.de/menschen/lieferanten 2026-08-12T12:00:41+00:00 weekly 1 https://pre.almirall.de/menschen/zweck 2026-07-28T07:29:13+00:00 weekly 1 https://pre.almirall.de/patienten 2026-08-20T11:14:46+00:00 weekly 1 https://pre.almirall.de/menschen/standorte 2026-07-22T10:49:04+00:00 weekly 1 https://pre.almirall.de/menschen/nachhaltigkeit/menschen 2026-06-29T10:28:13+00:00 weekly 1 https://pre.almirall.de/menschen/nachhaltigkeit/prinzipien 2026-07-23T08:40:52+00:00 weekly 1 https://pre.almirall.de/patienten/psychisches-wohlbefinden 2026-06-25T16:18:32+00:00 weekly 1 https://pre.almirall.de/patienten/engagement/kampagnen 2026-06-30T17:15:56+00:00 weekly 1 https://pre.almirall.de/menschen/nachhaltigkeit/planet 2026-06-29T10:25:10+00:00 weekly 1 https://pre.almirall.de/menschen/nachhaltigkeit 2026-06-30T16:24:39+00:00 weekly 1 https://pre.almirall.de/menschen/nachhaltigkeit/patienten 2026-06-25T18:02:52+00:00 weekly 1 https://pre.almirall.de/menschen/nachhaltigkeit/partner 2026-06-29T10:34:36+00:00 weekly 1 https://pre.almirall.de/patienten/geschichten 2026-06-25T16:25:36+00:00 weekly 1 https://pre.almirall.de/patients/commitment/campaigns/sanctuary-salon 2026-05-12T09:17:21+00:00 weekly 1 https://pre.almirall.de/investoren/CNMV-mitteilungen 2026-05-20T14:55:56+00:00 weekly 1 https://pre.almirall.de/investoren/corporate-governance 2026-05-20T14:56:38+00:00 weekly 1 https://pre.almirall.de/investoren/corporate-governance/hauptversammlung 2026-05-20T14:57:04+00:00 weekly 1 https://pre.almirall.de/innovation/clinical-trials 2026-05-11T12:38:21+00:00 weekly 1 https://pre.almirall.de/innovation/fe-kooperation 2026-06-16T06:29:27+00:00 weekly 1 https://pre.almirall.de/innovation/partnerschaften 2026-06-16T06:23:12+00:00 weekly 1 https://pre.almirall.de/investoren/corporate-governance/vereinbarungen 2026-05-20T14:57:18+00:00 weekly 1 https://pre.almirall.de/investoren/corporate-governance/vorstand 2026-05-20T15:03:56+00:00 weekly 1 https://pre.almirall.de/investoren/corporate-governance/vorstandsausschuesse 2026-05-20T15:02:44+00:00 weekly 1 https://pre.almirall.de/dermatologie 2026-06-30T15:36:05+00:00 weekly 1 https://pre.almirall.de/investoren/berichte/jahresberichte 2026-05-20T15:03:36+00:00 weekly 1 https://pre.almirall.de/innovation 2026-06-25T16:08:15+00:00 weekly 1 https://pre.almirall.de/investoren/boerseninformationen 2026-05-20T14:46:16+00:00 weekly 1 https://pre.almirall.de/investoren/boerseninformationen/aktienperformance 2026-05-20T14:47:04+00:00 weekly 1 https://pre.almirall.de/investoren/boerseninformationen/aktienkapital 2026-05-20T14:47:48+00:00 weekly 1 https://pre.almirall.de/investoren/boerseninformationen/analystenabdeckung 2026-05-20T14:54:53+00:00 weekly 1 https://pre.almirall.de/investoren/boerseninformationen/finanzierungsaktionen 2026-05-20T14:49:06+00:00 weekly 1 https://pre.almirall.de/investoren/finanzdaten/ergebnisse-abschluesse 2026-05-20T14:55:02+00:00 weekly 1 https://pre.almirall.de/investoren/finanzdaten/oeffentliche-informationen 2026-05-20T14:55:18+00:00 weekly 1 https://pre.almirall.de/investoren/finanzdaten/informationsmaterialien 2026-05-20T14:55:45+00:00 weekly 1 https://pre.almirall.de/innovation/pipeline 2026-07-28T07:14:33+00:00 weekly 1 https://pre.almirall.de/investoren/unternehmensfuhrung 2026-05-20T15:03:07+00:00 weekly 1 https://pre.almirall.de/investoren/berichte 2026-05-20T15:03:27+00:00 weekly 1 https://pre.almirall.de/nachrichten-medien/newsroom 2026-06-26T06:48:48+00:00 weekly 1 https://pre.almirall.de/patienten/engagement 2026-08-31T08:24:05+00:00 weekly 1 https://pre.almirall.de/investoren/corporate-governance/compliance 2026-05-20T15:03:51+00:00 weekly 1 https://pre.almirall.de/menschen/integritaet 2026-06-10T13:26:23+00:00 weekly 1 https://pre.almirall.de/menschen/faq 2026-06-15T11:21:02+00:00 weekly 1 https://pre.almirall.de/menschen/faq/produkte 2026-06-02T11:00:43+00:00 weekly 1 https://pre.almirall.de/menschen/faq/pathologie 2026-07-28T09:03:40+00:00 weekly 1 https://pre.almirall.de/menschen/faq/therapiegebiete 2026-06-25T18:51:31+00:00 weekly 1 https://pre.almirall.de/investoren/fuehrung/management-board 2026-05-20T15:03:18+00:00 weekly 1 https://pre.almirall.de/menschen/geschichte 2026-05-20T07:05:10+00:00 weekly 1 https://pre.almirall.de/investoren/unternehmensfuehrung/governance-direktor 2026-05-20T15:02:58+00:00 weekly 1 https://pre.almirall.de/kontakt/nebenwirkung-melden 2026-07-27T11:24:04+00:00 weekly 1 https://pre.almirall.de/vorstand-richtlinien 2026-05-19T11:00:17+00:00 weekly 1 https://pre.almirall.de/nachrichten-medien/kontakt 2026-05-19T11:11:44+00:00 weekly 1 https://pre.almirall.de/nachrichten-medien/veranstaltungskalender 2026-05-19T12:30:02+00:00 weekly 1 https://pre.almirall.de/nachrichten-medien 2026-06-25T16:06:12+00:00 weekly 1 https://pre.almirall.de/kontakt/medien 2026-05-19T11:50:52+00:00 weekly 1 https://pre.almirall.de/kontakt/investoren 2026-05-19T11:52:49+00:00 weekly 1 https://pre.almirall.de/kontakt/forschung-entwicklung 2026-05-19T12:00:30+00:00 weekly 1 https://pre.almirall.de/kontakt/menschen-kultur 2026-05-19T11:54:51+00:00 weekly 1 https://pre.almirall.de/kontakt/partner 2026-05-19T11:56:44+00:00 weekly 1 https://pre.almirall.de/kontakt/medizinische-informationen 2026-05-19T11:59:00+00:00 weekly 1 https://pre.almirall.de/kontakt/verbesserung 2026-05-19T12:02:28+00:00 weekly 1 https://pre.almirall.de/nachrichten-medien/medienressourcen 2026-06-25T16:00:21+00:00 weekly 1 https://pre.almirall.de/patients/commitment/campaigns/sanctuary-salon/patients 2026-05-12T09:21:16+00:00 weekly 1 https://pre.almirall.de/agb 2026-06-25T15:58:17+00:00 weekly 1 https://pre.almirall.de/menschen/nachhaltigkeit/transparenz 2026-07-06T07:52:45+00:00 weekly 1 https://pre.almirall.de/globale-datenschutzrichtlinie-veranstaltungen 2026-07-13T08:49:40+00:00 weekly 1 https://pre.almirall.de/datenschutzhinweis 2026-06-12T06:51:19+00:00 weekly 1 https://pre.almirall.de/datenschutzrichtlinie-hcp 2026-05-19T11:03:30+00:00 weekly 1 https://pre.almirall.de/barrierefreiheit 2026-06-30T07:03:59+00:00 weekly 1 https://pre.almirall.de/cookies-einstellungen 2026-05-19T11:05:07+00:00 weekly 1 https://pre.almirall.de/nutzungsbedingungen 2026-05-19T10:59:15+00:00 weekly 1 https://pre.almirall.de/arzneimittelsicherheit 2026-07-20T11:21:51+00:00 weekly 1 https://pre.almirall.de/company/sustainability/other-relevant-documentation 2026-05-11T10:24:51+00:00 weekly 1 https://pre.almirall.de/kontakt 2026-06-30T19:04:24+00:00 weekly 1 https://pre.almirall.de/datenschutzhinweise-karriere 2026-05-19T10:56:27+00:00 weekly 1 https://pre.almirall.de/impressum 2026-06-15T07:08:34+00:00 weekly 1 https://pre.almirall.de/medizinisches-fachpersonal/produkte 2026-06-30T17:28:52+00:00 weekly 1 https://pre.almirall.de/medizinisches-fachpersonal 2026-07-07T12:05:49+00:00 weekly 1 https://pre.almirall.de/news-media/newsroom/physiorelaxr-erweitert-portfolio-fur-aktive-lebensstile-bereit-fur-jede 2026-06-24T10:37:58+00:00 weekly 1 https://pre.almirall.de/news-media/newsroom/neu-ab-juni-weitere-darreichungsformen-und-packungsgrossen-physiorelaxr 2026-06-24T10:37:51+00:00 weekly 1 https://pre.almirall.de/news-media/newsroom/almirall-erweitert-portfolio-zur-behandlung-und-vorbeugung-von-haut-und 2026-06-24T10:37:44+00:00 weekly 1 https://pre.almirall.de/news-media/newsroom/almirall-erweitert-mykosenportfolio-neu-der-apotheke-pravention-und 2026-06-24T11:47:53+00:00 weekly 1 https://pre.almirall.de/dermatologie/akne 2026-06-25T21:14:46+00:00 weekly 1 https://pre.almirall.de/dermatologie/aktinische-keratosen 2026-06-30T18:04:55+00:00 weekly 1 https://pre.almirall.de/dermatologie/aktinische-keratosen/anzeichen-symptome 2026-06-25T20:45:27+00:00 weekly 1 https://pre.almirall.de/dermatologie/kreisrunder-haarausfall/anzeichen-symptome 2026-07-27T16:26:04+00:00 weekly 1 https://pre.almirall.de/dermatologie/atopische-dermatitis/anzeichen-symptome 2026-06-25T21:01:41+00:00 weekly 1 https://pre.almirall.de/dermatologie/pilzinfektionen/anzeichen-symptome 2026-06-25T21:34:42+00:00 weekly 1 https://pre.almirall.de/dermatologie/akne/anzeichen-symptome 2026-06-25T21:17:01+00:00 weekly 1 https://pre.almirall.de/dermatologie/keratozytenkrebs/anzeichen-symptome 2026-07-09T08:39:35+00:00 weekly 1 https://pre.almirall.de/dermatologie/schuppenflechte/anzeichen-symptome 2026-06-12T10:41:19+00:00 weekly 1 https://pre.almirall.de/dermatologie/aktinische-keratosen/typen 2026-06-12T10:51:41+00:00 weekly 1 https://pre.almirall.de/dermatologie/atopische-dermatitis/typen 2026-06-25T20:57:55+00:00 weekly 1 https://pre.almirall.de/dermatologie/kreisrunder-haarausfall/typen 2026-07-28T07:01:37+00:00 weekly 1 https://pre.almirall.de/dermatologie/akne/typen 2026-06-25T21:25:00+00:00 weekly 1 https://pre.almirall.de/dermatologie/keratozytenkrebs/typen 2026-05-20T13:38:18+00:00 weekly 1 https://pre.almirall.de/dermatologie/pilzinfektionen/typen 2026-06-25T21:35:12+00:00 weekly 1 https://pre.almirall.de/dermatologie/schuppenflechte/typen 2026-06-30T17:53:51+00:00 weekly 1 https://pre.almirall.de/dermatologie/kreisrunder-haarausfall/ausloesende-faktoren 2026-07-27T15:58:31+00:00 weekly 1 https://pre.almirall.de/dermatologie/pilzinfektionen/ausloesende-faktoren 2026-06-25T21:34:28+00:00 weekly 1 https://pre.almirall.de/dermatologie/aktinische-keratosen/ausloesende-faktoren 2026-06-25T20:41:27+00:00 weekly 1 https://pre.almirall.de/dermatologie/atopische-dermatitis/ausloesende-faktoren 2026-06-30T18:48:54+00:00 weekly 1 https://pre.almirall.de/dermatologie/akne/ausloesende-faktoren 2026-06-12T12:20:26+00:00 weekly 1 https://pre.almirall.de/dermatologie/keratozytenkrebs/ausloesende-faktoren 2026-06-25T21:59:02+00:00 weekly 1 https://pre.almirall.de/dermatologie/schuppenflechte/ausloesende-faktoren 2026-06-15T13:55:56+00:00 weekly 1 https://pre.almirall.de/dermatologie/aktinische-keratosen/behandlungen 2026-07-02T10:47:39+00:00 weekly 1 https://pre.almirall.de/dermatologie/pilzinfektionen/behandlungen 2026-06-25T21:30:30+00:00 weekly 1 https://pre.almirall.de/dermatologie/akne/behandlungen 2026-06-25T21:15:39+00:00 weekly 1 https://pre.almirall.de/dermatologie/atopische-dermatitis/behandlungen 2026-06-25T20:59:33+00:00 weekly 1 https://pre.almirall.de/dermatologie/atopische-dermatitis/diagnose 2026-06-25T20:57:44+00:00 weekly 1 https://pre.almirall.de/dermatologie/kreisrunder-haarausfall/diagnose 2026-07-27T16:40:47+00:00 weekly 1 https://pre.almirall.de/dermatologie/aktinische-keratosen/diagnose 2026-06-25T20:49:38+00:00 weekly 1 https://pre.almirall.de/dermatologie/pilzinfektionen/diagnose 2026-06-25T21:44:18+00:00 weekly 1 https://pre.almirall.de/dermatologie/akne/diagnose 2026-06-25T21:22:07+00:00 weekly 1 https://pre.almirall.de/dermatologie/keratozytenkrebs/diagnose 2026-06-09T08:43:30+00:00 weekly 1 https://pre.almirall.de/dermatologie/schuppenflechte/diagnose 2026-06-12T10:41:44+00:00 weekly 1 https://pre.almirall.de/dermatologie/keratozytenkrebs 2026-06-25T22:06:43+00:00 weekly 1 https://pre.almirall.de/dermatologie/kreisrunder-haarausfall 2026-07-27T12:52:12+00:00 weekly 1 https://pre.almirall.de/dermatologie/atopische-dermatitis 2026-08-20T10:54:59+00:00 weekly 1 https://pre.almirall.de/dermatologie/pilzinfektionen 2026-08-20T10:17:42+00:00 weekly 1 https://pre.almirall.de/dermatologie/schuppenflechte 2026-06-30T17:52:25+00:00 weekly 1 https://pre.almirall.de/dermatologie/schuppenflechte/behandlungen 2026-06-26T07:13:53+00:00 weekly 1 https://pre.almirall.de/dermatologie/seltene-hautkrankheiten 2026-07-27T11:14:27+00:00 weekly 1 https://pre.almirall.it 2026-07-24T08:37:55+00:00 weekly 1 https://pre.almirall.it/azienda 2026-09-01T15:32:26+00:00 weekly 1 https://pre.almirall.it/azienda/chi-siamo 2026-07-16T12:13:04+00:00 weekly 1 https://pre.almirall.it/azienda/fornitori 2026-09-02T09:16:41+00:00 weekly 1 https://pre.almirall.it/azienda/scopo 2026-07-10T10:20:06+00:00 weekly 1 https://pre.almirall.it/pazienti 2026-07-16T12:14:44+00:00 weekly 1 https://pre.almirall.it/azienda/sedi 2026-07-02T09:02:07+00:00 weekly 1 https://pre.almirall.it/azienda/sostenibilita/persone 2026-07-13T12:22:02+00:00 weekly 1 https://pre.almirall.it/azienda/sostenibilita/principi 2026-07-23T08:48:10+00:00 weekly 1 https://pre.almirall.it/pazienti/benessere-psicologico 2026-06-03T16:09:23+00:00 weekly 1 https://pre.almirall.it/pazienti/impegno/campagne 2026-08-26T11:29:20+00:00 weekly 1 https://pre.almirall.it/azienda/sostenibilita/pianeta 2026-07-10T10:10:01+00:00 weekly 1 https://pre.almirall.it/azienda/sostenibilita 2026-09-04T12:47:36+00:00 weekly 1 https://pre.almirall.it/azienda/sostenibilita/pazienti 2026-05-12T14:58:54+00:00 weekly 1 https://pre.almirall.it/azienda/sostenibilita/partner 2026-06-24T18:43:26+00:00 weekly 1 https://pre.almirall.it/pazienti/storie 2026-07-28T12:40:26+00:00 weekly 1 https://pre.almirall.it/pazienti/impegno/campagne/sanctuary-salon 2026-06-24T14:44:49+00:00 weekly 1 https://pre.almirall.it/investitori 2026-05-18T10:57:04+00:00 weekly 1 https://pre.almirall.it/investitori/comunicazioni-CNMV 2026-05-12T15:50:29+00:00 weekly 1 https://pre.almirall.it/investitori/governance-aziendale 2026-05-12T17:50:44+00:00 weekly 1 https://pre.almirall.it/investitori/governance-aziendale/assemblea-annuale 2026-05-12T15:51:45+00:00 weekly 1 https://pre.almirall.it/innovazione/studi-clinici 2026-07-13T12:38:32+00:00 weekly 1 https://pre.almirall.it/innovazione/collaborazione-rs 2026-07-13T12:40:41+00:00 weekly 1 https://pre.almirall.it/innovazione/partner 2026-05-12T09:26:56+00:00 weekly 1 https://pre.almirall.it/investitori/governance-aziendale/accordi 2026-05-12T15:50:08+00:00 weekly 1 https://pre.almirall.it/investitori/governance-aziendale/consiglio-amministrazione 2026-05-12T15:29:49+00:00 weekly 1 https://pre.almirall.it/investitori/governance-aziendale/commissioni-consiglio 2026-05-12T15:29:42+00:00 weekly 1 https://pre.almirall.it/dermatologia 2026-07-08T10:34:00+00:00 weekly 1 https://pre.almirall.it/investitori/report/annuale 2026-05-12T15:29:14+00:00 weekly 1 https://pre.almirall.it/investitori/report/annuale/2021 2026-05-12T15:29:06+00:00 weekly 1 https://pre.almirall.it/innovazione 2026-06-24T14:15:48+00:00 weekly 1 https://pre.almirall.it/innovazione/letteratura-scientifica 2026-05-27T05:58:46+00:00 weekly 1 https://pre.almirall.it/investitori/informazioni-borsistiche 2026-05-12T15:48:27+00:00 weekly 1 https://pre.almirall.it/investitori/informazioni-borsistiche/performance-azioni 2026-05-12T15:48:11+00:00 weekly 1 https://pre.almirall.it/investitori/informazioni-borsistiche/capitale-sociale 2026-05-12T15:49:45+00:00 weekly 1 https://pre.almirall.it/investitori/informazioni-borsistiche/copertura-analisti 2026-05-12T15:49:53+00:00 weekly 1 https://pre.almirall.it/investitori/informazioni-borsistiche/azioni-finanziamento 2026-05-12T15:48:18+00:00 weekly 1 https://pre.almirall.it/investitori/dati-finanziari/risultati-conti 2026-05-12T15:48:48+00:00 weekly 1 https://pre.almirall.it/investitori/dati-finanziari/informazioni-pubbliche 2026-05-12T15:48:41+00:00 weekly 1 https://pre.almirall.it/investitori/dati-finanziari/materiali-informativi 2026-05-12T15:30:13+00:00 weekly 1 https://pre.almirall.it/innovazione/pipeline 2026-05-12T15:19:59+00:00 weekly 1 https://pre.almirall.it/investitori/leadership 2026-05-12T15:29:32+00:00 weekly 1 https://pre.almirall.it/investitori/report 2026-05-12T15:50:00+00:00 weekly 1 https://pre.almirall.it/actualites-media/sala-stampa 2026-06-03T14:00:55+00:00 weekly 1 https://pre.almirall.it/pazienti/impegno 2026-09-07T11:40:52+00:00 weekly 1 https://pre.almirall.it/investitori/governance-aziendale/compliance 2026-05-12T15:30:07+00:00 weekly 1 https://pre.almirall.it/azienda/integrita 2026-06-24T18:06:27+00:00 weekly 1 https://pre.almirall.it/politica-privacy 2026-05-13T13:00:34+00:00 weekly 1 https://pre.almirall.it/termini-condizioni 2026-07-16T12:08:06+00:00 weekly 1 https://pre.almirall.it/politica-privacy-hcp 2026-05-13T12:58:09+00:00 weekly 1 https://pre.almirall.it/politica-accessibilita 2026-06-30T07:30:16+00:00 weekly 1 https://pre.almirall.it/azienda/faq 2026-07-08T11:14:01+00:00 weekly 1 https://pre.almirall.it/azienda/faq/prodotti 2026-06-03T15:46:55+00:00 weekly 1 https://pre.almirall.it/azienda/faq/patologia 2026-06-03T15:46:08+00:00 weekly 1 https://pre.almirall.it/azienda/faq/aree-terapeutiche 2026-06-03T15:45:16+00:00 weekly 1 https://pre.almirall.it/investitori/leadership/comitato-direzione 2026-05-12T15:29:23+00:00 weekly 1 https://pre.almirall.it/azienda/storia 2026-06-10T07:52:37+00:00 weekly 1 https://pre.almirall.it/investitori/governance-aziendale/direttore-governance 2026-05-12T15:29:59+00:00 weekly 1 https://pre.almirall.it/contatti/segnala-effetto-avverso 2026-09-02T09:48:58+00:00 weekly 1 https://pre.almirall.it/contatti 2026-09-02T09:49:00+00:00 weekly 1 https://pre.almirall.it/cookie-policy 2026-05-13T13:04:10+00:00 weekly 1 https://pre.almirall.it/politiche-consiglio 2026-09-02T09:25:53+00:00 weekly 1 https://pre.almirall.it/actualites-media/contatto 2026-05-12T16:29:26+00:00 weekly 1 https://pre.almirall.it/actualites-media/calendario-eventi 2026-05-12T15:51:28+00:00 weekly 1 https://pre.almirall.it/actualites-media 2026-07-22T09:43:58+00:00 weekly 1 https://pre.almirall.it/avvisi 2026-05-11T10:33:18+00:00 weekly 1 https://pre.almirall.it/contatti/media 2026-05-13T12:33:15+00:00 weekly 1 https://pre.almirall.it/contatti/investitori 2026-05-13T12:31:49+00:00 weekly 1 https://pre.almirall.it/contatti/ricerca-sviluppo 2026-05-12T16:42:03+00:00 weekly 1 https://pre.almirall.it/contatti/persone-cultura 2026-05-19T10:05:15+00:00 weekly 1 https://pre.almirall.it/contatti/partner 2026-05-12T16:40:30+00:00 weekly 1 https://pre.almirall.it/contatti/informazioni-mediche 2026-05-12T16:41:02+00:00 weekly 1 https://pre.almirall.it/contatti/aiutaci-migliorare 2026-06-25T06:39:44+00:00 weekly 1 https://pre.almirall.it/actualites-media/risorse-media 2026-06-03T14:10:55+00:00 weekly 1 https://pre.almirall.it/pazienti/impegno/campagne/sanctuary-salon/pazienti 2026-06-24T14:34:05+00:00 weekly 1 https://pre.almirall.it/informativa-privacy-carriere 2026-05-19T10:11:12+00:00 weekly 1 https://pre.almirall.it/sicurezza-farmaci 2026-05-12T10:18:19+00:00 weekly 1 https://pre.almirall.it/termini-utilizzo 2026-06-25T06:36:39+00:00 weekly 1 https://pre.almirall.it/azienda/sostenibilita/trasparenza 2026-09-08T15:44:26+00:00 weekly 1 https://pre.almirall.it/informativa-privacy-globale-eventi 2026-07-13T07:53:56+00:00 weekly 1 https://pre.almirall.it/professionisti-sanitari/prodotti 2026-06-24T14:24:17+00:00 weekly 1 https://pre.almirall.it/professionisti-sanitari 2026-07-13T12:28:05+00:00 weekly 1 https://pre.almirall.it/news/almirall-recognized-distinguished-corporate-leader-american-skin-association-unveiled-patient 2026-04-01T09:41:04+00:00 weekly 1 https://pre.almirall.it/news/fda-approves-duaklirr-new-drug-application-chronic-obstructive-pulmonary-disease-copd 2026-04-01T09:41:04+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-hitgen-will-develop-novel-oral-compounds-atopic-dermatitis 2026-04-01T09:41:04+00:00 weekly 1 https://pre.almirall.it/news/nice-provisionally-approves-almiralls-ilumetrirv-tildrakizumab-cost-effective-option-adults 2026-04-01T09:41:06+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-late-breaking-oral-presentation-kx2-391-ointment-two-phase-iii-studies 2026-04-01T09:41:06+00:00 weekly 1 https://pre.almirall.it/news/almirall-nuevolution-partnership-achieves-first-collaboration-milestone-dermatology-diseases 2026-04-01T09:41:07+00:00 weekly 1 https://pre.almirall.it/news/almiralls-full-year-2018-results 2026-04-01T09:41:07+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-dermira-enter-option-and-license-agreement-european-rights-lebrikizumab 2026-04-01T09:41:08+00:00 weekly 1 https://pre.almirall.it/news/almirallshare-successful-platform-find-innovative-solutions-medical-dermatology 2026-04-01T09:41:08+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-late-breaking-oral-presentation-kx2-391-ointment-two-phase-iii-studies-0 2026-04-01T09:41:08+00:00 weekly 1 https://pre.almirall.it/news/novel-oral-antibiotic-treatment-seysaratm-sarecycline-now-available-us 2026-04-01T09:41:10+00:00 weekly 1 https://pre.almirall.it/news/francesca-domenech-wuttke-new-chief-digital-officer-and-new-member-management-board-almirall 2026-04-01T09:41:10+00:00 weekly 1 https://pre.almirall.it/news/almirall-sa-present-jp-morgan-healthcare-conference-san-francisco 2026-04-01T09:41:10+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-successful-pricing-eu250-mm-offering-senior-unsecured-conditionally 2026-04-01T09:41:11+00:00 weekly 1 https://pre.almirall.it/news/almirall-refinance-us-medical-dermatology-acquisition 2026-04-01T09:41:11+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-ilumetrir-germany-moderate-severe-chronic-plaque-psoriasis-adults 2026-04-01T09:41:13+00:00 weekly 1 https://pre.almirall.it/news/almirall-9m-2018-business-results-strong-business-momentum 2026-04-01T09:41:13+00:00 weekly 1 https://pre.almirall.it/news/fda-approves-seysaratm-new-chemical-entity-moderate-severe-acne 2026-04-01T09:41:14+00:00 weekly 1 https://pre.almirall.it/news/almirall-closes-agreement-allergan-and-acquires-its-us-medical-dermatology-portfolio 2026-04-01T09:41:14+00:00 weekly 1 https://pre.almirall.it/news/european-commission-approves-almiralls-ilumetrir-tildrakizumab-moderate-severe-chronic-plaque 2026-04-01T09:41:15+00:00 weekly 1 https://pre.almirall.it/news/transformational-transaction-almirall-acquire-us-medical-dermatology-portfolio-allergan 2026-04-01T09:41:15+00:00 weekly 1 https://pre.almirall.it/news/strong-h1-2018-business-results-upgrading-ebitda-guidance 2026-04-01T09:41:17+00:00 weekly 1 https://pre.almirall.it/news/almirall-receives-positive-chmp-opinion-new-anti-il23-tildrakizumab-treatment-patients 2026-04-01T09:41:17+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-both-phase-iii-trials-kx2-391-actinic-keratosis-achieved-primary-endpoint 2026-04-01T09:41:18+00:00 weekly 1 https://pre.almirall.it/news/almirall-seeks-new-compounds-improve-skin-health 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/thermi-announces-settlement-patent-infringement-litigation-viveve 2026-04-01T09:41:18+00:00 weekly 1 https://pre.almirall.it/news/almirall-q1-2018-encouraging-financial-results 2026-04-01T09:41:20+00:00 weekly 1 https://pre.almirall.it/news/almiralls-full-year-2017-results 2026-04-01T09:41:20+00:00 weekly 1 https://pre.almirall.it/news/thermi-and-sinclair-terminate-their-collaboration-silhouette-instalifttm 2026-04-01T09:41:21+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-athenex-announce-strategic-partnership-treatment-actinic-keratosis 2026-04-01T09:41:21+00:00 weekly 1 https://pre.almirall.it/news/phase-iv-ascent-trial-shows-tudorza-reduces-copd-exacerbations-and-demonstrates-cardiovascular 2026-04-01T09:41:22+00:00 weekly 1 https://pre.almirall.it/news/almiralls-q3-results-2017 2026-04-01T09:41:22+00:00 weekly 1 https://pre.almirall.it/news/new-randomized-controlled-study-confirms-efficacy-and-tolerability-profile-sativexr-treatment 2026-04-01T09:41:24+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-skilarencer-europe-moderate-severe-chronic-plaque-psoriasis 2026-04-01T09:41:24+00:00 weekly 1 https://pre.almirall.it/news/almirall-renews-its-corporate-identity-aligned-its-focus-skin-health 2026-04-01T09:41:25+00:00 weekly 1 https://pre.almirall.it/news/phase-iii-amplify-study-shows-duaklir-significantly-improves-lung-function-moderate-very 2026-04-01T09:41:25+00:00 weekly 1 https://pre.almirall.it/news/almirall-appoints-peter-guenter-new-ceo 2026-04-01T09:41:25+00:00 weekly 1 https://pre.almirall.it/news/almiralls-h1-results-2017-reiterating-recent-guidance 2026-04-01T09:41:27+00:00 weekly 1 https://pre.almirall.it/news/almirall-collaborates-icmab-csic-and-leitat-technology-center-nanomedicine-applied-dermatology 2026-04-01T09:41:27+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-guidance-update-2017 2026-04-01T09:41:28+00:00 weekly 1 https://pre.almirall.it/news/international-experts-elaborate-consensus-effects-present-and-potential-medical-utilities 2026-04-01T09:41:28+00:00 weekly 1 https://pre.almirall.it/news/almiralls-q1-results-2017-driven-dermatology-europe 2026-04-01T09:41:28+00:00 weekly 1 https://pre.almirall.it/news/data-tildrakizumab-clinical-development-program-presented-2017-american-academy-dermatology 2026-04-01T09:41:30+00:00 weekly 1 https://pre.almirall.it/news/almirall-full-year-2016-results-strong-dermatology-results-and-promising-pipeline 2026-04-01T09:41:30+00:00 weekly 1 https://pre.almirall.it/news/almirall-y-mercachem-anuncian-una-colaboracion-para-el-desarrollo-de-bloqueadores-de 2026-04-01T09:41:30+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-nuevolution-enter-strategic-collaboration-develop-rorgt-inhibitors-treatment 2026-04-01T09:41:31+00:00 weekly 1 https://pre.almirall.it/news/almirall-9m-results-2016-strong-derma-performance-eu-and-solid-progress-us 2026-04-01T09:41:31+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-restructuring-plan-spain 2026-04-01T09:41:32+00:00 weekly 1 https://pre.almirall.it/news/almirall-h1-results-2016-growth-total-revenues-and-net-sales-driven-dermatology 2026-04-01T09:41:32+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-bicosome-enter-collaboration-and-sublicense-agreement-development-topical-drug 2026-04-01T09:41:32+00:00 weekly 1 https://pre.almirall.it/news/almiralls-q1-results-2016-track-achieve-yearly-guidance 2026-04-01T09:41:34+00:00 weekly 1 https://pre.almirall.it/news/almirall-reduces-its-accident-rate-69-spain-2015 2026-04-01T09:41:34+00:00 weekly 1 https://pre.almirall.it/news/almirall-full-year-2015-results-normalized-net-income-growth-90 2026-04-01T09:41:34+00:00 weekly 1 https://pre.almirall.it/news/almirall-closes-acquisition-thermigen-llc-entering-aesthetics-market 2026-04-01T09:41:36+00:00 weekly 1 https://pre.almirall.it/news/almirall-exercises-call-option-acquire-100-thermigen-llc 2026-04-01T09:41:36+00:00 weekly 1 https://pre.almirall.it/news/almirall-reaches-agreement-acquire-100-poli-group 2026-04-01T09:41:37+00:00 weekly 1 https://pre.almirall.it/news/almirall-has-acquired-rights-veltinr-and-altabaxr-stiefel-gsk-company-exchange-its 2026-04-01T09:41:37+00:00 weekly 1 https://pre.almirall.it/news/almiralls-september-ytd-results-2015-operational-business-outperformance-driven-dermatology 2026-04-01T09:41:38+00:00 weekly 1 https://pre.almirall.it/news/almirall-closes-15-million-strategic-investment-suneva-medical 2026-04-01T09:41:38+00:00 weekly 1 https://pre.almirall.it/news/almiralls-h1-results-2015-growth-driven-strong-sales-increase-dermatology 2026-04-01T09:41:39+00:00 weekly 1 https://pre.almirall.it/news/almiralls-q1-results-2015-growth-acceleration-driven-dermatology 2026-04-01T09:41:39+00:00 weekly 1 https://pre.almirall.it/news/almirall-full-year-2014-results-line-guidance 2026-04-01T09:41:39+00:00 weekly 1 https://pre.almirall.it/news/almirall-finaliza-el-acuerdo-con-astrazeneca-en-el-area-respiratoria 2026-04-01T09:41:41+00:00 weekly 1 https://pre.almirall.it/news/almiralls-aclidinium-bromideformoterol-fumarate-recommended-approval-europe-treat-copd 2026-04-01T09:41:41+00:00 weekly 1 https://pre.almirall.it/news/almirall-agrees-strategic-transaction-astrazeneca-respiratory-disease 2026-04-01T09:41:42+00:00 weekly 1 https://pre.almirall.it/news/almiralls-h1-results-2014-continued-growth-acceleration 2026-04-01T09:41:42+00:00 weekly 1 https://pre.almirall.it/news/almiralls-q1-results-2014-growth-acceleration 2026-04-01T09:41:42+00:00 weekly 1 https://pre.almirall.it/news/forest-laboratories-and-almirall-provide-update-fixed-dose-combination-aclidinium-and 2026-04-01T09:41:44+00:00 weekly 1 https://pre.almirall.it/news/index-pharmaceuticals-and-almirall-enter-license-agreement-european-rights-phase-iii-drug 2026-04-01T09:41:44+00:00 weekly 1 https://pre.almirall.it/news/almirall-completed-senior-notes-pricing-325-million-euros-7-year-maturity-and-4625-annual 2026-04-01T09:41:46+00:00 weekly 1 https://pre.almirall.it/news/almiralls-accident-rate-spain-2013-down-20 2026-04-01T09:41:46+00:00 weekly 1 https://pre.almirall.it/news/almiralls-full-year-results-2013-setting-foundations-accelerating-growth 2026-04-01T09:41:46+00:00 weekly 1 https://pre.almirall.it/news/almirall-reaches-agreement-implement-reestructuring-plan-spain 2026-04-01T09:41:47+00:00 weekly 1 https://pre.almirall.it/news/almirall-reaches-agreement-acquire-aqua-pharmaceuticals-us-based-specialty-dermatology-company 2026-04-01T09:41:47+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-reorganization-program-affecting-group-europe 2026-04-01T09:41:47+00:00 weekly 1 https://pre.almirall.it/news/around-clock-symptom-relief-vital-many-millions-chronic-obstructive-pulmonary-disease-copd 2026-04-01T09:41:49+00:00 weekly 1 https://pre.almirall.it/news/almiralls-q3-track-deliver-year-guidance-eklirar-genuairr-s-global-rollout-continues 2026-04-01T09:41:49+00:00 weekly 1 https://pre.almirall.it/news/aclidinium-and-formoterol-fixed-dose-combination-copd-submitted-registration-europe 2026-04-01T09:41:50+00:00 weekly 1 https://pre.almirall.it/news/aclidinium-chosen-one-best-spanish-therapeutic-innovations-international-reach 2026-04-01T09:41:50+00:00 weekly 1 https://pre.almirall.it/news/new-data-reinforce-efficacy-and-safety-profile-sativexr-multiple-sclerosis-spasticity 2026-04-01T09:41:50+00:00 weekly 1 https://pre.almirall.it/news/importance-24-hours-symptom-relief-those-suffering-copd 2026-04-01T09:41:51+00:00 weekly 1 https://pre.almirall.it/news/international-pharmaceutical-company-almirall-expands-global-footprint-new-canadian-affiliate 2026-04-01T09:41:51+00:00 weekly 1 https://pre.almirall.it/news/almiralls-h1-executing-growth-platforms-financial-delivery-track 2026-04-01T09:41:53+00:00 weekly 1 https://pre.almirall.it/news/almirall-50-below-pharmaceutical-sector-accident-rate 2026-04-01T09:41:53+00:00 weekly 1 https://pre.almirall.it/news/almirall-maintains-its-commitment-environment-spain-and-germany 2026-04-01T09:41:54+00:00 weekly 1 https://pre.almirall.it/news/almirall-pioneer-spain-being-awarded-iso-500012011-energy-management-system-certification 2026-04-01T09:41:54+00:00 weekly 1 https://pre.almirall.it/news/constellar-linaclotide-first-approved-prescription-therapy-new-class-treatments-adults-ibs-c 2026-04-01T09:41:54+00:00 weekly 1 https://pre.almirall.it/news/survey-reveals-two-five-european-persons-multiple-sclerosis-ms-under-35-are-unable-work-or 2026-04-01T09:41:56+00:00 weekly 1 https://pre.almirall.it/news/almirall-begins-transformation 2026-04-01T09:41:56+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-laboratories-announce-positive-results-second-phase-iii-study-aclidinium 2026-04-01T09:41:57+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-laboratories-announce-positive-results-phase-iii-study-aclidinium-and 2026-04-01T09:41:57+00:00 weekly 1 https://pre.almirall.it/news/almirall-presents-latest-news-respiratory-diseases 2026-04-01T09:41:58+00:00 weekly 1 https://pre.almirall.it/news/2012-results-line-guidance-positioning-almirall-transformative-growth-2013 2026-04-01T09:41:58+00:00 weekly 1 https://pre.almirall.it/news/coordination-among-professionals-crucial-good-vascular-patient-care 2026-04-01T09:42:00+00:00 weekly 1 https://pre.almirall.it/news/almirall-commercialises-neurofarmagen-innovative-genetic-test 2026-04-01T09:42:00+00:00 weekly 1 https://pre.almirall.it/news/eklirar-genuairr-almirall-available-spain-treatment-copd 2026-04-01T09:42:00+00:00 weekly 1 https://pre.almirall.it/news/almirall-celebrates-10-years-italy 2026-04-01T09:42:01+00:00 weekly 1 https://pre.almirall.it/news/almiralls-financial-calendar-2013 2026-04-01T09:42:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-laboratories-announce-commercial-availability-tudorzatm-pressairtm-us 2026-04-01T09:42:01+00:00 weekly 1 https://pre.almirall.it/news/constellar-linaclotide-approved-europe-treatment-irritable-bowel-syndrome-constipation-ibs-c 2026-04-01T09:42:05+00:00 weekly 1 https://pre.almirall.it/news/almirall-appoints-karin-louise-dorrepaal-new-independent-board-member 2026-04-01T09:42:05+00:00 weekly 1 https://pre.almirall.it/news/3rd-quarter-results 2026-04-01T09:42:05+00:00 weekly 1 https://pre.almirall.it/news/low-awareness-chronic-obstructive-pulmonary-disease-copd-confirmed-recent-survey 2026-04-01T09:42:07+00:00 weekly 1 https://pre.almirall.it/news/almirall-invests-personalised-medicine-becoming-part-share-capital-ab-biotics 2026-04-01T09:42:07+00:00 weekly 1 https://pre.almirall.it/news/almirall-incorporates-gerhard-mayr-board-directors 2026-04-01T09:42:08+00:00 weekly 1 https://pre.almirall.it/news/sativexr-confirms-clinically-relevant-benefits-multiple-sclerosis-spasticity 2026-04-01T09:42:08+00:00 weekly 1 https://pre.almirall.it/news/almirall-licenses-aclidinium-invida-australia-and 2026-04-01T09:42:09+00:00 weekly 1 https://pre.almirall.it/news/linaclotide-receives-positive-chmp-opinion-treatment-ibs-c 2026-04-01T09:42:09+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-eklirar-genuairr-aclidinium-europe 2026-04-01T09:42:09+00:00 weekly 1 https://pre.almirall.it/news/almirall-obtains-rights-linaclotide-mexico 2026-04-01T09:42:11+00:00 weekly 1 https://pre.almirall.it/news/almirall-opens-new-affiliate-canada 2026-04-01T09:42:11+00:00 weekly 1 https://pre.almirall.it/news/eklirar-genuairr-provides-meaningful-and-sustained-bronchodilation-first-dose-patients-prefer 2026-04-01T09:42:12+00:00 weekly 1 https://pre.almirall.it/news/almiralls-h1-strong-newsflow-and-guidance-reiterated 2026-04-01T09:42:12+00:00 weekly 1 https://pre.almirall.it/news/eklirarbretarisr-genuairr-aclidinium-bromide-approved-europe-maintenance-treatment-chronic 2026-04-01T09:42:13+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-laboratories-announce-fda-approval-tudorzatm-pressairtm-long-term 2026-04-01T09:42:13+00:00 weekly 1 https://pre.almirall.it/news/que-medicamentos-tendran-nuestros-hijos-retos-para-equilibrar-investigacion-y-coste-sanitario 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/abediterol-almiralls-od-laba-shows-superiority-vs-indacaterol-phase-iia 2026-04-01T09:42:15+00:00 weekly 1 https://pre.almirall.it/news/almiralls-aclidinium-recommended-approval-europe-treat-copd 2026-04-01T09:42:15+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-aslan-sign-global-agreement-novel-treatment-rheumatoid-arthritis 2026-04-01T09:42:16+00:00 weekly 1 https://pre.almirall.it/news/sativexr-starts-third-phase-iii-clinical-trial-cancer-pain 2026-04-01T09:42:16+00:00 weekly 1 https://pre.almirall.it/news/new-strategic-direction-almiralls-od-laba-following-successful-phase-iia-completion 2026-04-01T09:42:16+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-present-aclidinium-bromide-clinical-data-american-thoracic-society-ats 2026-04-01T09:42:18+00:00 weekly 1 https://pre.almirall.it/news/almirall-grows-internationally 2026-04-01T09:42:18+00:00 weekly 1 https://pre.almirall.it/news/sativexr-mutual-recognition-procedure-closes-recommendation-approval-ten-european-countries 2026-04-01T09:42:18+00:00 weekly 1 https://pre.almirall.it/news/almirall-annual-general-meeting-approves-018-euro-pay-out-share-scrip-dividend 2026-04-01T09:42:20+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-laboratories-announce-fda-has-extended-review-period-aclidinium-bromide 2026-04-01T09:42:20+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-menarini-sign-licence-agreement-and-commercial-alliance-aclidinium-majority 2026-04-01T09:42:21+00:00 weekly 1 https://pre.almirall.it/news/aclidinium-clinical-data-published-european-respiratory-journal-confirms-efficacy-and-safety 2026-04-01T09:42:21+00:00 weekly 1 https://pre.almirall.it/news/el-tratamiento-personalizado-de-la-epoc-principal-reto-para-los-especialistas-only-available 2026-04-01T09:42:22+00:00 weekly 1 https://pre.almirall.it/news/almirall-extends-sativexr-marketing-rights-mexico 2026-04-01T09:42:22+00:00 weekly 1 https://pre.almirall.it/news/almirall-supports-european-post-graduate-clinical-research-ms-spasticity-two-annual-grants 2026-04-01T09:42:22+00:00 weekly 1 https://pre.almirall.it/news/almirall-results-2011-line-positive-newsflow-start-2012 2026-04-01T09:42:24+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-announce-positive-fda-advisory-committees-recommendation-approval 2026-04-01T09:42:24+00:00 weekly 1 https://pre.almirall.it/news/la-vi-reunion-vam-presenta-las-nuevas-evidencias-en-el-tratamiento-de-las-enfermedades 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-licenses-aclidinium-daewoong-korea 2026-04-01T09:42:25+00:00 weekly 1 https://pre.almirall.it/news/desciende-el-tabaquismo-pasivo-gracias-la-ley-antitabaco-y-se-mantiene-el-numero-de-fumadores 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/bayer-and-almirall-co-promote-anticoagulant-rivaroxaban-spain 2026-04-01T09:42:27+00:00 weekly 1 https://pre.almirall.it/news/sativexr-starts-new-wave-regulatory-submissions-europe 2026-04-01T09:42:27+00:00 weekly 1 https://pre.almirall.it/news/almirall-celebrates-10-years-mexico 2026-04-01T09:42:28+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-galapagos-enter-research-alliance 2026-04-01T09:42:28+00:00 weekly 1 https://pre.almirall.it/news/almirall-colabora-con-la-fundacion-vicente-ferrer-en-un-proyecto-de-construccion-de-viviendas 2026-04-01T09:42:28+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-solarazer-spain-treatment-actinic-keratosis 2026-04-01T09:42:30+00:00 weekly 1 https://pre.almirall.it/news/almirall-starts-phase-iii-aclidinium-and-formoterol-copd 2026-04-01T09:42:30+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-biofocus-announce-collaboration-find-new-hit-compounds-against-key-targets 2026-04-01T09:42:30+00:00 weekly 1 https://pre.almirall.it/news/almirall-colabora-con-la-sed-en-el-dia-mundial-de-la-diabetes-only-available-spanish 2026-04-01T09:42:31+00:00 weekly 1 https://pre.almirall.it/news/mas-de-la-mitad-de-los-diabeticos-tipo-2-no-tiene-un-control-adecuado-de-la-enfermedad-only 2026-04-01T09:42:31+00:00 weekly 1 https://pre.almirall.it/news/q3-results-almirall-prepares-future-growth 2026-04-01T09:42:33+00:00 weekly 1 https://pre.almirall.it/news/8-de-cada-10-espanoles-no-sabe-que-es-la-epoc 2026-04-01T09:42:33+00:00 weekly 1 https://pre.almirall.it/news/full-phase-iii-data-highlight-efficacy-and-tolerability-sativexr-therapy-treatment-spasticity 2026-04-01T09:42:34+00:00 weekly 1 https://pre.almirall.it/news/linaclotide-provides-long-term-relief-symptoms-irritable-bowel-syndrome-constipation 2026-04-01T09:42:34+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-lundbeck-announce-co-promotion-agreement-escitalopram-italy 2026-04-01T09:42:35+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-spanish-pharmacological-society-recognise-research-diabetes 2026-04-01T09:42:35+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-roflumilast-spain 2026-04-01T09:42:36+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-regulatory-filing-linaclotide-treatment-irritable-bowel-syndrome 2026-04-01T09:42:36+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-nycomed-announce-licensing-agreement-ebastine-china-and-other-key-southeast-asia 2026-04-01T09:42:36+00:00 weekly 1 https://pre.almirall.it/news/una-nueva-guia-ayudara-los-medicos-en-el-manejo-de-la-osteoporosis-postmenopausica 2026-04-01T09:42:38+00:00 weekly 1 https://pre.almirall.it/news/copd-patients-experienced-benefits-first-dose-when-treated-aclidinium-shown-attain-phase-iii 2026-04-01T09:42:38+00:00 weekly 1 https://pre.almirall.it/news/almirall-enters-integrated-discovery-agreement-proteros 2026-04-01T09:42:38+00:00 weekly 1 https://pre.almirall.it/news/almirall-appoints-alfredo-baron-area-director-southern-and-eastern-europe 2026-04-01T09:42:39+00:00 weekly 1 https://pre.almirall.it/news/almirall-h1-financial-results 2026-04-01T09:42:39+00:00 weekly 1 https://pre.almirall.it/news/aclidinium-bromide-submitted-registration-europe 2026-04-01T09:42:39+00:00 weekly 1 https://pre.almirall.it/news/almirall-strengthens-its-german-business-two-new-products-sativexr-and-actikerallr 2026-04-01T09:42:41+00:00 weekly 1 https://pre.almirall.it/news/farid-taha-new-general-manager-almirall-germany-austria-and-switzerland 2026-04-01T09:42:41+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-announce-regulatory-submission-aclidinium-bromide-treatment-copd-usa 2026-04-01T09:42:41+00:00 weekly 1 https://pre.almirall.it/news/nuevos-datos-avalan-la-seguridad-y-la-eficacia-del-bazedoxifeno-para-prevenir-fracturas 2026-04-01T09:42:43+00:00 weekly 1 https://pre.almirall.it/news/almirall-empresa-comprometida-con-la-formacion-de-los-gestores-sanitarios 2026-04-01T09:42:43+00:00 weekly 1 https://pre.almirall.it/news/la-sepd-en-colaboracion-con-almirall-presenta-el-libro-el-paciente-con-sintomas-digestivos 2026-04-01T09:42:43+00:00 weekly 1 https://pre.almirall.it/news/sativexr-approved-denmark-treatment-spasticity-due-multiple-sclerosis-ms 2026-04-01T09:42:45+00:00 weekly 1 https://pre.almirall.it/news/actikerallr-launched-uk-treatment-actinic-keratosis-including-grade-i-and-ii-severity 2026-04-01T09:42:45+00:00 weekly 1 https://pre.almirall.it/news/daniel-martinez-carretero-appointed-chief-financial-officer-cfo-almirall 2026-04-01T09:42:47+00:00 weekly 1 https://pre.almirall.it/news/almirall-strengthens-their-ongoing-commitment-patients-multiple-sclerosis-through-their 2026-04-01T09:42:47+00:00 weekly 1 https://pre.almirall.it/news/sativexr-approved-germany-treatment-spasticity-due-multiple-sclerosis 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-q1-financial-results-line-attain-yearly-guidance 2026-04-01T09:42:49+00:00 weekly 1 https://pre.almirall.it/news/almiralls-annual-general-meeting-approves-dividend-029-euros-share 2026-04-01T09:42:49+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-present-data-phase-iii-studies-aclidinium-bromide-chronic-obstructive 2026-04-01T09:42:49+00:00 weekly 1 https://pre.almirall.it/news/regulators-confirm-actikerallr-treatment-actinic-keratoses-including-grade-i-and-ii-approvable 2026-04-01T09:42:51+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-nycomed-announce-commercialization-agreement-roflumilast-spain 2026-04-01T09:42:51+00:00 weekly 1 https://pre.almirall.it/news/el-tabaquismo-es-la-enfermedad-respiratoria-mas-frecuente 2026-04-01T09:42:53+00:00 weekly 1 https://pre.almirall.it/news/almirall-strengthens-its-respiratory-franchise-new-generation-chronic-obstructive-pulmonary 2026-04-01T09:42:53+00:00 weekly 1 https://pre.almirall.it/news/almirall-apuesta-por-la-formacion-gestores-sanitarios-en-un-modelo-efectivo-de-liderazgo 2026-04-01T09:42:53+00:00 weekly 1 https://pre.almirall.it/news/almirall-meets-guidance-2025-delivering-124-net-sales-growth-and-further-pipeline-progress 2026-04-01T09:33:55+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-lumine-phase-iii-clinical-study-assessing-efficacy-lebrikizumab-treatment 2026-04-01T13:10:01+00:00 weekly 1 https://pre.almirall.it/news/almiralls-immunoskin-gathers-leading-experts-advance-science-and-treatment-inflammatory-skin 2026-04-01T13:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-continues-its-sustained-growth-trajectory-9m-2025-delivering-128-net-sales-growth 2026-04-01T09:34:00+00:00 weekly 1 https://pre.almirall.it/news/almirall-presents-long-term-results-first-real-world-dermatology-study-using-who-5-well-being 2026-04-01T09:34:00+00:00 weekly 1 https://pre.almirall.it/news/eadv-2025-almirall-advances-skin-science-and-leads-innovation-holistic-patient-care-medical 2026-04-01T09:34:02+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-absci-expand-ai-drug-creation-collaboration-adding-second-dermatology-target 2026-04-01T09:34:02+00:00 weekly 1 https://pre.almirall.it/news/almirall-h1-2025-results-almirall-continues-deliver-its-long-term-growth-strategy-net-sales 2026-04-01T09:34:03+00:00 weekly 1 https://pre.almirall.it/news/almirall-shows-efficacy-biologics-real-world-evidence-and-new-patient-centric-research 2026-04-01T09:34:03+00:00 weekly 1 https://pre.almirall.it/news/almirall-leads-paradigm-shift-holistic-patient-care-dermatology-applying-who-5-well-being 2026-04-01T09:34:04+00:00 weekly 1 https://pre.almirall.it/news/almirall-delivers-strong-start-2025-growing-q1-overall-sales-15-and-234-its-european 2026-04-01T09:34:04+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-biofrontera-launch-hats-challenge-raise-awareness-and-support-actinic-keratosis 2026-04-01T09:34:06+00:00 weekly 1 https://pre.almirall.it/news/almiralls-16th-skin-academy-brings-together-leading-experts-advance-skin-science-and-treatment 2026-04-01T09:34:06+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-cfo-transition-plan-and-appoints-jon-u-garay-alonso-cfo-succeed-mike 2026-04-01T09:34:07+00:00 weekly 1 https://pre.almirall.it/news/almirall-surpassed-guidance-2024-entering-era-sustained-growth-and-further-advancing-its 2026-04-01T09:34:07+00:00 weekly 1 https://pre.almirall.it/news/almirall-jpmorgan-conference-entering-new-era-sustained-growth 2026-04-01T09:34:08+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-almirall-innovation-hub-hive-creating-novel-collaborative-innovation-hub 2026-04-01T09:34:08+00:00 weekly 1 https://pre.almirall.it/news/almiralls-nine-month-2024-results-almirall-reports-strong-performance-q3-2024-driven 2026-04-01T09:34:10+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-campaign-me-my-inner-circle-acknowledge-vital-role-friends-and-family-people 2026-04-01T09:34:10+00:00 weekly 1 https://pre.almirall.it/news/almiralls-2024-immunoskin-conference-hosts-leading-experts-inflammatory-skin-conditions 2026-04-01T09:34:11+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-completion-decentralized-regulatory-approval-procedure-efinaconazole-europe 2026-04-01T09:34:11+00:00 weekly 1 https://pre.almirall.it/news/new-data-show-almiralls-ebglyssr-lebrikizumab-provided-sustained-disease-control-three-years 2026-04-01T09:34:12+00:00 weekly 1 https://pre.almirall.it/news/33rd-congress-european-academy-dermatology-and-venereology-eadv 2026-04-01T09:34:12+00:00 weekly 1 https://pre.almirall.it/news/14th-september-world-atopic-eczema-day 2026-04-01T09:34:14+00:00 weekly 1 https://pre.almirall.it/news/almiralls-h1-2024-results 2026-04-01T09:34:14+00:00 weekly 1 https://pre.almirall.it/news/nice-recommends-ebglyss-lebrikizumab-use-moderate-severe-atopic-dermatitis-nhs-england 2026-04-01T09:34:15+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-act4impact-its-updated-sustainability-strategy-setting-ambitious-targets 2026-04-01T09:34:15+00:00 weekly 1 https://pre.almirall.it/news/almiralls-ilumetrir-tildrakizumab-demonstrates-high-rates-skin-clearance-and-sustained 2026-04-01T09:34:16+00:00 weekly 1 https://pre.almirall.it/news/fda-approves-almiralls-klisyrir-tirbanibulin-treatment-actinic-keratosis-expanded-area-face-or 2026-04-01T09:34:16+00:00 weekly 1 https://pre.almirall.it/news/ebglyssr-lebrikizumab-ranked-number-one-interleukin-inhibitors-severe-atopic-dermatitis-adults 2026-04-01T09:34:17+00:00 weekly 1 https://pre.almirall.it/news/may-24th-actinic-keratosis-ak-global-day 2026-04-01T09:34:17+00:00 weekly 1 https://pre.almirall.it/news/almiralls-q1-2024-results-almirall-delivers-strong-start-2024-q1-net-sales-growth-66-overall 2026-04-01T09:34:19+00:00 weekly 1 https://pre.almirall.it/news/almirall-licenses-anti-il-21-monoclonal-antibody-novo-nordisk-develop-it-first-class-agent 2026-04-01T09:34:20+00:00 weekly 1 https://pre.almirall.it/news/almirall-receives-rating-cdp-its-contributions-fight-against-climate-change 2026-04-01T09:34:20+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-partnership-centre-genomic-regulation-crg-identify-biomarkers-novel-atopic 2026-04-01T09:34:21+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-microsoft-announce-partnership-digital-transformation-enable-development-novel 2026-04-01T09:34:21+00:00 weekly 1 https://pre.almirall.it/news/almirall-initiates-first-phase-i-clinical-study-alm223-interleukin-2-mutant-fusion-protein 2026-04-01T09:34:21+00:00 weekly 1 https://pre.almirall.it/news/almirall-participate-42nd-annual-jp-morgan-healthcare-conference 2026-04-01T09:34:23+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-etherna-enter-multi-target-alliance-develop-mrna-based-therapies-medical 2026-04-01T09:34:23+00:00 weekly 1 https://pre.almirall.it/news/almirall-barcelona-supercomputing-center-bsc-and-nostrum-biodiscovery-collaborate-seek-new 2026-04-01T09:34:24+00:00 weekly 1 https://pre.almirall.it/news/almirall-receives-european-commission-approval-ebglyssr-lebrikizumab-moderate-severe-atopic 2026-04-01T09:34:24+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-absci-announce-ai-drug-discovery-partnership-rapidly-develop-novel-treatments 2026-04-01T09:34:26+00:00 weekly 1 https://pre.almirall.it/news/almirall-achieves-net-sales-growth-64-driven-strong-european-dermatology-performance 2026-04-01T09:34:26+00:00 weekly 1 https://pre.almirall.it/news/psoriasis-was-found-impact-wellbeing-similar-level-breast-cancer 2026-04-01T09:34:27+00:00 weekly 1 https://pre.almirall.it/news/almirall-opens-new-call-proposals-better-understand-key-pathological-mechanisms-several-skin 2026-04-01T09:34:27+00:00 weekly 1 https://pre.almirall.it/news/almirall-nearly-80-patients-moderate-severe-atopic-dermatitis-maintained-clear-or-almost-clear 2026-04-01T09:34:28+00:00 weekly 1 https://pre.almirall.it/news/almiralls-lebrikizumab-improves-signs-and-symptoms-moderate-severe-atopic-dermatitis-ad 2026-04-01T09:34:28+00:00 weekly 1 https://pre.almirall.it/news/epimab-biotherapeutics-and-almirall-announce-bispecific-antibody-license-agreement 2026-04-01T13:10:01+00:00 weekly 1 https://pre.almirall.it/news/almiralls-ilumetrir-tildrakizumab-significantly-improves-wellbeing-patients-and-their 2026-04-01T09:34:30+00:00 weekly 1 https://pre.almirall.it/news/centrient-pharmaceuticals-joins-almiralls-growing-innovation-hub-barcelona 2026-04-01T09:34:31+00:00 weekly 1 https://pre.almirall.it/news/ebglyssr-lebrikizumab-receives-positive-chmp-opinion-moderate-severe-atopic-dermatitis 2026-04-01T09:34:31+00:00 weekly 1 https://pre.almirall.it/news/moving-ahead-almirall-message-raise-awareness-about-atopic-eczema 2026-04-01T09:34:31+00:00 weekly 1 https://pre.almirall.it/news/almirall-achieves-net-sales-growth-7-eu4661mm-driven-strong-growth-european-dermatology 2026-04-01T09:34:33+00:00 weekly 1 https://pre.almirall.it/news/science-based-targets-initiative-sbti-validates-almiralls-2030-emission-reduction-targets-and 2026-04-01T09:34:33+00:00 weekly 1 https://pre.almirall.it/news/almirall-ilumetrir-tildrakizumab-significantly-improved-wellbeing-patients-moderate-severe 2026-04-01T09:34:34+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-pricing-and-closing-its-eu200mm-non-pre-emptive-share-capital-increase 2026-04-01T09:34:34+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-launch-eu200mm-non-pre-emptive-share-capital-increase 2026-04-01T09:34:34+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-nina-first-series-highlight-major-impact-psoriasis-patients-wellbeing 2026-04-01T09:34:35+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-centre-genomic-regulation-crg-collaborate-develop-and-characterize-novel 2026-04-01T09:34:35+00:00 weekly 1 https://pre.almirall.it/news/85-people-unaware-actinic-keratosis-most-common-pre-cancerous-skin-condition 2026-04-01T09:34:35+00:00 weekly 1 https://pre.almirall.it/news/almiralls-net-sales-reach-eu-232mm-and-increase-6-boosted-solid-european-dermatology-business 2026-04-01T09:34:37+00:00 weekly 1 https://pre.almirall.it/news/almirall-73-atopic-dermatitis-patients-taking-lebrikizumab-had-improved-or-cleared-skin-face 2026-04-01T09:34:37+00:00 weekly 1 https://pre.almirall.it/news/almirall-first-assess-wellbeing-dermatology-clinical-study 2026-04-01T09:34:37+00:00 weekly 1 https://pre.almirall.it/news/almirall-new-england-journal-medicine-nejm-and-british-journal-dermatology-bjd-publish-ph3 2026-04-01T09:34:39+00:00 weekly 1 https://pre.almirall.it/news/almiralls-full-year-2022-results-almirall-closes-2022-core-net-sales-growth-66-driven-its 2026-04-01T09:34:40+00:00 weekly 1 https://pre.almirall.it/news/almirall-participate-41st-annual-jp-morgan-healthcare-conference 2026-04-01T09:34:40+00:00 weekly 1 https://pre.almirall.it/news/almirall-appoints-mercedes-diz-vp-corporate-strategy 2026-04-01T09:34:41+00:00 weekly 1 https://pre.almirall.it/news/almirall-joins-facilitate-patient-driven-innovative-medicines-initiative-imi-project-enable 2026-04-01T09:34:41+00:00 weekly 1 https://pre.almirall.it/news/almiralls-nine-month-2022-results-almirall-achieves-core-net-sales-eu6338-mm-euros-first-nine 2026-04-01T09:34:41+00:00 weekly 1 https://pre.almirall.it/news/almirall-opens-new-subsidiary-czech-republic-and-slovakia 2026-04-01T09:34:43+00:00 weekly 1 https://pre.almirall.it/news/almiralls-chairman-carlos-gallardo-appointed-interim-ceo 2026-04-01T09:34:43+00:00 weekly 1 https://pre.almirall.it/news/almiralls-shedding-light-psoriasis-campaign-exposes-impact-disease-mental-health-and-wellbeing 2026-04-01T09:34:43+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-ema-acceptance-filing-marketing-authorization-application-maa-lebrikizumab 2026-04-01T09:34:44+00:00 weekly 1 https://pre.almirall.it/news/almirall-partners-chemical-institute-sarria-iqs-bring-pharmacy-students-training-closer-real 2026-04-01T09:34:44+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-simcere-enter-licensing-agreement-il-2-mu-fc 2026-04-01T09:34:44+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-initiation-phase-i-study-anti-il-1rap-first-class-monoclonal-antibody 2026-04-01T09:34:46+00:00 weekly 1 https://pre.almirall.it/news/almirall-lebrikizumab-dosed-every-four-weeks-maintained-durable-skin-clearance-phase-3 2026-04-01T09:34:46+00:00 weekly 1 https://pre.almirall.it/news/almirall-lebrikizumabs-52-week-late-breaking-data-will-be-presented-31st-european-academy 2026-04-01T09:34:47+00:00 weekly 1 https://pre.almirall.it/news/almiralls-h1-2022-results 2026-04-01T09:34:47+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-new-call-find-innovative-therapies-skin-diseases 2026-04-01T09:34:47+00:00 weekly 1 https://pre.almirall.it/news/happify-health-and-almirall-go-live-digital-solution-support-psoriasis-patients 2026-04-01T09:34:48+00:00 weekly 1 https://pre.almirall.it/news/almirall-eight-out-ten-patients-maintained-skin-clearance-one-year-lebrikizumab-atopic 2026-04-01T09:34:48+00:00 weekly 1 https://pre.almirall.it/news/almirall-initiates-decentralised-procedure-europe-treatment-mild-moderate-fungal-nail 2026-04-01T09:34:48+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-innovative-wynzorar-cream-denmark-treatment-mild-moderate-plaque-psoriasis 2026-04-01T09:34:50+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-actinic-keratosis-ak-global-day-during-skin-cancer-awareness-month 2026-04-01T09:34:50+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-happify-health-go-live-digital-therapeutics-support-psoriasis-patients 2026-04-01T09:34:50+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-evotec-enter-multi-target-alliance-medical-dermatology 2026-04-01T09:34:51+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-inserm-transfert-enter-licensing-and-research-collaboration-develop-innovative 2026-04-01T09:34:51+00:00 weekly 1 https://pre.almirall.it/news/almirall-delivers-good-business-performance-q1-and-reiterates-full-year-2022-guidance 2026-04-01T09:34:51+00:00 weekly 1 https://pre.almirall.it/news/carlos-gallardo-asume-la-presidencia-de-almirall 2026-04-01T09:34:53+00:00 weekly 1 https://pre.almirall.it/news/almirall-lebrikizumab-combined-topical-corticosteroids-showed-significant-improvements-disease 2026-04-01T09:34:53+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-new-research-collaboration-university-dundee-develop-innovative-and 2026-04-01T09:34:54+00:00 weekly 1 https://pre.almirall.it/news/almirall-majority-patients-treated-lebrikizumab-achieved-skin-clearance-pivotal-phase-3-atopic 2026-04-01T09:34:54+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-collaboration-university-michigan-gain-understanding-disease-drivers 2026-04-01T09:34:55+00:00 weekly 1 https://pre.almirall.it/news/dr-jorge-gallardo-ballart-announces-his-intention-retire-his-positions-president-board 2026-04-01T09:34:55+00:00 weekly 1 https://pre.almirall.it/news/almiralls-full-year-2021-results 2026-04-01T09:34:55+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-multi-target-licensing-agreement-ablexis-and-collaboration-alivamab 2026-04-01T09:34:59+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-irb-barcelona-announce-research-collaboration-discover-novel-molecular-glue 2026-04-01T09:34:59+00:00 weekly 1 https://pre.almirall.it/news/almirall-lebrikizumab-demonstrated-significant-skin-improvement-and-itch-relief-when-combined 2026-04-01T09:34:59+00:00 weekly 1 https://pre.almirall.it/news/hoy-si-me-puedo-levantar-campaign-support-people-living-multiple-sclerosis-ms 2026-04-01T09:35:01+00:00 weekly 1 https://pre.almirall.it/news/ichnos-sciences-and-almirall-enter-licensing-agreement-first-class-il-1rap-antagonist 2026-04-01T09:35:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-delivers-solid-nine-months-2021-results-and-tightens-its-upgraded-guidance 2026-04-01T09:35:02+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-shedding-light-psoriasis-campaign-raise-awareness-world-psoriasis-day 2026-04-01T09:35:02+00:00 weekly 1 https://pre.almirall.it/news/almiralls-roadmap-more-sustainable-future 2026-04-01T09:35:02+00:00 weekly 1 https://pre.almirall.it/news/experts-highlight-need-focus-psoriasis-patients-wellbeing-clinical-practice 2026-04-01T13:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-klisyrirvtirbanibulin-treatment-actinic-keratosis-europe 2026-04-01T13:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-pricing-eu300-million-issuance-senior-notes-due-2026 2026-04-01T09:35:03+00:00 weekly 1 https://pre.almirall.it/news/lebrikizumab-significantly-improved-skin-clearance-and-itch-people-moderate-severe-atopic 2026-04-01T09:35:05+00:00 weekly 1 https://pre.almirall.it/news/almirall-delivers-robust-h1-performance-and-increases-full-year-guidance 2026-04-01T09:35:05+00:00 weekly 1 https://pre.almirall.it/news/almirall-receives-european-commission-approval-klisyrir-v-tirbanibulin-innovative-topical 2026-04-01T09:35:06+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-mc2-therapeutics-announce-completion-decentralized-procedure-europe-topical 2026-04-01T09:35:06+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-new-call-establish-partnerships-innovative-therapies-skin-diseases 2026-04-01T09:35:06+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-kaken-pharmaceutical-enter-license-and-distribution-agreement-european-rights 2026-04-01T09:35:08+00:00 weekly 1 https://pre.almirall.it/news/almirall-joins-biomap-new-partner-advance-field-inflammatory-skin-conditions 2026-04-01T09:35:08+00:00 weekly 1 https://pre.almirall.it/news/almirall-appoints-dr-karl-ziegelbauer-chief-scientific-officer 2026-04-01T09:35:08+00:00 weekly 1 https://pre.almirall.it/news/almirall-receives-fda-approval-produce-seysara-r-sarecycline-sant-andreu-de-la-barca-barcelona 2026-04-01T09:35:10+00:00 weekly 1 https://pre.almirall.it/news/almirall-receives-positive-chmp-opinion-klisyrirv-tirbanibulin-innovative-topical-treatment 2026-04-01T09:35:10+00:00 weekly 1 https://pre.almirall.it/news/almiralls-solid-core-business-q1-performance-boosted-growth-drivers-momentum 2026-04-01T09:35:11+00:00 weekly 1 https://pre.almirall.it/news/almirall-proposes-ruud-dobber-new-member-its-board-directors 2026-04-01T09:35:11+00:00 weekly 1 https://pre.almirall.it/news/almirall-receives-qualification-excellent-profarma-2020-program 2026-04-01T09:35:11+00:00 weekly 1 https://pre.almirall.it/news/almiralls-2020-full-year-results 2026-04-01T09:35:12+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-mc2-therapeutics-enter-license-collaboration-and-commercialization-agreement 2026-04-01T09:35:12+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-new-england-journal-medicine-publication-phase-iii-data-demonstrating 2026-04-01T09:35:14+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-new-publication-british-journal-dermatology-ilumetrirv-tildrakizumab-first 2026-04-01T09:35:14+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-gianfranco-nazzi-new-ceo 2026-04-01T09:35:15+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-happify-health-enter-strategic-partnership-develop-evidence-supported-digital 2026-04-01T09:35:15+00:00 weekly 1 https://pre.almirall.it/news/cdp-recognizes-almirall-its-commitment-fight-against-climate-change 2026-04-01T09:35:15+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-tyris-therapeutics-enter-strategic-partnership-develop-next-generation-gene 2026-04-01T09:35:16+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-fda-approval-klisyrir-tirbanibulin-new-innovative-topical-treatment-actinic 2026-04-01T09:35:16+00:00 weekly 1 https://pre.almirall.it/news/almirall-has-selected-six-digital-health-start-ups-join-second-harvest-digital-garden 2026-04-01T09:35:18+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-collaborations-university-south-australia-and-fundacio-institut-de-recerca 2026-04-01T09:35:18+00:00 weekly 1 https://pre.almirall.it/news/popit-and-almirall-start-offering-new-support-tool-help-psoriasis-patients 2026-04-01T09:35:19+00:00 weekly 1 https://pre.almirall.it/news/pablo-alvarez-appointed-president-and-gm-almirall-us 2026-04-01T09:35:19+00:00 weekly 1 https://pre.almirall.it/news/almirall-demonstrates-resilient-performance-year-date-despite-covid-19-impacts 2026-04-01T09:35:20+00:00 weekly 1 https://pre.almirall.it/news/board-directors-nominates-carlos-gallardo-vice-president-board 2026-04-01T09:35:20+00:00 weekly 1 https://pre.almirall.it/news/first-complete-dataset-il-23p19-class-demonstrates-ilumetrirv-tildrakizumab-long-term-efficacy 2026-04-01T09:35:22+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-its-second-innovation-initiative-dermatology-focused-digital-health-start 2026-04-01T09:35:22+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-approval-reimbursed-price-ilumetrirtildrakizumab-france-treatment-adult 2026-04-01T09:35:23+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-university-dundee-announce-multi-target-research-collaboration-develop-novel 2026-04-01T09:35:23+00:00 weekly 1 https://pre.almirall.it/news/ceo-peter-guenter-leave-almirall-31122020-pursue-new-opportunities 2026-04-01T09:35:23+00:00 weekly 1 https://pre.almirall.it/news/sustained-performance-key-growth-drivers-and-excellent-progress-pipeline-h1-despite-negative 2026-04-01T09:35:25+00:00 weekly 1 https://pre.almirall.it/news/almirall-calls-collaborative-innovation-advance-new-treatments-skin-diseases 2026-04-01T09:35:25+00:00 weekly 1 https://pre.almirall.it/news/almirall-joins-amr-action-fund-support-fight-against-antimicrobial-resistance 2026-04-01T09:35:26+00:00 weekly 1 https://pre.almirall.it/news/almirall-enters-ibex-35 2026-04-01T09:35:26+00:00 weekly 1 https://pre.almirall.it/news/almirall-e-ms-experts-summit-season-2020 2026-04-01T09:35:27+00:00 weekly 1 https://pre.almirall.it/news/almirall-uc3m-and-medina-foundation-research-new-treatments-rare-genetic-diseases 2026-04-01T09:35:27+00:00 weekly 1 https://pre.almirall.it/news/solid-q1-2020-performance 2026-04-01T09:35:27+00:00 weekly 1 https://pre.almirall.it/news/almirall-ensure-business-continuity-all-drugs-essential-patients 2026-04-01T09:35:29+00:00 weekly 1 https://pre.almirall.it/news/almirall-announcement 2026-04-01T09:35:29+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-fda-acceptance-filing-us-new-drug-application-nda-tirbanibulin-actinic 2026-04-01T09:35:31+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-ema-acceptance-filing-marketing-authorization-application-maa-tirbanibulin 2026-04-01T09:35:31+00:00 weekly 1 https://pre.almirall.it/news/almiralls-full-year-2019-results-strong-operational-performance-excellent-pipeline-progress 2026-04-01T09:35:31+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-paratek-enter-license-agreement-seysarar-china 2026-04-01T09:35:33+00:00 weekly 1 https://pre.almirall.it/news/almirall-partners-plug-and-play-accelerate-digital-innovation-dermatology 2026-04-01T09:35:33+00:00 weekly 1 https://pre.almirall.it/news/almirall-participate-jp-morgan-healthcare-conference-san-francisco 2026-04-01T09:35:33+00:00 weekly 1 https://pre.almirall.it/news/almirall-signs-strategic-agreement-23andme-license-rights-bispecific-monoclonal-antibody 2026-04-01T09:35:35+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-wuxi-biologics-sign-strategic-collaboration-agreement-multiple-bispecific 2026-04-01T09:35:35+00:00 weekly 1 https://pre.almirall.it/news/almirall-enters-option-agreement-acquire-bioniz-therapeutics-and-establish-broad-research 2026-04-01T09:35:35+00:00 weekly 1 https://pre.almirall.it/news/almirallshare-responsible-50-private-public-collaborations-almirall 2026-04-01T09:35:37+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-iktos-announce-research-collaboration-artificial-intelligence-new-drug-design 2026-04-01T09:35:37+00:00 weekly 1 https://pre.almirall.it/news/volker-koscielny-new-chief-medical-officer-and-new-member-management-board-almirall 2026-04-01T09:35:37+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-accelerator-digital-garden-drive-digital-innovation-dermatology 2026-04-01T09:35:38+00:00 weekly 1 https://pre.almirall.it/news/majority-shareholders-almirall-give-mandate-increase-free-float 2026-04-01T09:35:38+00:00 weekly 1 https://pre.almirall.it/news/almirall-llc-announces-publication-long-term-safety-data-use-seysarar-sarecycline-tablets 2026-04-01T09:35:38+00:00 weekly 1 https://pre.almirall.it/news/almirall-9m-2019-business-results-continued-good-business-momentum-driven-positive-uptake 2026-04-01T09:35:40+00:00 weekly 1 https://pre.almirall.it/news/duaklirr-will-be-available-united-states-21st-october 2026-04-01T09:35:40+00:00 weekly 1 https://pre.almirall.it/news/tildrakizumab-confirms-its-long-term-efficacy-and-safety-longest-il23p19-data-available 2026-04-01T09:35:41+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-initiation-phase-3-program-evaluating-lebrikizumab-patients-moderate-severe 2026-04-01T09:35:41+00:00 weekly 1 https://pre.almirall.it/news/almirall-takes-leap-dermatology-digital-health-innovation 2026-04-01T09:35:41+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-cfo-leadership-transition-mike-mcclellan-join-almirall-november-11-new 2026-04-01T09:35:43+00:00 weekly 1 https://pre.almirall.it/news/scottish-medicines-consortium-smc-provisionally-approves-almiralls-ilumetrirv-tildrakizumab 2026-04-01T09:35:43+00:00 weekly 1 https://pre.almirall.it/news/almirall-h1-2019-continued-strong-business-momentum-while-reinforcing-pipeline 2026-04-01T09:35:43+00:00 weekly 1 https://pre.almirall.it/news/almirall-calls-partners-develop-new-immune-dermatology-therapies 2026-04-01T09:35:44+00:00 weekly 1 https://pre.almirall.it/news/almirall-revalidates-its-excellence-occupational-health-and-safety-environment-and-energy 2026-04-01T09:35:44+00:00 weekly 1 https://pre.almirall.it/news/almirall-exercises-its-option-dermira-license-rights-lebrikizumab-europe-atopic-dermatitis 2026-04-01T09:35:44+00:00 weekly 1 https://pre.almirall.it/news/investment-plan-europe-eib-finances-almiralls-research-new-skin-disease-treatments 2026-04-01T09:35:46+00:00 weekly 1 https://pre.almirall.it/news/almirall-q1-2019-strong-operating-performance 2026-04-01T09:35:46+00:00 weekly 1 https://pre.almirall.it/news/nice-publishes-final-recommendation-almiralls-ilumetrirv-tildrakizumab-cost-effective-option 2026-04-01T09:35:47+00:00 weekly 1 https://pre.almirall.it/news/almirall-excellent-company-according-profarma-plan-ministry-industry-tourism-and-commerce 2026-04-01T09:44:42+00:00 weekly 1 https://pre.almirall.it/news/ignasi-marti-rague-director-institutional-relations-almirall 2026-04-01T09:44:42+00:00 weekly 1 https://pre.almirall.it/news/sativexr-mutual-recognition-procedure-closes-recommendation-approval-all-six-european 2026-04-01T09:44:42+00:00 weekly 1 https://pre.almirall.it/news/lanzamiento-balneum-intensive-espana 2026-04-01T09:44:44+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-appointment-eduardo-sanchiz-new-ceo-july-1st-2011 2026-04-01T09:44:44+00:00 weekly 1 https://pre.almirall.it/news/sativexr-launched-spain-treat-spasticity 2026-04-01T09:44:45+00:00 weekly 1 https://pre.almirall.it/news/almirall-2010-financial-results-line-guidance 2026-04-01T09:44:45+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-kyorin-announce-licensing-agreement-japan-aclidinium-bromide 2026-04-01T09:44:45+00:00 weekly 1 https://pre.almirall.it/news/almirall-appoints-eloi-crespo-new-general-director-industrial-area 2026-04-01T09:44:47+00:00 weekly 1 https://pre.almirall.it/news/el-manejo-precoz-del-paciente-diabetico-clave-para-conseguir-una-prevencion-vascular-eficiente 2026-04-01T09:44:47+00:00 weekly 1 https://pre.almirall.it/news/sativex-granted-reimbursement-spain-treatment-spasticity-multiple-sclerosis 2026-04-01T09:44:47+00:00 weekly 1 https://pre.almirall.it/news/almirall-mexico-receives-distinction-companies-transparent-practices 2026-04-01T09:44:48+00:00 weekly 1 https://pre.almirall.it/news/los-ultimos-avances-debate-en-el-x-symposium-de-psiquiatria-organizado-por-almirall 2026-04-01T09:44:48+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-announce-positive-results-attain-phase-iii-study-aclidinium-bromide-and 2026-04-01T09:44:49+00:00 weekly 1 https://pre.almirall.it/news/sativexr-enters-phase-iii-clinical-programme-oncological-pain 2026-04-01T09:44:51+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-ironwood-announce-positive-results-second-phase-iii-trial-linaclotide-patients 2026-04-01T09:44:52+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-report-preliminary-topline-results-accord-copd-ii-phase-iii-study 2026-04-01T09:44:52+00:00 weekly 1 https://pre.almirall.it/news/almirall-apoya-el-programa-de-actividades-puesto-en-marcha-por-la-sed-y-su-fundacion-para-el 2026-04-01T09:44:54+00:00 weekly 1 https://pre.almirall.it/news/sativexr-data-presented-ectrims-congress-highlights-its-efficacy-add-therapy-treatment 2026-04-01T09:44:54+00:00 weekly 1 https://pre.almirall.it/news/almirall-pioneer-obtaining-ohsas-18001-occupational-health-and-safety-renews-certificate 2026-04-01T09:44:55+00:00 weekly 1 https://pre.almirall.it/news/launch-spain-urorecrsilodyxtm-new-treatment-symptoms-associated-benign-prostatic-hyperplasia 2026-04-01T09:44:55+00:00 weekly 1 https://pre.almirall.it/news/conbrizar-bazedoxifene-approved-spanish-agency-medicines-and-healthcare-products-aemps 2026-04-01T09:44:55+00:00 weekly 1 https://pre.almirall.it/news/research-chronic-pain-winning-project-pharmacology-award-presented-almirall-and-spanish 2026-04-01T09:44:57+00:00 weekly 1 https://pre.almirall.it/news/almirall-receives-company-rating-excellent-ministry-industry-tourism-and-trade 2026-04-01T09:44:57+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-ironwood-announce-positive-results-phase-3-trial-linaclotide-patients-irritable 2026-04-01T09:44:58+00:00 weekly 1 https://pre.almirall.it/news/almirall-awarded-zero-rate-accident-frequency-2009 2026-04-01T09:44:58+00:00 weekly 1 https://pre.almirall.it/news/sativexr-receives-regulatory-authorisation-spain 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-signs-co-promotion-agreement-pfizer-commercialise-conbrizar-spain-new-therapeutic 2026-04-01T09:45:00+00:00 weekly 1 https://pre.almirall.it/news/almirall-reaffirms-its-commitment-environment-renewal-its-iso-140012004-certificate 2026-04-01T09:45:01+00:00 weekly 1 https://pre.almirall.it/news/el-tratamiento-integral-de-la-diabetes-tipo-2-y-su-cumplimiento-por-parte-del-paciente-claves 2026-04-01T09:45:01+00:00 weekly 1 https://pre.almirall.it/news/presentation-neogenius-project-brings-together-around-hundred-investigators 2026-04-01T09:45:03+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-international-agreement-basilea-commercialize-toctinor-alitretinoin-severe 2026-04-01T09:45:03+00:00 weekly 1 https://pre.almirall.it/news/almirall-organiza-la-i-reunion-de-centros-de-excelencia-en-cardiologia-de-espana 2026-04-01T09:45:04+00:00 weekly 1 https://pre.almirall.it/news/regulators-uk-and-spain-confirm-sativexr-approvable 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almiralls-annual-general-meeting-approves-dividend-033-euros-share-figure-5-last-year 2026-04-01T09:45:05+00:00 weekly 1 https://pre.almirall.it/news/almirall-first-quarter-2010-track 2026-04-01T09:45:05+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-present-data-studies-eklirar-aclidinium-bromide-chronic-obstructive 2026-04-01T09:45:05+00:00 weekly 1 https://pre.almirall.it/news/20-years-antihistamine-ebastelr-ebastine 2026-04-01T09:45:07+00:00 weekly 1 https://pre.almirall.it/news/almirall-grants-eisai-marketing-rights-cinitapride-china 2026-04-01T09:45:07+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-thiomucase-extreme-areas-first-anti-cellulite-stick-rebellious-areas 2026-04-01T09:45:07+00:00 weekly 1 https://pre.almirall.it/news/almirall-solid-performance-2009-setting-basis-sustainable-long-term-growth 2026-04-01T09:45:09+00:00 weekly 1 https://pre.almirall.it/news/neogenius-alliance-between-almirall-esteve-palau-pharma-and-proteomika-investigate-new 2026-04-01T09:45:09+00:00 weekly 1 https://pre.almirall.it/news/multidisciplinary-approach-improve-treatment-and-reduce-patient-cardiovascular-risk 2026-04-01T09:45:10+00:00 weekly 1 https://pre.almirall.it/news/silodosin-indicated-benign-prostatic-hyperplasia-bph-has-been-approved-european-commission 2026-04-01T09:45:10+00:00 weekly 1 https://pre.almirall.it/news/almirall-strengthens-its-focus-twice-daily-dosing-eklirar-chronic-obstructive-pulmonary 2026-04-01T09:45:11+00:00 weekly 1 https://pre.almirall.it/news/9th-psychiatry-symposium-organized-almirall-presents-latest-advances-area 2026-04-01T09:45:11+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-announce-positive-results-accord-copd-i-phase-iii-study-aclidinium-bromide 2026-04-01T09:45:13+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-laboratories-expand-respiratory-collaboration-las100977 2026-04-01T09:45:13+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-parapres-plus-32r-and-parapres-plus-forter-treat-hypertension 2026-04-01T09:45:14+00:00 weekly 1 https://pre.almirall.it/news/emeachmp-adopts-positive-opinion-silodosin 2026-04-01T09:45:14+00:00 weekly 1 https://pre.almirall.it/news/almirall-reports-net-sales-7013-million-euros-increase-24 2026-04-01T09:45:16+00:00 weekly 1 https://pre.almirall.it/news/almiralls-dhodh-inhibitor-recognized-windhover-top-10-partnering-list-immunology-category 2026-04-01T09:45:16+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-us-15-m-equity-investment-ironwood-pharmaceuticals-linaclotide 2026-04-01T09:45:17+00:00 weekly 1 https://pre.almirall.it/news/update-eklirar-aclidinium-bromide-chronic-obstructive-pulmonary-disease-copd-positive-results 2026-04-01T09:45:17+00:00 weekly 1 https://pre.almirall.it/news/blastoactiva-first-skin-cell-repair-cream-double-select-centella-asiatica 2026-04-01T09:45:18+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-spanish-society-pharmacology-present-8th-pharmacology-award-2009-seville 2026-04-01T09:45:18+00:00 weekly 1 https://pre.almirall.it/news/almirall-aims-file-once-daily-aclidinium-bromide-copd-europe-early-2010 2026-04-01T09:45:18+00:00 weekly 1 https://pre.almirall.it/news/almirall-reports-over-103-million-euros-net-income-first-half-year-2009 2026-04-01T09:45:20+00:00 weekly 1 https://pre.almirall.it/news/almirall-offers-its-employees-6500-hours-training-health-and-safety 2026-04-01T09:45:20+00:00 weekly 1 https://pre.almirall.it/news/almirall-appoints-new-managing-director-its-market-company-poland 2026-04-01T09:45:20+00:00 weekly 1 https://pre.almirall.it/news/almotriptan-axertralmogranr-approved-fda-treatment-migraine-adolescents 2026-04-01T09:45:21+00:00 weekly 1 https://pre.almirall.it/news/almirall-awards-dividend-payments-52-million-euros-its-shareholders 2026-04-01T09:45:21+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-filing-sativexr-regulatory-submission 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-reports-over-63-million-euros-net-income-first-quarter-2009 2026-04-01T09:45:24+00:00 weekly 1 https://pre.almirall.it/news/almirall-launches-efficibr-spain-combination-product-sitagliptin-and-metformin-intended 2026-04-01T09:45:24+00:00 weekly 1 https://pre.almirall.it/news/almirall-signs-pan-european-licensing-agreement-ironwood-linaclotide-novel-gastrointestinal 2026-04-01T09:45:25+00:00 weekly 1 https://pre.almirall.it/news/almiralls-respiratory-pipeline-update-aclidinium-bromide-and-las100977-once-daily-laba 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-opens-its-doors-pharmaceutical-industry-mark-opening-new-london-headquarters 2026-04-01T09:45:27+00:00 weekly 1 https://pre.almirall.it/news/steve-webber-new-senior-discovery-director-almirall 2026-04-01T09:45:27+00:00 weekly 1 https://pre.almirall.it/news/almirall-signs-co-marketing-agreement-recordati-marketing-silodosin-spain-new-compound-benign 2026-04-01T09:45:27+00:00 weekly 1 https://pre.almirall.it/news/almirall-obtains-net-income-1361-million-euros-2008-38-more-previous-year 2026-04-01T09:45:29+00:00 weekly 1 https://pre.almirall.it/news/between-15-and-20-population-will-suffer-depression-some-time-during-their-lives 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/promising-results-almiralls-once-daily-long-acting-beta-agonist-laba-expected-lead-development 2026-04-01T09:45:32+00:00 weekly 1 https://pre.almirall.it/news/marc-ayas-new-director-international-human-resources-and-compensation-almirall 2026-04-01T09:45:32+00:00 weekly 1 https://pre.almirall.it/news/almirall-ranke-quimica-reduced-its-accident-rate-57-2007 2026-04-01T09:45:32+00:00 weekly 1 https://pre.almirall.it/news/almirall-obtains-total-revenues-around-809-million-euros-18-more-same-period-previous-year 2026-04-01T09:45:34+00:00 weekly 1 https://pre.almirall.it/news/almirall-signs-agreement-pfizer-commercialise-new-medicine-reduces-cardiovascular-risk 2026-04-01T09:45:34+00:00 weekly 1 https://pre.almirall.it/news/almirall-signs-co-marketing-agreement-msd-commercialise-spain-new-medicine-type-2-diabetes 2026-04-01T09:45:34+00:00 weekly 1 https://pre.almirall.it/news/daniel-martinez-takes-new-position-deputy-cfo-almirall 2026-04-01T09:45:36+00:00 weekly 1 https://pre.almirall.it/news/almirall-upgrades-its-company-website-wwwalmirallcom 2026-04-01T09:45:36+00:00 weekly 1 https://pre.almirall.it/news/almirall-moving-forward-development-aclidinium-bromide 2026-04-01T09:45:36+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-spanish-society-pharmacology-confer-pharmacology-award-2008 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/marketing-sales-team-almirall-germany-has-received-golden-tablet-award-best-company 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/phase-iii-clinical-studies-aclidinium-bromide-show-statistical-significance-vs-placebo 2026-04-01T09:45:39+00:00 weekly 1 https://pre.almirall.it/news/clarification-regarding-news-almirall-receiving-offer-acquiring-package-almirall-shares 2026-04-01T09:45:40+00:00 weekly 1 https://pre.almirall.it/news/almirall-obtains-total-revenues-around-547-million-euros-first-half-year 2026-04-01T09:45:40+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-initial-agreement-sale-its-plant-sant-just-desvern-lesvi 2026-04-01T09:45:40+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-proteros-biostructures-announce-successful-achievement-key-scientific-milestone 2026-04-01T09:45:42+00:00 weekly 1 https://pre.almirall.it/news/laboratorios-almirall-sa-and-forest-laboratories-inc-complete-phase-iii-studies-copd 2026-04-01T09:45:42+00:00 weekly 1 https://pre.almirall.it/news/doctors-and-pharmacists-pool-knowledge-tackle-digestive-diseases 2026-04-01T09:45:42+00:00 weekly 1 https://pre.almirall.it/news/philippe-bouissou-new-senior-development-director-almirall 2026-04-01T09:45:43+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-laboratories-announce-positive-results-clinical-studies-aclidinium-bromide 2026-04-01T09:45:43+00:00 weekly 1 https://pre.almirall.it/news/almirall-obtains-total-revenues-269-million-euros-first-quarter-year 2026-04-01T09:45:47+00:00 weekly 1 https://pre.almirall.it/news/almirall-awards-dividend-40-its-shareholders 2026-04-01T09:45:47+00:00 weekly 1 https://pre.almirall.it/news/almirall-reinforces-its-european-expansion-opening-new-affiliates-poland-and-switzerland 2026-04-01T09:45:47+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-promising-results-new-compound-asthma-and-copd 2026-04-01T09:45:48+00:00 weekly 1 https://pre.almirall.it/news/israel-garcia-and-ma-eugenia-vellve-new-almirall-general-managers-mexico-and-portugal 2026-04-01T09:45:48+00:00 weekly 1 https://pre.almirall.it/news/almirall-reports-total-revenues-917-million-euros-2007 2026-04-01T09:45:48+00:00 weekly 1 https://pre.almirall.it/news/carlos-gallardo-general-manager-almirall-united-kingdom-and-ireland 2026-04-01T09:45:49+00:00 weekly 1 https://pre.almirall.it/news/almirall-reinforces-its-presence-europe-opening-new-affiliate-united-kingdom 2026-04-01T09:45:49+00:00 weekly 1 https://pre.almirall.it/news/almirall-closes-acquisition-portfolio-8-products-shire-plc 2026-04-01T09:45:52+00:00 weekly 1 https://pre.almirall.it/news/almirall-contributes-almost-2-million-euros-renew-collaboration-agreement-barcelona-science 2026-04-01T09:45:52+00:00 weekly 1 https://pre.almirall.it/news/almirall-increases-its-net-sales-38 2026-04-01T09:45:53+00:00 weekly 1 https://pre.almirall.it/news/christophe-vandeputte-and-dominique-humblet-new-almirall-general-managers-france-and-belgium 2026-04-01T09:45:55+00:00 weekly 1 https://pre.almirall.it/news/anselm-divi-new-almirall-corporate-director-human-resources 2026-04-01T09:45:57+00:00 weekly 1 https://pre.almirall.it/news/almirall-acquires-portfolio-eight-products-shire-plc-us213-million-eu151-million 2026-04-01T09:45:59+00:00 weekly 1 https://pre.almirall.it/news/klaus-melchers-new-senior-discovery-director-almirall 2026-04-01T09:45:59+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-spanish-pharmacology-society-confer-pharmacology-award-2007 2026-04-01T09:45:59+00:00 weekly 1 https://pre.almirall.it/news/aclidinium-bromide-demonstrates-rapid-and-long-acting-bronchodilatory-effect-copd 2026-04-01T09:46:00+00:00 weekly 1 https://pre.almirall.it/news/almirall-closes-process-acquisition-hermal-after-clearance-german-regulatory-authorities 2026-04-01T09:46:00+00:00 weekly 1 https://pre.almirall.it/news/almirall-closes-its-acquisition-hermal-after-clearance-german-regulatory-authorities 2026-04-01T09:46:02+00:00 weekly 1 https://pre.almirall.it/news/almirall-half-year-results-2007-almirall-reports-net-sales-4129-million-euros 2026-04-01T09:46:02+00:00 weekly 1 https://pre.almirall.it/news/almirall-reports-net-sales-4129-million-euros 2026-04-01T09:46:02+00:00 weekly 1 https://pre.almirall.it/news/almirall-again-receives-iso-140012004-environmental-management-certificate 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-acquires-hermal-european-prescription-dermatology-business-reckitt-benckiser-ps-255 2026-04-01T09:46:05+00:00 weekly 1 https://pre.almirall.it/news/almirall-priced-14-euros-share-its-first-day-listed-company 2026-04-01T09:46:05+00:00 weekly 1 https://pre.almirall.it/news/almirall-shares-close-first-day-trading-rising-714-over-offer-price 2026-04-01T09:46:06+00:00 weekly 1 https://pre.almirall.it/news/jordi-molina-alsina-investor-relations-manager-almirall 2026-04-01T09:46:06+00:00 weekly 1 https://pre.almirall.it/news/CNMV-spanish-stock-exchange-commission-registers-prospectus-public-offering-sale-and 2026-04-01T09:46:07+00:00 weekly 1 https://pre.almirall.it/news/almirall-will-reserve-shares-its-stock-market-listing-company-employees 2026-04-01T09:46:07+00:00 weekly 1 https://pre.almirall.it/news/sativex 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-receives-fundamed-el-global-award-best-pharmaceutical-company-year 2026-04-01T09:46:08+00:00 weekly 1 https://pre.almirall.it/news/almirall-certifies-its-occupational-risk-prevention-management-system-surpassing-current 2026-04-01T09:46:10+00:00 weekly 1 https://pre.almirall.it/news/almirall-selects-morgan-stanley-and-santander-next-phase-stock-market-listing 2026-04-01T09:46:10+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-its-intention-list-its-shares-spanish-stock-market 2026-04-01T09:46:10+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-council-catalonian-medical-associations-fundacio-galatea-sign-agreement-undertake 2026-04-01T09:46:11+00:00 weekly 1 https://pre.almirall.it/news/almirall-spa-be-awarded-spanish-company-year-italy 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/stress-and-anxiety-are-among-main-causes-acidity-spain 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-confers-2006-pharmacology-award-during-spanish-pharmacology-society-congress 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-extends-its-collaboration-sareum 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/strategic-partnership-almirall-meda 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/his-majesty-king-spain-inaugurates-almiralls-new-research-and-development-centre-sant-feliu-de 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almiralls-new-research-and-development-centre-reference-point-biomedical-research 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-expands-12-international-pharmaceutical-market 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/el-dr-carsten-niederlander-nuevo-director-de-desarrollo-farmaceutico 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-forest-announce-development-and-marketing-collaboration-agreement-new-therapy 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-publish-clinical-trials 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-gw-announce-european-development-and-marketing-agreement-sativexr 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-grants-commercialisation-almogran-switzerland-pharmaceutical-company-merz 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-italy-signs-agreement-altana-pharma-ag-commercialisation-pantopan-pantoprazole 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-only-pharmaceutical-company-be-awarded-best-european-business-prize-innovation 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-confers-2005-pharmacology-award 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-collaboration-sareum-protein-structure-determination 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-enters-long-term-compound-library-agreement-evotec 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/according-survey-el-club-de-la-farmacia-website-portal-which-over-30000-pharmacists-subscribe 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-reaches-sales-figures-900-million-euros-2004 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-awarded-prince-felipe-prize-business-competitiveness-large-enterprises-ministry 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-parkinsons-disease-research-programme-licensing-agreement-neurocrine 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-confers-2004-pharmacology-award 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-has-taken-strategic-decision-registering-almotriptan-japan 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-increases-sales-64-2003 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almotriptan-receives-approval-be-sold-canada 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-awarded-iso-1400196-environmental-management-certification 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-confers-2003-pharmacology-award 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/canada-another-key-approval-almotriptan 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-presents-its-new-corporate-website 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-has-licensed-its-triptan-ortho-mcneil-pharmaceutical-inc-us-and-canada 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-prodesfarma-consolidates-its-international-expansion-opening-subsidiary-italy 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-prodesfarma-confers-2002-pharmacology-award 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-prodesfarma-invests-30-million-euros-new-research-and-development-centre 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/comparative-study-classifies-almogran-one-best-choices-treatment-migraines 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-prodesfarma-opens-new-laboratory-barcelona-science-park 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-prodesfarma-establishes-its-presence-france-acquisition-pharmafarm-laboratories 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-prodesfarma-licenses-antipsychotic-agent-blonanserin-dainippon 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almotriptan-almogran-licensed-fda-marketing-united-states 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-prodesfarma-acquires-prasfarma 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-recognized-top-employer-spain-and-germany 2026-03-30T13:39:13+00:00 weekly 1 https://pre.almirall.it/news/dr-olof-andersson-new-executive-director-rd-area-almirall 2026-04-01T11:26:17+00:00 weekly 1 https://pre.almirall.it/news/dr-john-efthimiou-new-rd-global-medical-director-almirall 2026-04-01T11:29:57+00:00 weekly 1 https://pre.almirall.it/news/almirall-presents-rd-pipeline-advances-supported-sustained-growth-and-leadership-medical 2026-04-01T11:30:07+00:00 weekly 1 https://pre.almirall.it/news/gonzalo-de-miquel-new-global-medical-director-almirall-rd-area 2026-04-01T11:30:51+00:00 weekly 1 https://pre.almirall.it/news/first-half-2010-line-guidance-strong-rd-catalysts-expected-second-half 2026-04-01T11:31:01+00:00 weekly 1 https://pre.almirall.it/news/q3-line-guidance-rd-momentum-continues 2026-04-01T11:31:09+00:00 weekly 1 https://pre.almirall.it/news/bertil-lindmark-new-executive-director-rd-almirall 2026-04-01T11:31:18+00:00 weekly 1 https://pre.almirall.it/news/almirall-opens-doors-its-rd-centre-biotech-zeclinics 2026-04-01T11:31:41+00:00 weekly 1 https://pre.almirall.it/news/almirall-maintains-its-shareholder-return-thanks-its-rd-and-internationalisation-results 2026-04-01T11:31:45+00:00 weekly 1 https://pre.almirall.it/news/almirall-and-eloxx-pharmaceuticals-enter-exclusive-agreement-license-zkn-013-rare 2026-04-01T13:10:01+00:00 weekly 1 https://pre.almirall.it/news/encouraging-results-support-further-development-almiralls 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-receipt-15-million-dollars-eu105-million-forest-laboratories-connection 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-commemorates-5th-anniversary-almogran-its-own-rd-medicine-treatment-migraine 2026-04-01T11:39:47+00:00 weekly 1 https://pre.almirall.it/news/almirall-reveals-promising-phase-ii-data-its-once-daily-long-acting-low-systemic-exposure 2026-04-01T12:10:01+00:00 weekly 1 https://pre.almirall.it/news/almirall-commemorates-5th-anniversary-almogran-its-own-rd-medicine-treatment-migraine-0 2026-04-01T16:01:10+00:00 weekly 1 https://pre.almirall.it/news/dr-olof-andersson-new-executive-director-rd-area-almirall-0 2026-04-01T16:01:24+00:00 weekly 1 https://pre.almirall.it/news/dr-john-efthimiou-new-rd-global-medical-director-almirall-0 2026-04-01T16:01:32+00:00 weekly 1 https://pre.almirall.it/news/gonzalo-de-miquel-new-global-medical-director-almirall-rd-area-0 2026-04-01T16:01:40+00:00 weekly 1 https://pre.almirall.it/news/first-half-2010-line-guidance-strong-rd-catalysts-expected-second-half-0 2026-04-01T16:01:44+00:00 weekly 1 https://pre.almirall.it/news/q3-line-guidance-rd-momentum-continues-0 2026-04-01T16:01:49+00:00 weekly 1 https://pre.almirall.it/news/bertil-lindmark-new-executive-director-rd-almirall-0 2026-04-01T16:01:54+00:00 weekly 1 https://pre.almirall.it/news/almirall-maintains-its-shareholder-return-thanks-its-rd-and-internationalisation-results-0 2026-04-01T16:01:59+00:00 weekly 1 https://pre.almirall.it/news/almirall-opens-doors-its-rd-centre-biotech-zeclinics-0 2026-04-01T16:02:03+00:00 weekly 1 https://pre.almirall.it/news/almirall-presents-rd-pipeline-advances-supported-sustained-growth-and-leadership-medical-0 2026-04-01T16:02:10+00:00 weekly 1 https://pre.almirall.it/news/almirall-announces-approval-seysarar-china-treatment-moderate-severe-acne 2026-04-07T08:46:40+00:00 weekly 1 https://pre.almirall.it/news-media/newsroom/diversi-scelta-un-nuovo-modo-di-pensare-plasmare-il-futuro-della-dermatologia 2026-06-03T09:57:56+00:00 weekly 1 https://pre.almirall.it/news-media/newsroom/skin-academy-avanzando-nello-scambio-scientifico-e-nella-cura-olistica 2026-06-03T14:33:57+00:00 weekly 1 https://pre.almirall.it/news-media/newsroom/promuovere-linnovazione-nella-dermatologia-medica-attraverso-partnership-cina 2026-06-04T09:18:45+00:00 weekly 1 https://pre.almirall.it/news-media/newsroom/donne-il-progresso-della-scienza 2026-06-04T09:22:39+00:00 weekly 1 https://pre.almirall.it/news-media/newsroom/almirall-raggiunge-gli-obiettivi-previsti-il-2025-registrando-una-crescita-del 2026-06-04T09:24:51+00:00 weekly 1 https://pre.almirall.it/dermatologia/acne 2026-08-17T12:21:44+00:00 weekly 1 https://pre.almirall.it/dermatologia/alopecia-areata 2026-07-07T09:39:22+00:00 weekly 1 https://pre.almirall.it/dermatologia/carcinoma-cheratinociti 2026-08-17T10:55:23+00:00 weekly 1 https://pre.almirall.it/dermatologia/cheratosi-attinica 2026-08-17T12:37:36+00:00 weekly 1 https://pre.almirall.it/dermatologia/dermatite-atopica 2026-07-07T09:33:26+00:00 weekly 1 https://pre.almirall.it/dermatologia/acne/diagnosi 2026-06-24T10:53:41+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle/epidermolisi-bollosa-congenita/diagnosi 2026-05-13T13:52:57+00:00 weekly 1 https://pre.almirall.it/dermatologia/psoriasi/diagnosi 2026-08-17T12:04:31+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle/pustolosi-palmoplantare/diagnosi 2026-05-13T11:30:21+00:00 weekly 1 https://pre.almirall.it/dermatologia/vitiligine/diagnosi 2026-07-08T09:20:03+00:00 weekly 1 https://pre.almirall.it/dermatologia/onicomicosi/diagnosi 2026-08-17T11:34:38+00:00 weekly 1 https://pre.almirall.it/dermatologia/alopecia-areata/diagnosi 2026-08-17T12:34:18+00:00 weekly 1 https://pre.almirall.it/dermatologia/carcinoma-cheratinociti/diagnosi 2026-07-09T06:22:02+00:00 weekly 1 https://pre.almirall.it/dermatologia/cheratosi-attinica/diagnosi 2026-07-07T06:59:43+00:00 weekly 1 https://pre.almirall.it/dermatologia/dermatite-atopica/diagnosi 2026-06-03T16:57:38+00:00 weekly 1 https://pre.almirall.it/dermatologia/idrosadenite-suppurativa/diagnosi 2026-06-24T07:28:02+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle/epidermolisi-bollosa-congenita 2026-07-07T09:45:48+00:00 weekly 1 https://pre.almirall.it/dermatologia/carcinoma-cheratinociti/fattori-scatenanti 2026-06-24T09:23:19+00:00 weekly 1 https://pre.almirall.it/dermatologia/acne/fattori-scatenanti 2026-06-03T16:38:50+00:00 weekly 1 https://pre.almirall.it/dermatologia/alopecia-areata/fattori-scatenanti 2026-05-13T17:44:15+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle/epidermolisi-bollosa-congenita/fattori-scatenanti 2026-06-24T07:18:44+00:00 weekly 1 https://pre.almirall.it/dermatologia/idrosadenite-suppurativa/fattori-scatenanti 2026-06-24T07:30:43+00:00 weekly 1 https://pre.almirall.it/dermatologia/cheratosi-attinica/fattori-scatenanti 2026-08-17T12:23:36+00:00 weekly 1 https://pre.almirall.it/dermatologia/dermatite-atopica/fattori-scatenanti 2026-06-03T17:10:15+00:00 weekly 1 https://pre.almirall.it/dermatologia/psoriasi/fattori-scatenanti 2026-06-24T13:47:25+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle/pustolosi-palmoplantare/fattori-scatenanti 2026-05-13T11:54:29+00:00 weekly 1 https://pre.almirall.it/dermatologia/vitiligine/fattori-scatenanti 2026-05-13T16:05:47+00:00 weekly 1 https://pre.almirall.it/dermatologia/onicomicosi/fattori-scatenanti 2026-08-17T11:01:00+00:00 weekly 1 https://pre.almirall.it/dermatologia/idrosadenite-suppurativa 2026-07-07T09:40:54+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle 2026-05-19T09:50:51+00:00 weekly 1 https://pre.almirall.it/dermatologia/onicomicosi 2026-07-07T09:39:11+00:00 weekly 1 https://pre.almirall.it/dermatologia/psoriasi 2026-08-17T12:44:53+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle/pustolosi-palmoplantare 2026-07-07T09:46:16+00:00 weekly 1 https://pre.almirall.it/dermatologia/carcinoma-cheratinociti/segni-sintomi 2026-06-25T07:52:07+00:00 weekly 1 https://pre.almirall.it/dermatologia/acne/segni-sintomi 2026-08-17T11:12:51+00:00 weekly 1 https://pre.almirall.it/dermatologia/alopecia-areata/segni-sintomi 2026-06-24T09:33:21+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle/epidermolisi-bollosa-congenita/segni-sintomi 2026-06-23T14:22:08+00:00 weekly 1 https://pre.almirall.it/dermatologia/idrosadenite-suppurativa/segni-sintomi 2026-06-25T06:26:19+00:00 weekly 1 https://pre.almirall.it/dermatologia/cheratosi-attinica/segni-sintomi 2026-08-17T12:26:19+00:00 weekly 1 https://pre.almirall.it/dermatologia/dermatite-atopica/segni-sintomi 2026-07-16T11:42:51+00:00 weekly 1 https://pre.almirall.it/dermatologia/psoriasi/segni-sintomi 2026-08-17T12:18:28+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle/pustolosi-palmoplantare/segni-sintomi 2026-05-13T11:41:22+00:00 weekly 1 https://pre.almirall.it/dermatologia/vitiligine/segni-sintomi 2026-06-03T16:08:48+00:00 weekly 1 https://pre.almirall.it/dermatologia/onicomicosi/segni-sintomi 2026-08-17T11:23:09+00:00 weekly 1 https://pre.almirall.it/dermatologia/alopecia-areata/tipi 2026-05-13T17:24:17+00:00 weekly 1 https://pre.almirall.it/dermatologia/carcinoma-cheratinociti/tipi 2026-08-17T11:06:27+00:00 weekly 1 https://pre.almirall.it/dermatologia/cheratosi-attinica/tipi 2026-08-17T12:32:19+00:00 weekly 1 https://pre.almirall.it/dermatologia/dermatite-atopica/tipi 2026-06-03T16:51:36+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle/epidermolisi-bollosa-congenita/tipi 2026-05-12T13:21:34+00:00 weekly 1 https://pre.almirall.it/dermatologia/idrosadenite-suppurativa/tipi 2026-06-03T15:17:38+00:00 weekly 1 https://pre.almirall.it/dermatologia/onicomicosi/tipi 2026-05-13T17:46:08+00:00 weekly 1 https://pre.almirall.it/dermatologia/psoriasi/tipi 2026-07-09T06:45:03+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle/pustolosi-palmoplantare/tipi 2026-06-23T14:05:11+00:00 weekly 1 https://pre.almirall.it/dermatologia/vitiligine/tipi 2026-06-24T08:15:22+00:00 weekly 1 https://pre.almirall.it/dermatologia/acne/tipi 2026-06-24T10:51:58+00:00 weekly 1 https://pre.almirall.it/dermatologia/carcinoma-cheratinociti/trattamento 2026-07-08T09:12:09+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle/pustolosi-palmoplantare/trattamento 2026-06-23T14:07:26+00:00 weekly 1 https://pre.almirall.it/dermatologia/acne/trattamento 2026-08-17T11:09:57+00:00 weekly 1 https://pre.almirall.it/dermatologia/alopecia-areata/trattamento 2026-06-24T10:31:22+00:00 weekly 1 https://pre.almirall.it/dermatologia/malattie-rare-pelle/epidermolisi-bollosa-congenita/trattamento 2026-05-12T13:24:40+00:00 weekly 1 https://pre.almirall.it/dermatologia/idrosadenite-suppurativa/trattamento 2026-06-24T08:13:02+00:00 weekly 1 https://pre.almirall.it/dermatologia/cheratosi-attinica/trattamento 2026-07-08T07:38:41+00:00 weekly 1 https://pre.almirall.it/dermatologia/dermatite-atopica/trattamento 2026-07-09T06:33:35+00:00 weekly 1 https://pre.almirall.it/dermatologia/psoriasi/trattamento 2026-08-17T11:37:50+00:00 weekly 1 https://pre.almirall.it/dermatologia/vitiligine/trattamento 2026-05-13T16:19:38+00:00 weekly 1 https://pre.almirall.it/dermatologia/onicomicosi/trattamento 2026-07-08T08:07:23+00:00 weekly 1 https://pre.almirall.it/dermatologia/vitiligine 2026-07-07T09:40:41+00:00 weekly 1 https://pre.almirall.es 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/compania 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/compania/sobre-nosotros 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/compania/proveedores 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/compania/proposito 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/pacientes 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/compania/localizaciones 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/compania/sostenibilidad/personas 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/compania/sostenibilidad/principios 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/pacientes/bienestar-psicologico 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/pacientes/compromiso/campanas 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/compania/sostenibilidad/planeta 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/compania/sostenibilidad 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/compania/sostenibilidad/pacientes 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/compania/sostenibilidad/socios 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/pacientes/historias 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/pacientes/compromiso/campanas/sanctuary-salon 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/inversores 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/inversores/comunicaciones-CNMV 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/inversores/responsabilidad-corporativa 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/inversores/responsabilidad-corporativa/junta-anual 2026-09-09T07:11:57+00:00 weekly 1 https://pre.almirall.es/innovacion/ensayos-clinicos 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/innovacion/colaboracion-id 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/innovacion/colaboraciones 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/inversores/responsabilidad-corporativa/acuerdos 2026-09-04T15:10:01+00:00 weekly 1 https://pre.almirall.es/inversores/responsabilidad-corporativa/consejo-administracion 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/inversores/responsabilidad-corporativa/comisiones-consejo 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/dermatologia 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/inversores/informes/anual 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/inversores/informes/anual/2021 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/innovacion 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/inversores/informacion-bursatil 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/inversores/informacion-stock/rendimiento-acciones 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/inversores/informacion-stock/capital-social 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/inversores/informacion-bursatil/cobertura-analistas 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/inversores/informacion-bursatil/acciones-financiacion 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/inversores/datos-financieros/resultados-cuentas 2026-09-09T07:15:44+00:00 weekly 1 https://pre.almirall.es/inversores/datos-financieros/informacion-publica 2026-09-09T07:16:54+00:00 weekly 1 https://pre.almirall.es/inversores/datos-financieros/materiales-informativos 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/innovacion/pipeline 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/inversores/nuestro-liderazgo 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/inversores/informes 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/pacientes/compromiso 2026-09-08T07:47:07+00:00 weekly 1 https://pre.almirall.es/inversores/responsabilidad-corporativa/cumplimiento 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/compania/integridad 2026-09-04T15:10:13+00:00 weekly 1 https://pre.almirall.es/compania/faq 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/compania/faq/tratamientos 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/compania/faq/patologia 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/compania/faq/areas-terapeuticas 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/inversores/liderazgo/comite-direccion 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/compania/historia 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/inversores/responsabilidad-corporativa/director-gobernanza 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/contacto/comunicar-efecto-adverso 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/inversores/responsabilidad-corporativa/politicas-consejo 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/news-media/contact 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/prensa-medios/calendario-eventos 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/prensa-medios 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/contacto/medios 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/contacto/inversores 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/contacto/recursos-desarrollo 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/contacto/personas-cultura 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/contacto/socios 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/contacto/informacion-medica 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/contacto/ayuda-mejorar 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/prensa-medios/recursos-medios 2026-09-04T15:10:25+00:00 weekly 1 https://pre.almirall.es/pacientes/compromiso/campanas/sanctuary-salon/pacientes 2026-09-08T15:46:35+00:00 weekly 1 https://pre.almirall.es/terminos-condiciones 2026-09-04T15:10:36+00:00 weekly 1 https://pre.almirall.es/compania/sostenibilidad/transparencia 2026-09-08T15:43:39+00:00 weekly 1 https://pre.almirall.es/politica-privacidad-global-eventos 2026-09-04T15:10:36+00:00 weekly 1 https://pre.almirall.es/politica-privacidad 2026-09-04T15:10:36+00:00 weekly 1 https://pre.almirall.es/politica-privacidad-hcp 2026-09-04T15:10:36+00:00 weekly 1 https://pre.almirall.es/politica-accesibilidad 2026-09-08T07:40:04+00:00 weekly 1 https://pre.almirall.es/politica-cookies 2026-09-04T15:10:36+00:00 weekly 1 https://pre.almirall.es/terminos-uso 2026-09-04T15:10:36+00:00 weekly 1 https://pre.almirall.es/seguridad-medicamentos 2026-09-04T15:10:36+00:00 weekly 1 https://pre.almirall.es/compania/sostenibilidad/otra-documentacion-relevante 2026-09-04T15:10:36+00:00 weekly 1 https://pre.almirall.es/contacto 2026-09-04T15:10:36+00:00 weekly 1 https://pre.almirall.es/aviso-privacidad-profesional 2026-09-04T15:10:36+00:00 weekly 1 https://pre.almirall.es/test-documents 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/profesionales-sanitarios/tratamientos 2026-09-07T11:14:07+00:00 weekly 1 https://pre.almirall.es/profesionales-sanitarios 2026-09-07T11:11:31+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-barcelona-supercomputing-center-bsc-amplian-su-colaboracion 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/lebrikizumab-demuestra-control-sostenido-de-la-enfermedad-hasta-cuatro 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-17a-skin-academy-de-almirall-destaca-los-avances-cientificos-en 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/lebrikizumab-proporciona-un-aclaramiento-de-la-piel-significativo-y 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-inaugura-oficinas-en-china-para-impulsar-la-innovacion-en 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-impulsa-el-abordaje-integral-en-la-dermatitis-atopica-de-la-mano 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-cumple-sus-previsiones-en-2025-logra-un-crecimiento-del-124-en 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-cdti-innovacion-concede-almirall-dos-ayudas-que-ascienden-168-millones 2026-05-27T11:03:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/top-employer-reconoce-de-nuevo-almirall-por-su-compromiso-con-el-talento 2026-05-27T11:03:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-presenta-los-progresos-de-su-cartera-de-id-respaldados-por-un 2026-05-27T11:03:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-alcanza-la-segunda-posicion-en-reputacion-en-dermatologia-entre 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-pone-en-marcha-con-el-apoyo-de-aada-una-iniciativa-social-sobre 2026-05-27T11:03:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-impulsa-la-innovacion-tecnologica-y-el-seguimiento-integral-del 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-apuesta-por-la-formacion-de-profesionales-de-atencion-primaria 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-promueve-en-biospain-2025-la-importancia-de-los-hubs-de 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-presenta-los-resultados-largo-plazo-del-primer-estudio-de 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-impulsa-la-dermatologia-con-nueva-evidencia-en-la-practica 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-demuestra-la-eficacia-de-los-biologicos-con-evidencias-en-la 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lidera-un-cambio-de-paradigma-hacia-una-atencion-holistica-al 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-junta-general-de-accionistas-de-almirall-respalda-la-estrategia-de-la 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-impulsa-el-conocimiento-en-dermatitis-atopica-y-psoriasis-con 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-reune-expertos-en-su-16-edicion-de-skin-academy-para-impulsar 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-presenta-nuevos-datos-sobre-su-pipeline-y-datos-en-practica 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-17-anos-consecutivos-siendo-top-employer 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-entra-en-una-nueva-etapa-de-crecimiento-sostenido 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-celebra-80-anos-de-compromiso-con-los-pacientes-y-con-la 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-reune-lideres-mundiales-en-enfermedades-inflamatorias-de-la-piel 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almaxr-celebra-40-anos-consolidado-como-un-medicamento-antiacido-de 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-la-finalizacion-del-procedimiento-descentralizado-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/nuevos-datos-muestran-que-ebglyssrv-lebrikizumab-proporciona-un-control 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/33o-congreso-de-la-academia-europea-de-dermatologia-y-venereologia-eadv 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-de-almirall-del-primer-semestre-de-2024 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-act4impact-su-estrategia-de-sostenibilidad-actualizada-que 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/ilumetrir-tildrakizumab-de-almirall-en-los-pacientes-con-psoriasis-en 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-fda-de-eeuu-aprueba-la-extension-de-tratamiento-de-klisyrirv 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/24-de-mayo-dia-internacional-de-la-queratosis-actinica 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-eloxx-pharmaceuticals-firman-un-acuerdo-exclusivo-de-licencia 2026-05-27T11:03:33+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-adquiere-la-licencia-del-anticuerpo-monoclonal-anti-il-21-de 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-logra-la-calificacion-de-cdp-por-sus-contribuciones-la-lucha 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-microsoft-colaboran-para-impulsar-la-transformacion-digital-en 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-inicia-el-primer-estudio-clinico-en-fase-i-de-alm223-una-il 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-participara-en-la-42a-edicion-anual-de-la-jp-morgan-healthcare 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-barcelona-supercomputing-center-bsc-y-nostrum-biodiscovery 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/ebglyssr-lebrikizumab-de-almirall-recibe-la-aprobacion-de-la-comision 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-absci-firman-un-acuerdo-para-desarrollar-nuevos-tratamientos 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-psoriasis-puede-afectar-al-bienestar-de-la-persona-un-nivel-similar-al 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-busca-colaboraciones-para-estudiar-mecanismos-patologicos-clave 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-casi-ocho-de-cada-diez-pacientes-con-dermatitis-atopica-de 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lebrikizumab-mejora-los-signos-y-sintomas-de-la-dermatitis 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-ilumetrir-tildrakizumab-mejora-significativamente-el-bienestar 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/centrient-pharmaceuticals-se-une-al-centro-de-innovacion-de-almirall-en 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/ebglyssr-lebrikizumab-recibe-la-opinion-positiva-del-chmp-para-el 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-la-campana-moving-ahead-para-concienciar-sobre-la 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-iniciativa-science-based-targets-sbti-valida-los-objetivos-de 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-ilumetrir-tildrakizumab-mejora-significativamente-el-bienestar-0 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-la-fijacion-del-precio-y-el-cierre-de-su-aumento-de 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-el-lanzamiento-de-un-aumento-de-capital-con-exclusion 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/nina-una-obra-audiovisual-sobre-el-impacto-de-la-psoriasis-en-la-salud 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-el-centro-de-regulacion-genomica-crg-colaboran-para 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-85-de-los-espanoles-desconoce-la-existencia-de-la-queratosis-actinica 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-hasta-el-73-de-los-pacientes-con-dermatitis-atopica-tratados-con 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-primera-compania-en-evaluar-el-bienestar-del-paciente-en-un 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-el-new-england-journal-medicine-nejm-y-el-british-journal 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-abre-las-puertas-de-su-centro-de-id-la-biotecnologica-zeclinics 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-nombra-mercedes-diz-vicepresidenta-de-estrategia-corporativa 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-se-une-al-proyecto-europeo-facilitate-para-promover-un 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-accion-psoriasis-renuevan-su-acuerdo-de-colaboracion-para 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-abre-una-nueva-filial-para-republica-checa-y-eslovaquia 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/carlos-gallardo-actual-presidente-de-almirall-es-nombrado-ceo-interino 2026-05-27T05:31:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-muestra-el-impacto-de-la-psoriasis-en-la-salud-mental-y-el 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-la-aceptacion-por-parte-de-la-ema-de-la-solicitud-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-el-institut-quimic-de-sarria-iqs-inician-una-colaboracion-para 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-simcere-firman-un-acuerdo-de-licencia-para-il-2mu-fc 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-el-inicio-de-un-estudio-de-fase-i-del-anticuerpo 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lebrikizumab-cada-cuatro-semanas-mantiene-un-aclaramiento 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-nuevos-datos-de-lebrikizumab-las-52-semanas-seran-presentados-en 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-del-primer-semestre-de-2022 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-una-nueva-convocatoria-para-descubrir-terapias-innovadoras 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-ocho-de-cada-diez-pacientes-mantuvieron-el-aclaramiento-de-la 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-inicia-el-procedimiento-en-europa-para-solicitar-la-aprobacion 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-relanza-ony-tecr-en-espana-un-tratamiento-antifungico-topico 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-el-dia-internacional-de-la-queratosis-actinica-durante-el 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-accion-psoriasis-lanzan-claro-una-app-destinada-mejorar-el 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-evotec-firman-una-alianza-multidiana-en-dermatologia-medica 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-e-inserm-transfert-firman-un-acuerdo-de-licencia-e-investigacion 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-la-campana-observadores-de-la-piel-para-concienciar-sobre 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-obtiene-un-buen-rendimiento-empresarial-en-el-primer-trimestre-y 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/carlos-gallardo-asume-la-presidencia-de-almirall 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lebrikizumab-combinado-con-corticosteroides-topicos-muestra 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-una-nueva-colaboracion-de-investigacion-con-la 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-la-mayoria-de-los-pacientes-tratados-con-lebrikizumab-logro-el 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-una-colaboracion-con-la-universidad-de-michigan-para 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-en-espana-una-innovadora-crema-de-calbdp-para-el 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-dr-jorge-gallardo-ballart-anuncia-su-intencion-de-retirarse-de-sus 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-financieros-2021 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-un-acuerdo-de-licencia-multidiana-con-ablexis-y-una 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-el-irb-barcelona-anuncian-una-colaboracion-de-investigacion 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lebrikizumab-demuestra-una-mejora-significativa-de-la-piel-y-un 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/hoy-si-me-puedo-levantar-una-campana-en-apoyo-las-personas-que-viven-con 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/ichnos-sciences-y-almirall-firman-un-acuerdo-de-licencia-para-un 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-innovacion-y-la-evaluacion-de-tecnologias-sanitarias-ejes-del-iv 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-presenta-solidos-resultados-en-los-ultimos-9-meses-de-2021-y 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-la-campana-shedding-light-psoriasis-para-concienciar-sobre 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-actualiza-su-hoja-de-ruta-hacia-un-futuro-mas-sostenible 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/expertos-destacan-la-necesidad-de-centrarse-en-el-bienestar-de-los 2026-05-27T11:03:38+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-en-europa-klisyrir-tirbanibulina-para-el-tratamiento-de-la 2026-05-27T11:03:40+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-la-upf-barcelona-school-management-crean-una-catedra-sobre 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-la-fijacion-del-precio-de-su-oferta-de-obligaciones 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/lebrikizumab-mejoro-significativamente-el-aclaramiento-de-la-piel-y-el 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-logra-un-solido-rendimiento-en-el-primer-semestre-y-aumenta-el 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-12-de-octubre-disena-una-app-de-monitorizacion-de-lesiones-en 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-mc2-therapeutics-anuncian-la-finalizacion-del-procedimiento 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-una-nueva-convocatoria-para-establecer-colaboraciones-en 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-kaken-pharmaceutical-firman-un-acuerdo-de-licencia-y 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-se-une-biomap-como-nuevo-socio-para-avanzar-en-la-investigacion 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-nombra-al-dr-karl-ziegelbauer-nuevo-director-cientifico-cso 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-celebra-sus-ii-jornadas-multidisciplinares-entre-farmacia 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-recibe-la-aprobacion-de-la-fda-para-producir-seysarar 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-recibe-la-opinion-positiva-del-chmp-para-klisyrirtirbanibulina 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-logra-un-solido-rendimiento-durante-el-primer-trimestre-gracias 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-propone-ruud-dobber-como-nuevo-miembro-del-consejo-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-recibe-la-calificacion-de-excelente-en-el-programa-profarma-2020 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-mc2-therapeutics-firman-un-acuerdo-de-licencia-colaboracion-y 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-la-publicacion-en-new-england-journal-medicine-de-datos 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-la-publicacion-en-el-british-journal-dermatology-de 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-el-nombramiento-de-gianfranco-nazzi-como-nuevo-ceo 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-happify-health-firman-una-colaboracion-estrategica-para 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/cdp-reconoce-almirall-por-su-compromiso-en-la-lucha-contra-el-cambio 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-tyris-therapeutics-inician-una-alianza-estrategica-para 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-fda-aprueba-klisyrir-tirbanibulina-de-almirall-un-nuevo-tratamiento 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-selecciona-seis-start-ups-de-salud-digital-en-el-marco-de-la 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-colaboraciones-con-la-universidad-de-south-australia 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/popit-y-almirall-lanzan-una-nueva-herramienta-de-apoyo-para-ayudar-los 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/pablo-alvarez-nuevo-presidente-y-general-manager-de-almirall-estados 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-demuestra-un-rendimiento-resiliente-en-los-ultimos-9-meses-pese 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-nombra-carlos-gallardo-vicepresidente-del-consejo-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/ilumetrir-tildrakizumab-primer-il23p19-que-demuestra-datos-completos-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-refuerza-sus-actividades-de-dermatologia-medica-en-francia 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-la-segunda-edicion-de-su-programa-para-start-ups-de-salud 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-la-aprobacion-de-precio-y-reembolso-de-ilumetrir 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-la-universidad-de-dundee-anuncian-una-colaboracion-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-consejero-delegado-peter-guenter-deja-almirall-el-proximo-31122020 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-financieros-almirall-1s-rendimiento-sostenido-de-los-motores 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-busca-innovacion-colaborativa-para-descubrir-nuevos-tratamientos 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-se-une-al-amr-action-fund-para-dar-soporte-en-la-lucha-contra-la 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-entra-en-el-ibex-35 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-e-ms-experts-summit-2020 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-la-uc3m-y-la-fundacion-medina-investigan-nuevos-tratamientos 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/solido-rendimiento-en-el-primer-trimestre-de-2020 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-garantiza-la-continuidad-de-las-operaciones-para-todos-los 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/comunicado-de-almirall 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-que-la-fda-ha-aceptado-la-presentacion-de-la-solicitud 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-que-la-ema-ha-aceptado-la-presentacion-de-solicitud-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-financieros-2019-solido-rendimiento-operativo-con-un-excelente 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-paratek-llegan-un-acuerdo-de-licencia-para-seysarar-en-china 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-se-asocia-con-plug-and-play-para-acelerar-la-innovacion-digital 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-participa-en-la-jp-morgan-healthcare-conference-de-san-francisco 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-firma-un-acuerdo-estrategico-con-23andme-para-licenciar-los 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-wuxi-biologics-firman-un-acuerdo-de-colaboracion-estrategico 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-alcanza-un-acuerdo-de-opcion-para-adquirir-bioniz-therapeutics-y 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirallshare-representa-el-50-de-las-colaboraciones-publico-privadas-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/iktos-y-almirall-anuncian-una-colaboracion-en-el-campo-de-la-inteligencia 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/volker-koscielny-nuevo-chief-medical-officer-y-nuevo-miembro-del-comite 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-su-aceleradora-digital-garden-para-impulsar-la-innovacion 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/accionistas-mayoritarios-de-almirall-otorgan-mandato-con-el-proposito-de 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/duaklirr-estara-disponible-en-los-estados-unidos-partir-del-21-de-octubre 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/tildrakizumab-confirma-su-eficacia-y-seguridad-con-los-datos-mas-extensos 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-el-inicio-del-programa-en-fase-3-que-evalua-lebrikizumab 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-da-el-salto-hacia-la-innovacion-digital-en-dermatologia 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-transformacion-de-la-compra-de-medicamentos-del-producto-al-resultado 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-inicia-la-comercializacion-de-sativexr-el-unico-medicamento-base 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-en-espana-ilumetrir-para-el-tratamiento-de-la-psoriasis-en 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/scottish-medicines-consortium-smc-provisionally-approves-almiralls 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-busca-colaboraciones-para-desarrollar-nuevas-terapias 2026-05-27T11:03:43+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-revalida-su-excelencia-en-la-gestion-de-seguridad-y-salud 2026-05-27T11:03:43+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-ejerce-su-opcion-con-dermira-para-licenciar-los-derechos-de 2026-05-27T11:03:47+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/plan-de-inversiones-para-europa-el-bei-financia-almirall-para-investigar 2026-05-27T11:03:43+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/nice-publica-recomendacion-final-para-ilumetrir-tildrakizumab-para-la 2026-05-27T11:03:47+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-ha-recibido-el-premio-distinguished-corporate-leadership-de-la 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-hitgen-desarrollaran-nuevos-compuestos-orales-para-la 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-la-presentacion-de-las-ultimas-novedades-de-dos-ensayos 2026-05-27T11:03:50+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-nuevolution-alcanzan-el-primer-hito-en-su-colaboracion-para 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-dermira-firman-un-acuerdo-de-opcion-y-licencia-para-los 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirallshare-una-exitosa-plataforma-para-identificar-soluciones 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/ya-esta-disponible-en-eeuu-seysaratm-sareciclina-un-innovador-antibiotico 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/francesca-domenech-wuttke-nueva-chief-digital-officer-y-nuevo-miembro-del 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-sa-estara-presente-en-la-jp-morgan-healthcare-conference-en-san 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-que-ha-completado-con-exito-la-fijacion-del-precio-de-la 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-cierra-la-financiacion-de-su-adquisicion-de-dermatologia-medica 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-financieros-de-almirall-en-el-9m-de-2018-fuerte-impulso-del 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-cierra-el-acuerdo-con-allergan-y-adquiere-su-portfolio-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/transaccion-transformadora-almirall-adquiere-de-allergan-su-portfolio-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/solidos-resultados-del-negocio-en-el-primer-semestre-de-2018 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-recibe-la-opinion-positiva-del-chmp-para-el-nuevo-anti-il23 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/thermi-anuncia-un-acuerdo-transaccional-sobre-el-litigio-por-infraccion 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-en-el-1t-de-2018-resultados-financieros-prometedores 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-financieros-2017-de-almirall 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-athenex-anuncian-un-acuerdo-estrategico-para-el-tratamiento-de 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/ensayo-en-fase-iv-ascent-muestra-que-tudorza-reduce-las-exacerbaciones-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-de-almirall-tercer-trimestre-2017 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-renueva-su-identidad-corporativa-en-linea-con-su-foco-en-la 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-estudio-en-fase-iii-de-amplify-demuestra-que-duaklir-mejora 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-el-nombramiento-de-peter-guenter-como-nuevo-consejero 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-de-almirall-en-el-primer-semestre-2017-se-reiteran-las 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-un-acuerdo-de-colaboracion-con-icmab-csic-y-el-centro 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-actualizacion-de-las-estimaciones-para-2017 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/expertos-nivel-internacional-elaboran-un-consenso-sobre-las-terapias 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/dermatologia-en-europa-impulsa-los-resultados-de-almirall-en-el-primer 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/nuevos-datos-del-programa-de-desarrollo-clinico-de-tildrakizumab 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-financieros-2016-de-almirall-solidos-resultados-en 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-almirall-de-enero-septiembre-2016-fuerte-comportamiento-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-un-plan-de-reestructuracion-en-espana 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-almirall-primer-semestre-2016-crecimiento-en-ingresos-totales 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-bicosome-firman-un-acuerdo-de-colaboracion-y-sublicencia-para 2026-05-27T11:03:58+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-resultados-1t-2016-en-linea-para-alcanzar-las-estimaciones-del 2026-05-27T11:03:58+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-reduce-un-69-su-indice-de-accidentalidad-en-espana-en-2015 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-resultados-anuales-2015-el-resultado-neto-normalizado-aumento-un 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-cierra-la-adquisicion-de-thermigen-llc-entrando-en-el-mercado-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-ejecuta-la-opcion-de-compra-para-adquirir-el-100-de-thermigen 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-alcanza-un-acuerdo-para-adquirir-el-100-de-poli-group 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-acuerda-una-inversion-estrategica-de-15-millones-con-suneva 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/aclidinioformoterol-ha-sido-recomendado-para-su-aprobacion-en-europa-para 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-acuerda-una-transaccion-estrategica-con-astrazeneca-en-el-area 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-almirall-primer-semestre-2014-continua-el-crecimiento 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/forest-laboratories-y-almirall-actualizan-sobre-la-combinacion-de-dosis 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-cierra-el-precio-de-325-millones-de-euros-en-bonos-senior-7-anos 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-reduce-un-20-su-indice-de-accidentalidad-en-espana-en-2013 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-alcanza-un-acuerdo-para-implementar-el-plan-de-reestructuracion 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-llega-un-acuerdo-para-adquirir-aqua-pharmaceuticals-compania 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-un-programa-de-reorganizacion-que-afecta-al-grupo-en 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-alivio-de-los-sintomas-durante-las-24-horas-es-fundamental-para 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-presenta-en-europa-la-solicitud-de-registro-de-la-combinacion-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/aclidinio-elegido-como-una-de-las-mayores-innovaciones-terapeuticas 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-control-de-los-sintomas-las-24-horas-del-dia-proporciona-una-mejoria 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-compania-farmaceutica-almirall-amplia-su-presencia-internacional-con 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-un-50-por-debajo-del-indice-de-accidentalidad-del-sector 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-reafirma-su-compromiso-medioambiental-en-espana-y-alemania 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-pionera-en-espana-en-obtener-el-certificado-sistema-de-gestion 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/una-encuesta-revela-que-dos-de-cada-cinco-personas-menores-de-35-anos-en 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-inicia-su-transformacion 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-mantiene-la-retribucion-al-accionista-gracias-los-resultados-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-laboratories-anuncian-resultados-positivos-del-segundo 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-anuncian-resultados-positivos-de-un-estudio-pivotal-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-presenta-las-ultimas-novedades-en-enfermedades-respiratorias 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/2012-resultados-segun-previsiones-almirall-se-posiciona-para-un 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-coordinacion-entre-profesionales-es-clave-para-una-buena-atencion-al 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-comercializa-neurofarmagen-un-test-genetico-innovador 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-cumple-10-anos-en-italia 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/calendario-financiero-2013 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-nombra-karin-louise-dorrepaal-como-nueva-consejera-independiente 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-3er-trimestre 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/7-de-cada-10-espanoles-no-saben-que-es-la-epoc-o-tienen-un-conocimiento 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-apuesta-por-la-medicina-personalizada-con-su-entrada-en-el 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-incorpora-gerhard-mayr-al-consejo-de-administracion 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/sativex-confirma-beneficios-clinicamente-relevantes-en-espasticidad-en 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-licencia-aclidinio-invida-en-australia-y-nueva-zelanda 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/linaclotida-recibe-la-opinion-positiva-del-chmp-para-el-tratamiento-del 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-obtiene-derechos-para-linaclotida-en-mexico 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-abre-una-nueva-filial-en-canada 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-1er-semestre-excelentes-noticias-en-id-y-previsiones-confirmadas 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/que-medicamentos-tendran-nuestros-hijos-retos-para-equilibrar 2026-05-27T11:04:05+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/abediterol-el-laba-una-vez-al-dia-de-almirall-muestra-superioridad 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/aclidinio-de-almirall-recomendado-para-aprobacion-en-europa-para-el 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-aslan-firman-un-acuerdo-global-para-un-tratamiento-novedoso 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/nueva-orientacion-estrategica-para-el-od-laba-de-almirall-tras-la-exitosa 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-presentan-datos-clinicos-de-bromuro-de-aclidinio-en-la 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-crece-nivel-internacional 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-junta-general-de-accionistas-de-almirall-aprueba-018-euros-por-accion 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-laboratories-anuncian-que-la-fda-ha-extendido-el 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-menarini-firman-un-acuerdo-de-licencia-y-alianza-comercial 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-estudio-attain-con-aclidinio-publicado-en-la-european-respiratory 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-tratamiento-personalizado-de-la-epoc-principal-reto-para-los 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-apoya-la-investigacion-europea-sobre-espasticidad-en-esclerosis 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-resultados-2011-segun-previsiones-y-noticias-positivas-al-inicio 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-anuncian-que-el-comite-asesor-de-la-fda-ha-recomendado 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-vi-reunion-vam-presenta-las-nuevas-evidencias-en-el-tratamiento-de-las 2026-05-27T11:04:06+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/desciende-el-tabaquismo-pasivo-gracias-la-ley-antitabaco-y-se-mantiene-el 2026-05-27T11:04:06+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/bayer-y-almirall-co-promocionaran-el-anticoagulante-rivaroxaban-en-espana 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-cumple-10-anos-en-mexico 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-galapagos-se-alian-en-un-programa-de-investigacion 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-colabora-con-la-fundacion-vicente-ferrer-en-un-proyecto-de 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-comienza-la-fase-iii-del-aclidinio-mas-formoterol-para-el 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/alianza-entre-almirall-y-biofocus-para-identificar-nuevos-compuestos 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-colabora-con-la-sed-en-el-dia-mundial-de-la-diabetes 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/mas-de-la-mitad-de-los-diabeticos-tipo-2-no-tiene-un-control-adecuado-de 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-del-3er-trimestre-almirall-prepara-su-crecimiento-futuro 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/8-de-cada-10-espanoles-no-sabe-que-es-la-epoc 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-linaclotida-proporciona-alivio-largo-plazo-de-los-sintomas-del 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-lundbeck-anuncian-un-acuerdo-de-co-promocion-para-escitalopram 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-la-sociedad-espanola-de-farmacologia-premian-la-investigacion 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-el-roflumilast-en-espana 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-presenta-registro-la-linaclotida-en-europa-para-el-tratamiento 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-nycomed-anuncian-un-acuerdo-de-licencia-para-la-ebastina-en 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/una-nueva-guia-ayudara-los-medicos-en-el-manejo-de-la-osteoporosis 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/los-pacientes-con-epoc-tratados-con-aclidinio-perciben-la-mejoria-desde 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-proteros-firman-un-acuerdo-de-investigacion-para-el-area-de 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-nombra-alfredo-baron-como-director-area-europa-sur-y-este 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-resultados-del-primer-semestre-de-2011 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/presentada-la-solicitud-de-registro-del-bromuro-de-aclidinio-en-europa 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/farid-taha-nuevo-director-general-de-almirall-en-alemania-austria-y-suiza 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-anuncian-la-presentacion-del-registro-del-bromuro-de 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-empresa-comprometida-con-la-formacion-de-los-gestores-sanitarios 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/daniel-martinez-carretero-nombrado-director-general-financiero-chief 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-refuerza-su-compromiso-con-los-pacientes-de-esclerosis-multiple 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-resultados-del-1er-trimestre-en-linea-con-las-previsiones 2026-05-26T16:14:50+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-junta-general-de-accionistas-de-almirall-aprueba-un-dividendo-de-029 2026-05-26T16:14:50+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-presentan-resultados-de-los-estudios-de-fase-iii-con 2026-05-26T16:14:50+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-nycomed-anuncian-un-acuerdo-comercial-para-roflumilast-en 2026-05-26T16:14:50+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-tabaquismo-es-la-enfermedad-respiratoria-mas-frecuente 2026-05-26T16:14:50+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-refuerza-su-franquicia-respiratoria-con-un-tratamiento-de-nueva 2026-05-26T16:14:50+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-apuesta-por-la-formacion-gestores-sanitarios-en-un-modelo 2026-05-26T16:14:53+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-empresa-excelente-segun-el-plan-profarma 2026-05-26T16:14:53+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/ignasi-marti-rague-director-de-relaciones-institucionales-de-almirall 2026-05-26T16:14:53+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/lanzamiento-balneum-intensive-espana 2026-05-26T16:14:53+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-el-nombramiento-de-eduardo-sanchiz-como-nuevo-consejero 2026-05-26T16:14:53+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-resultados-financieros-2010-en-linea-con-las-previsiones 2026-05-26T16:14:53+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-kyorin-anuncian-un-acuerdo-de-licencia-en-japon-con-el-bromuro 2026-05-26T16:14:53+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-nombra-eloi-crespo-nuevo-director-general-industrial 2026-05-26T16:14:53+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-manejo-precoz-del-paciente-diabetico-clave-para-conseguir-una 2026-05-26T16:14:57+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/aprobada-la-financiacion-publica-de-sativex-en-espana-para-el-tratamiento 2026-05-26T16:14:57+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-mexico-recibe-el-distintivo-de-empresa-con-practicas 2026-05-26T16:14:57+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/los-ultimos-avances-debate-en-el-x-symposium-de-psiquiatria-organizado 2026-05-26T16:14:57+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/bertil-lindmark-nuevo-director-general-ejecutivo-id-de-almirall 2026-05-26T16:14:57+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-anuncian-resultados-positivos-del-estudio-attain-de 2026-05-26T16:14:57+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-del-3er-trimestre-en-linea-con-las-previsiones 2026-05-26T16:14:57+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-e-ironwood-anuncian-resultados-positivos-del-segundo-ensayo 2026-05-26T16:14:57+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-anuncian-resultados-preliminares-de-un-estudio-de-fase 2026-05-26T16:14:57+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-apoya-el-programa-de-actividades-puesto-en-marcha-por-la-sed-y 2026-05-26T16:14:57+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-pionera-en-obtener-el-certificado-ohsas-18001-en-materia-de 2026-05-26T16:15:02+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-investigacion-del-dolor-cronico-proyecto-ganador-del-premio-en 2026-05-26T16:15:02+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-ironwood-anuncian-resultados-positivos-de-un-ensayo-clinico-de 2026-05-26T16:15:02+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-del-1er-semestre-en-linea-con-las-previsiones-importante 2026-05-26T16:15:02+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-compromiso-medioambiental-de-almirall-se-reafirma-con-la-renovacion 2026-05-26T16:15:07+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-tratamiento-integral-de-la-diabetes-tipo-2-y-su-cumplimiento-por-parte 2026-05-26T16:15:07+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-presentacion-del-proyecto-neogenius-reune-mas-de-un-centenar-de 2026-05-26T16:15:07+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-organiza-la-i-reunion-de-centros-de-excelencia-en-cardiologia-de 2026-05-26T16:15:07+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-junta-general-de-accionistas-de-almirall-aprueba-un-dividendo-de-033 2026-05-26T16:15:07+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-resultados-del-1er-trimestre-en-linea-con-las-previsiones-0 2026-05-26T16:15:11+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-concede-eisai-la-comercializacion-de-la-cinitaprida-en-china 2026-05-26T16:15:11+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-thiomucase-extreme-areas-el-primer-anticelulitico-en-stick 2026-05-26T16:15:11+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-solidos-resultados-financieros-en-2009 2026-05-26T16:15:11+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/neogenius-alianza-entre-almirall-esteve-palau-pharma-y-proteomika 2026-05-26T16:15:11+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/un-enfoque-multidisciplinar-permite-mejorar-el-tratamiento-y-reducir-el 2026-05-26T16:15:11+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-silodosina-indicada-para-el-tratamiento-de-la-hiperplasia-benigna-de 2026-05-26T16:15:11+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-ix-symposium-de-psiquiatria-organizado-por-almirall-presenta-los 2026-05-26T16:15:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-anuncian-resultados-positivos-del-estudio-de-fase-iii 2026-05-26T16:15:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-laboratories-amplian-su-colaboracion-respiratoria-con 2026-05-26T16:15:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-emeachmp-adopta-una-opinion-positiva-para-la-silodosina 2026-05-26T16:15:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/un-inhibidor-de-la-dhodh-de-almirall-en-el-top-10-de-partnering-windhover 2026-05-26T16:15:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-una-inversion-de-us-15-m-en-el-capital-de-ironwood 2026-05-26T16:15:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/blastoactiva-es-el-primer-reparador-dermocelular-con-centella-asiatica 2026-05-26T16:15:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-la-sociedad-espanola-de-farmacologia-entregan-en-sevilla-el 2026-05-26T16:15:20+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-su-intencion-de-presentar-registro-el-bromuro-de 2026-05-26T16:15:22+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-supera-los-103-millones-de-euros-de-resultado-neto-en-el-primer 2026-05-26T16:15:22+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-imparte-sus-empleados-6500-horas-de-formacion-sobre-prevencion 2026-05-26T16:15:22+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-nombra-nuevo-director-general-en-su-filial-de-polonia 2026-05-26T16:15:22+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-destina-mas-de-52-millones-de-euros-al-pago-de-dividendos-entre 2026-05-26T16:15:22+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-supera-los-63-millones-de-euros-de-resultado-neto-en-el-primer 2026-05-26T16:15:22+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-firma-un-acuerdo-paneuropeo-de-licencia-con-ironwood-para-la 2026-05-26T16:15:22+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/actualizacion-del-pipeline-respiratorio-de-almirall-el-bromuro-de 2026-05-27T11:04:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-abre-sus-puertas-la-industria-farmaceutica-para-celebrar-la 2026-05-26T16:15:27+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/steve-webber-nuevo-director-senior-de-investigacion 2026-05-27T05:31:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-firma-un-acuerdo-de-co-marketing-con-recordati-para-la 2026-05-26T16:15:27+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-logra-un-beneficio-neto-de-1361-millones-de-euros-en-2008-un-38 2026-05-26T16:15:27+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-prometedores-avalan-continuar-el-desarrollo-del-beta-agonista 2026-05-27T11:04:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/entre-un-15-y-un-20-de-la-poblacion-sufrira-una-depresion-lo-largo-de-su 2026-05-27T11:04:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/con-los-prometedores-resultados-del-beta-agonista-de-larga-duracion-laba 2026-05-26T16:15:27+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/marc-ayas-nuevo-director-de-recursos-humanos-internacional-compensacion 2026-05-26T16:15:27+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-ranke-quimica-redujo-el-indice-de-frecuencia-de-accidentes-en-un 2026-05-26T16:15:27+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-obtiene-unos-ingresos-totales-de-cerca-de-809-millones-de-euros 2026-05-26T16:15:31+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-firma-un-acuerdo-con-pfizer-para-la-comercializacion-de-un 2026-05-26T16:15:31+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-firma-un-acuerdo-de-co-marketing-con-msd-para-la 2026-05-26T16:15:31+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/daniel-martinez-ocupa-el-nuevo-puesto-de-director-financiero-corporativo 2026-05-26T16:15:31+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-renueva-su-web-corporativa-wwwalmirallcom 2026-05-26T16:15:31+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-sigue-adelante-con-el-desarrollo-del-bromuro-de-aclidinio 2026-05-26T16:15:31+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/sociedad-espanola-de-farmacologia-conceden-el-premio-en-farmacologia-2008 2026-05-27T11:04:19+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-equipo-de-marketing-y-ventas-de-almirall-en-alemania-ha-recibido-el 2026-05-27T11:04:19+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/estudios-de-fase-iii-muestran-una-diferencia-estadisticamente 2026-05-26T16:15:31+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/aclaracion-sobre-una-noticia-erronea-relacionada-con-una-oferta-de-compra 2026-05-26T16:15:31+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-obtiene-unos-ingresos-totales-de-cerca-de-547-millones-de-euros 2026-05-26T16:15:36+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-un-principio-de-acuerdo-para-la-venta-de-la-planta-de 2026-05-26T16:15:36+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-resultados-de-exito-en-su-colaboracion-con-proteros 2026-05-26T16:15:36+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-finaliza-los-estudios-de-fase-iii-del-bromuro-de-aclidinio 2026-05-26T16:15:36+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/medicos-y-farmaceuticos-unifican-criterios-en-el-abordaje-de-las 2026-05-26T16:15:36+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/philippe-bouissou-nuevo-director-senior-de-desarrollo-de-almirall 2026-05-26T16:15:36+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/estudios-clinicos-revelan-resultados-positivos-del-bromuro-de-aclidinio 2026-05-26T16:15:36+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-obtiene-unos-ingresos-totales-de-269-millones-de-euros-en-el 2026-05-26T16:15:36+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-destina-un-dividendo-del-40-para-remunerar-sus-accionistas 2026-05-26T16:15:36+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-fortalece-su-expansion-europea-con-la-apertura-de-nuevas 2026-05-26T16:15:36+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-resultados-prometedores-con-un-nuevo-compuesto-para-el 2026-05-26T16:15:40+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/israel-garcia-y-ma-eugenia-vellve-nuevos-directores-generales-de-almirall 2026-05-26T16:15:40+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-alcanza-los-917-millones-de-euros-de-ingresos-totales-en-2007 2026-05-27T05:30:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/carlos-gallardo-director-general-de-almirall-en-reino-unido-e-irlanda 2026-05-26T16:15:40+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-refuerza-su-presencia-en-europa-con-la-apertura-de-una-filial-en 2026-05-26T16:15:40+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-cierra-la-adquisicion-de-una-cartera-de-8-productos-shire-plc 2026-05-26T16:15:40+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-aporta-casi-2-millones-de-euros-para-renovar-el-acuerdo-de 2026-05-26T16:15:40+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-incrementa-sus-ventas-netas-en-un-38 2026-05-26T16:15:40+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/christophe-vandeputte-y-dominique-humblet-nuevos-directores-generales-de 2026-05-26T16:15:40+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/anselm-divi-nuevo-director-corporativo-de-recursos-humanos-de-almirall 2026-05-26T16:15:40+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-adquiere-una-cartera-de-8-productos-shire-plc-por-213-millones 2026-05-26T16:15:44+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/klaus-melchers-nuevo-director-senior-de-investigacion-de-almirall 2026-05-26T16:15:44+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-la-sociedad-espanola-de-farmacologia-conceden-el-premio-en 2026-05-26T16:15:44+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-bromuro-de-aclidinio-demuestra-un-rapido-y-prolongado-efecto 2026-05-26T16:15:44+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-cierra-el-proceso-de-adquisicion-de-hermal-tras-recibir-la 2026-05-26T16:15:44+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-cierra-la-adquisicion-de-hermal-despues-de-haber-recibido-la 2026-05-26T16:15:44+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-semestrales-de-almirall-en-el-ejercicio-de-2007-almirall 2026-05-26T16:15:44+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-alcanza-una-cifra-de-negocio-de-4129-millones-de-euros 2026-05-26T16:15:44+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/gonzalo-de-miquel-nuevo-director-global-medico-del-area-de-id-de-almirall 2026-05-26T16:15:44+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-renueva-el-certificado-de-gestion-medioambiental-iso-140012004 2026-05-27T11:04:21+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-debuta-en-la-bolsa-espanola-con-un-precio-de-14-euros-por-accion 2026-05-26T16:15:48+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-inicia-su-cotizacion-en-la-bolsa-espanola-con-un-repunte-de-un 2026-05-26T16:15:48+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/jordi-molina-alsina-manager-del-departamento-de-relaciones-con-inversores 2026-05-26T16:15:48+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-CNMV-registra-el-folleto-de-oferta-publica-de-venta-y-suscripcion-de 2026-05-26T16:15:48+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-contemplara-en-la-oferta-de-salida-bolsa-un-tramo-para-empleados 2026-05-26T16:15:48+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-certifica-su-sistema-de-gestion-de-prevencion-de-riesgos 2026-05-26T16:15:48+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-selecciona-morgan-stanley-y-santander-para-la-siguiente-fase-de 2026-05-26T16:15:48+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-su-intencion-de-cotizar-en-la-bolsa-espanola 2026-05-26T16:15:48+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-estres-y-la-ansiedad-entre-las-principales-causas-de-la-acidez-en 2026-05-27T11:04:24+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-concede-el-premio-en-farmacologia-2006-durante-el-congreso-de-la 2026-05-27T11:04:24+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-renueva-su-colaboracion-con-sareum-sobre-biologia-estructural 2026-05-27T11:04:24+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-una-alianza-estrategica-con-la-compania-sueca-meda 2026-05-27T11:04:24+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/su-majestad-el-rey-inaugura-el-nuevo-centro-de-investigacion-y-desarrollo 2026-05-27T11:04:24+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-nuevo-centro-de-investigacion-y-desarrollo-de-almirall-un-referente-en 2026-05-27T11:04:24+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-crece-un-12-en-el-mercado-farmaceutico-internacional 2026-05-27T11:04:24+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-dr-carsten-niederlander-nuevo-director-de-desarrollo-farmaceutico 2026-05-27T11:04:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-anuncian-un-acuerdo-de-colaboracion-para-el-desarrollo 2026-05-27T11:04:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-dr-john-efthimiou-nuevo-global-medical-director-de-id-de-almirall 2026-05-27T11:04:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-hara-publicos-sus-ensayos-clinicos 2026-05-27T11:04:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-dr-olof-andersson-nuevo-director-general-ejecutivo-del-area-de-id-de 2026-05-27T11:04:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-conmemora-el-5-aniversario-de-almogran-su-medicamento-de-id 2026-05-27T11:04:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-concede-la-farmaceutica-merz-la-comercializacion-de-almogran-en 2026-05-27T11:04:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-italia-firma-un-acuerdo-con-altana-pharma-ag-para-la 2026-05-27T11:04:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-concede-el-premio-en-farmacologia-2005 2026-05-27T11:04:34+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-un-acuerdo-de-colaboracion-con-sareum-para-la 2026-05-27T11:04:34+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-un-acuerdo-de-colaboracion-de-larga-duracion-con-evotec 2026-05-27T11:04:34+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-presenta-resultados-prometedores-de-su-compuesto-broncodilatador 2026-05-27T11:04:34+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/segun-la-encuesta-de-la-pagina-web-de-el-club-de-la-farmacia-un-portal-al 2026-05-27T11:04:34+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-alcanza-unas-ventas-de-900-millones-de-euros-en-el-ano-2004 2026-05-27T11:04:34+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-licencia-neurocrine-biosciences-un-programa-de-investigacion 2026-05-27T11:04:34+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-toma-la-decision-estrategica-de-comercializar-el-almotriptan-en 2026-05-27T11:04:39+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-aumenta-un-64-las-ventas-en-el-ano-2003 2026-05-27T11:04:39+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-almotriptan-consigue-la-aprobacion-para-ser-comercializado-en-canada 2026-05-27T11:04:39+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-recibe-el-certificado-de-gestion-medioambiental-iso-1400196 2026-05-27T11:04:39+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-concede-el-premio-en-farmacologia-2003-123 2026-05-27T11:04:39+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/canada-otra-aprobacion-historica-para-el-almotriptan 2026-05-27T11:04:39+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-presenta-su-nuevo-web-corporativo 2026-05-27T11:04:39+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-concede-la-licencia-del-almotripan-ortho-mcneil-pharmaceutical 2026-05-27T11:04:39+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-prodesfarma-consolida-su-expansion-internacional-con-la-apertura 2026-05-27T11:04:43+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-prodesfarma-concede-el-premio-de-farmacologia-2002 2026-05-27T11:04:43+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-prodesfarma-invierte-30-millones-de-euros-en-un-nuevo-centro-de 2026-05-27T11:04:43+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/un-estudio-comparativo-situa-almogran-como-una-de-las-mejores-opciones 2026-05-27T11:04:43+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-prodesfarma-inaugura-un-nuevo-laboratorio-en-el-parc-cientific 2026-05-27T11:04:43+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-prodesfarma-se-implanta-en-francia-con-la-adquisicion-del 2026-05-27T11:04:43+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-prodesfarma-obtiene-la-licencia-para-el-desarrollo-y 2026-05-27T11:04:43+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-almotriptan-2-almogran-recibe-la-autorizacion-de-la-fda-para-su 2026-05-27T11:04:43+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-prodesfarma-adquiere-prasfarma 2026-05-27T11:04:48+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-la-unica-compania-farmaceutica-galardonada-con-el-premio-la 2026-05-27T14:15:52+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-gw-anuncian-un-acuerdo-europeo-de-desarrollo-y 2026-05-27T14:16:08+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-spa-ha-sido-galardonada-con-el-premio-la-mejor-empresa-espanola 2026-05-27T14:16:40+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/un-estudio-clinico-confirma-que-sativex-consigue-mejoras-en-la 2026-05-27T14:17:07+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-que-ha-recibido-15-millones-de-dolares-105eu-millones-de 2026-05-27T14:17:51+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/sativex-aprobado-en-alemania-para-el-tratamiento-de-la-espasticidad-en-la 2026-05-27T14:18:13+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/sativex-recibe-la-aprobacion-regulatoria-en-espana 2026-05-27T14:18:34+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/sativex-aprobado-en-dinamarca-para-el-tratamiento-de-la-espasticidad-en 2026-05-27T14:18:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-en-espana-solaraze-para-el-tratamiento-de-la-queratosis 2026-05-27T14:19:10+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-laboratories-anuncian-la-aprobacion-de-tudorza-pressair 2026-05-27T14:19:56+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-eklira-genuair-aclidinio-en-europa 2026-05-27T14:20:26+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-laboratories-anuncian-que-tudorza-pressair-ya-esta 2026-05-27T14:20:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/constella-linaclotida-un-medicamento-first-class-de-prescripcion-aprobado 2026-05-27T14:21:14+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/index-pharmaceuticals-y-almirall-firman-un-acuerdo-de-licencia-para-los 2026-05-27T14:22:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-adquiere-los-derechos-de-veltin-y-altabax-de-stiefel-compania-de 2026-05-27T14:22:42+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-nuevolution-firman-una-colaboracion-estrategica-para 2026-05-27T14:23:12+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-skilarence-en-europa-para-psoriasis-cronica-en-placa-de 2026-05-27T14:23:52+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-comision-europea-aprueba-ilumetri-tildrakizumab-de-almirall-para-la 2026-05-27T14:24:21+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-fda-aprueba-seysara-una-nueva-entidad-quimica-para-el-tratamiento-de 2026-05-27T14:24:49+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-ilumetri-para-la-psoriasis-cronica-en-placa-de-moderada 2026-05-27T14:25:17+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-fda-aprueba-duakli-un-nuevo-farmaco-para-tratar-la-enfermedad 2026-05-27T14:26:49+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-premiada-por-un-indice-cero-en-frecuencia-de-accidentes-durante 2026-05-27T14:27:22+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/actikerall-se-lanza-en-el-reino-unido-para-el-tratamiento-de-la 2026-05-27T14:27:51+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-sepd-en-colaboracion-con-almirall-presenta-el-libro-el-paciente-con 2026-05-27T14:28:17+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-refuerza-su-negocio-en-alemania-con-dos-nuevos-productos-sativex 2026-05-27T14:28:24+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/los-resultados-de-fase-iii-destacan-la-eficacia-y-tolerabilidad-de 2026-05-27T14:28:32+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/sativex-inicia-otra-ronda-de-aprobaciones-regulatorias-en-europa 2026-05-27T14:29:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-amplia-los-derechos-de-comercializacion-de-sativex-mexico 2026-05-27T14:29:24+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/sativex-recomendado-para-aprobacion-en-diez-paises-tras-el-proceso 2026-05-27T14:29:37+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/sativex-inicia-un-tercer-ensayo-clinico-de-fase-iii-para-dolor-oncologico 2026-05-27T14:29:44+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/eklirabretaris-genuair-aprobado-en-europa-como-tratamiento-de 2026-05-27T14:30:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/eklira-genuair-proporciona-una-broncodilatacion-significativa-y-sostenida 2026-05-27T14:30:20+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/constella-linaclotida-aprobada-en-europa-para-el-sindrome-del-intestino 2026-05-27T14:30:29+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/eklira-genuair-de-almirall-disponible-en-espana-para-el-tratamiento-de-la 2026-05-27T14:30:38+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/nuevos-datos-refuerzan-la-eficacia-y-perfil-de-seguridad-de-sativex-para 2026-05-27T14:30:47+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-nice-aprueba-de-forma-provisional-ilumetri-v-tildrakizumab-como-una 2026-05-27T14:31:04+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-presenta-me-my-inner-circle-una-campana-para-destacar-el-apoyo 2026-05-27T14:31:21+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-adquiere-hermal-la-compania-europea-de-prescripcion-especialista 2026-05-27T14:32:17+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-en-espana-efficib-combinacion-de-sitagliptina-y-metformina 2026-05-27T14:32:31+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-la-presentacion-del-dossier-de-registro-de-sativex 2026-05-27T14:32:36+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-la-presentacion-del-dossier-de-registro-de-sativex-0 2026-05-27T14:32:42+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-fda-ha-aprobado-el-almotriptan-axertalmogran-para-el-tratamiento-de-la 2026-05-27T14:32:53+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/actualizacion-sobre-eklira-bromuro-de-aclidinio-para-el-tratamiento-de-la 2026-05-27T14:33:06+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-parapres-plus-32-y-parapres-plus-forte-para-el-tratamiento 2026-05-27T14:33:19+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-centra-sus-esfuerzos-en-la-dosificacion-de-eklira-dos-veces-al 2026-05-27T14:33:48+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-antihistaminico-ebastel-ebastina-cumple-20-anos 2026-05-27T14:33:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-la-fundacio-galatea-del-consell-de-collegis-de-metges-de 2026-05-27T14:35:51+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-recibe-el-premio-principe-felipe-la-competitividad-empresarial 2026-05-27T14:36:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-forest-presentan-resultados-positivos-de-eklira-para-la 2026-05-27T14:36:14+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-que-sativex-recibe-la-aprobacion-regulatoria-en-espana 2026-05-27T14:36:21+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/las-autoridades-regulatorias-del-reino-unido-y-espana-confirman-que 2026-05-27T14:36:27+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-que-las-autoridades-regulatorias-del-reino-unido-y 2026-05-27T14:36:35+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-anuncia-un-acuerdo-internacional-con-basilea-para-comercializar 2026-05-27T14:36:55+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-firma-un-acuerdo-de-co-promocion-con-pfizer-para-la 2026-05-27T14:37:02+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-recibe-la-calificacion-de-empresa-excelente-otorgada-por-el 2026-05-27T14:37:14+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/conbriza-bazedoxifeno-aprobado-por-la-aemps-para-el-tratamiento-de-la 2026-05-27T14:37:34+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/lanzamiento-en-espana-de-urorecsilodyxtm-un-novedoso-tratamiento-para-los 2026-05-27T14:37:43+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/informacion-clinica-de-sativex-presentada-en-el-congreso-ectrims-resalta 2026-05-27T14:37:50+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/sativex-inicia-el-desarrollo-clinico-de-la-fase-iii-en-dolor-oncologico 2026-05-27T14:37:55+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/sativex-lanzado-en-espana-para-el-tratamiento 2026-05-27T14:37:59+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/sativex-obtiene-la-recomendacion-para-aprobacion-en-seis-paises-europeos 2026-05-27T14:38:03+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/las-autoridades-sanitarias-confirman-que-actikerall-es-aprobable-para-el 2026-05-27T14:38:11+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-recibe-la-aprobacion-de-la-comision-europea-de-klisyrirv 2026-05-27T14:40:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-recibe-el-premio-fundamed-el-global-la-mejor-compania 2026-05-27T15:07:47+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/nuevos-datos-avalan-la-seguridad-y-la-eficacia-del-bazedoxifeno-para 2026-05-27T15:18:38+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-licencia-el-aclidinio-daewoong-en-corea 2026-05-27T15:19:37+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-alcanza-una-cifra-de-ventas-netas-de-7013-millones-de-euros-con 2026-05-27T15:20:26+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-1er-semestre-en-ejecucion-comercial-de-las-plataformas-de 2026-05-27T15:22:17+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-almirall-primer-trimestre-2014-crecimiento-acelerado 2026-05-27T15:23:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-3er-trimestre-en-linea-con-las-previsiones-anuales-continuan-los 2026-05-27T15:23:36+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-resultados-anuales-2013-sentando-las-bases 2026-05-27T15:25:25+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-resultados-anuales-2014-en-linea-con-las-previsiones 2026-05-27T15:28:23+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-almirall-primer-trimestre-2015-crecimiento-acelerado-impulsado 2026-05-27T15:28:39+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-de-almirall-enero-septiembre-2015-mejora-del-comportamiento 2026-05-27T15:31:34+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-almirall-primer-semestre-2015-crecimiento-impulsado-por-el 2026-05-27T15:31:47+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-financieros-2018-de-almirall 2026-05-27T15:32:37+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-1s-2019-solido-impulso-del-negocio-y-consolidacion-del-pipeline 2026-05-27T15:32:49+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-en-el-1t-2019-solido-rendimiento-operativo 2026-05-27T15:33:00+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-financieros-2020 2026-05-27T15:37:32+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/las-ventas-netas-de-almirall-alcanzaron-los-232-meu-y-aumentaron-un-6 2026-05-27T15:44:39+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-de-almirall-en-los-nueve-meses-de-2022-almirall-logra-unas 2026-05-27T15:44:54+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-de-almirall-en-2022-almirall-cierra-2022-con-un-crecimiento-de 2026-05-27T15:45:32+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-alcanza-un-crecimiento-de-las-ventas-netas-del-7-hasta-los-4661 2026-05-27T15:47:58+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-logra-un-crecimiento-de-las-ventas-netas-del-64-impulsado-por 2026-05-27T15:49:02+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-del-primer-trimestre-de-2024-almirall-logra-un-solido-comienzo 2026-05-27T15:49:35+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-inicia-el-ano-con-solido-crecimiento-en-ventas-totales-y 2026-05-27T15:50:10+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-supera-sus-estimaciones-y-entra-en-una-era-de-crecimiento 2026-05-27T15:50:47+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-del-tercer-trimestre-de-2024-almirall-alcanza-un-solido 2026-05-27T15:51:50+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-crece-un-128-en-ventas-netas-impulsado-por-su-solido-desempeno 2026-05-27T15:52:25+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-financieros-del-primer-semestre-2025-almirall-impulsa-su 2026-05-27T15:52:57+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-absci-amplian-la-colaboracion-para-la-creacion-de-farmacos-con 2026-05-27T15:58:11+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-mantiene-su-trayectoria-positiva-en-linea-con-las-expectativas 2026-06-25T10:16:33+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/las-unidades-especificas-para-trastornos-digestivos-funcionales-permiten 2026-06-25T10:41:33+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/las-manchas-solares-debidas-la-exposicion-al-sol-de-forma-cronica-pueden 2026-06-25T11:11:49+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/las-cifras-de-la-farmacia-espanola-rompen-la-tendencia-negativa-de-los 2026-06-29T06:52:42+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-fundacio-institut-de-investigacion-en-ciencies-de-la-salut-germans 2026-06-29T06:53:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/rino-ebastelr-optimiza-la-app-polen-control-para-un-mejor-control-de-los 2026-06-29T06:53:08+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-almirall-smart-glass-program-va-permitir-crear-una-aplicacion-pionera 2026-06-29T06:53:27+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/se-edita-la-guia-irpf-2014-para-la-oficina-de-farmacia 2026-06-29T06:54:09+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/el-anuncio-de-television-almax-contra-la-acidez-en-1-minuto-de-almirall 2026-06-29T06:54:22+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/los-sellos-de-calidad-online-mas-prestigiosos-en-informacion-sanitaria 2026-06-29T06:54:41+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/se-estima-que-hasta-un-10-de-la-queratosis-actinica-puede-derivar-en 2026-06-29T07:11:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-announces-global-licensing-agreement-patagonia-congenital 2026-06-29T07:14:01+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-aplifarma-se-alian-para-ofrecer-autoinspeccion-integral-las 2026-06-29T07:34:05+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/dermatologos-europeos-debaten-sobre-los-ultimos-tratamientos-e 2026-06-29T07:37:04+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/primer-consenso-europeo-sobre-el-uso-clinico-dimetilfumarato 2026-06-29T08:01:13+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-construye-la-planta-fotovoltaica-de-autoconsumo-mas-grande-de 2026-06-29T08:26:15+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-healthcare-ofrece-los-pacientes-con-dolor-una-web-para-conocer 2026-06-29T08:57:25+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-una-campana-social-para-aumentar-la-concienciacion-sobre 2026-07-02T07:40:16+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/14-de-septiembre-dia-mundial-de-la-dermatitis-atopica 2026-07-02T07:45:48+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-reduce-un-16-el-consumo-de-agua-en-espana-y-se-acerca-su 2026-07-02T07:47:28+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-lanza-la-campana-hats-para-visibilizar-la-queratosis-actinica-la 2026-07-02T07:49:21+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-y-etherna-firman-una-alianza-multidiana-para-desarrollar 2026-07-02T07:52:46+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-inicia-una-colaboracion-con-el-centro-de-regulacion-genomica-crg 2026-07-02T07:53:24+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-concede-el-premio-en-farmacologia-2004 2026-07-03T08:43:31+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-pone-en-marcha-en-espana-la-iniciativa-skin-scouts-observa 2026-09-08T07:55:10+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/thermi-y-sinclair-finalizan-su-acuerdo-de-comercializacion-de-silhouette 2026-09-08T07:59:04+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/resultados-financieros-en-el-9m-de-2019-continua-el-impulso-del-negocio 2026-09-08T08:00:29+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/la-ema-acepta-la-solicitud-de-almirall-para-el-registro-pediatrico-de-su 2026-09-08T08:09:38+00:00 weekly 1 https://pre.almirall.es/prensa-medios/sala-prensa/almirall-impulsa-su-crecimiento-con-un-aumento-del-75-en-ventas 2026-09-08T08:20:12+00:00 weekly 1 https://pre.almirall.es/dermatologia/acne 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/otras-areas-terapeuticas/alergia-alergenos-sintomas-diagnostico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/alopecia-areata 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/cancer-queratinocitos 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/dermatitis-atopica 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/otras-areas-terapeuticas/diabetes 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/alopecia-areata/diagnostico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/dermatitis-atopica/diagnostico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras/epidermolisis-bullosa-congenita/diagnostico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/hidradenitis-supurativa/diagnostico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/onicomicosis/diagnostico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/psoriasis/diagnostico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras/pustulosis-palmoplantar/diagnostico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/queratosis-actinica/diagnostico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/acne/diagnostico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/cancer-queratinocitos/diagnostico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/vitiligo/diagnostico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/otras-areas-terapeuticas/dolor-cronico 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/otras-areas-terapeuticas/dolor-espalda-lumbalgia 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/otras-areas-terapeuticas/enfermedades-cardiovasculares 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras/epidermolisis-bullosa-congenita 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/otras-areas-terapeuticas/espasticidad-esclerosis-multiple 2026-09-04T15:10:48+00:00 weekly 1 https://pre.almirall.es/dermatologia/alopecia-areata/factores-desencadenantes 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/dermatitis-atopica/factores-desencadenantes 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras/epidermolisis-bullosa-congenita/factores-desencadenantes 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/hidradenitis-supurativa/factores-desencadenantes 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/onicomicosis/factores-desencadenantes 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/psoriasis/factores-desencadenantes 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras/pustulosis-palmoplantar/factores-desencadenantes 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/queratosis-actinica/factores-desencadenantes 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/acne/factores-desencadenantes 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/cancer-queratinocitos/factores-desencadenantes 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/vitiligo/factores-desencadenantes 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/hidradenitis-supurativa 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/onicomicosis 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/otras-areas-terapeuticas 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/otras-areas-terapeuticas/problemas-digestivos 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/psoriasis 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras/pustulosis-palmoplantar 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/queratosis-actinica 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/alopecia-areata/signos-sintomas 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/dermatitis-atopica/signos-sintomas 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras/epidermolisis-bullosa-congenita/signos-sintomas 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/hidradenitis-supurativa/signos-sintomas 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/onicomicosis/signos-sintomas 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/psoriasis/signos-sintomas 2026-09-04T15:10:56+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras/pustulosis-palmoplantar/signos-sintomas 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/queratosis-actinica/signos-sintomas 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/acne/signos-sintomas 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/cancer-queratinocitos/signos-sintomas 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/vitiligo/signos-sintomas 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/acne/tipos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/alopecia-areata/tipos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/cancer-queratinocitos/tipos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/dermatitis-atopica/tipos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras/epidermolisis-bullosa-congenita/tipos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/hidradenitis-supurativa/tipos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/onicomicosis/tipos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/psoriasis/tipos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras/pustulosis-palmoplantar/tipos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/queratosis-actinica/tipos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/vitiligo/tipos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras/epidermolisis-bullosa-congenita/tratamientos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/hidradenitis-supurativa/tratamientos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/psoriasis/tratamientos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/enfermedades-cutaneas-raras/pustulosis-palmoplantar/tratamientos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/queratosis-actinica/tratamientos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/vitiligo/tratamientos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/dermatitis-atopica/tratamientos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/acne/tratamientos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/cancer-queratinocitos/tratamientos 2026-09-04T15:11:03+00:00 weekly 1 https://pre.almirall.es/dermatologia/alopecia-areata/tratamientos 2026-09-04T15:11:10+00:00 weekly 1 https://pre.almirall.es/dermatologia/onicomicosis/tratamientos 2026-09-04T15:11:10+00:00 weekly 1 https://pre.almirall.es/dermatologia/vitiligo 2026-09-04T15:11:10+00:00 weekly 1